Top ▲

The IUPHAR/BPS Guide to PHARMACOLOGY complete ligand list

All peptide in GtoPdb, both endogenous (encoded in human, rat and mouse genomes) and synthetic, semi-synthetic and natural peptides encoded in genomes other than human, rat and mouse (including oligopeptides and cyclic peptides).
Ligand name ID Synonyms
A Back to top
A-71378 894 A 71378, A71378
A-71623 858 A 71623, A71623, L-phenylalaninamide
A-71915 4856 A 71915, A71915, H-3048
A8Δ71-73 5780
abaloparatide Approved drug 8299 BA058, Tymlos®
abarelix Approved drug 1188 Plenaxis®, PPI 149, R 3827
abatacept Approved drug Immunopharmacology Ligand 6891 BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077
A13:B7-24-GG 14153
A(4-24)(B7-24)H2 8346 A(4-24)(B7-24)H2 relaxin
A(4-24)(B7-24)H2 chain A 8347 A(4-24)H2 relaxin
A(4-24)(B7-24)H2 chain B 8348 (B7-24)H2 relaxin
abicipar pegol 8371 AGN-150998, MP0112
ABS-201 5308 ABS 201, ABS201, HPI-201, HPI201, KK13
ABS-212 5307 ABS 212, ABS212
Abz-Ser-Pro-Tyr(NO2)-OH 5132 o-aminobenzoyl-Ser-Pro-Tyr(NO2)-OH, TBC5182
AC-178,335 2065 AC 178335
AC187 689 AC 187, AC-187, acetyl-(Asn30,Tyr32)-calcitonin8-32, salmon calcitonin (8-32) reduced
Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH2 1342
Ac-[13C,15N]PGP Ligand is labelled Ligand is radioactive 12599
[Ac-D-2Nal1,D4CPA2,D-3Pal3,6,Leu8, D-Ala10]GnRH-II 5583
Ac-GRP-(20-26)-methylester 625 N-acetyl-GRP-(20-26)-ethylester
[Ac-His1]PACAP-27 2263 [Ac-His1]pituitary adenylate cyclase activating polypeptide-27
[125I][Ac-His1]PACAP-27 Ligand is labelled Ligand is radioactive 2260 [125I]-[Ac-His1]pituitary adenylate cyclase activating polypeptide-27
Ac-hMCH-(6-16)-NH2 1290 hAc-MCH(6-16)-NH2, human Ac-MCH6-16-NH2
A(Δ10/15C)INSL3 8332
aclerastide 8300 DSC-127, DSC127, NorLeu3-A(1-7)
Ac-Lys-[MeAla6,Leu8,des-Arg9]bradykinin 651 N-acetylated-[Lys,MeAla6,Leu8,des-Arg9]bradykinin, Ac-[MeAla6,Leu8,des-Arg9]kallidin
AcPhe-Orn-Pro-D-Cha-Trp-Arg 3853 AcF[OP-D-Cha-Wr]
Ac-Phe-Trp-Ala-His(τBZL)-Nip-Gly-Arg-NH2 6191
Ac-RHYPLWR 8380
Ac-RYYRIK-NH2 1679
Ac-RYYRWK-NH2 1680
Ac-SDKP Immunopharmacology Ligand 10060 goralatide, seraspenide
A(C10/15S)INSL3 8331
ACTH  {Sp: Human} Approved drug Immunopharmacology Ligand 3633 Acthar®, adrenocorticotropic hormone (1-39), corticotropin
ACTH  {Sp: Mouse, Rat} 1331 ACTH (1-39), adrenocorticotrophin, adrenocorticotropic hormone (1-39), corticotropin
ACTH-(11-24) 1332 ACTH (11-24), adrenocorticotropic hormone (11-24)
ACTH-(1-24) 1330 ACTH (1-24), adrenocorticotropic hormone (1-24)
[125I]ACTH-(1-24) Ligand is labelled Ligand is radioactive 3767 [125I]-ACTH(1-24), [125I]-adrenocorticotropin(1-24)
activin A  {Sp: Human} 4857
activin AB  {Sp: Human} 4858
activin B  {Sp: Human} 4859
[Ac-Tyr1, D-Arg2]GHRH-(1-29)-NH2 (human) 1125
acyl-CoA-binding protein  {Sp: Human} 13696 endozepine
adaptavir 11692 D-Ala-peptide T-amide, DAPTA
adiponectin  {Sp: Human} 3726 flAdipo
ADP400 14562
ADP355 amide Immunopharmacology Ligand 14561 ADP 355-P-AlaNH2, ADP-355 amide, ADP355-NH2, SEQ ID NO: 6 [WO2012142142]
ADP-ribosylation factor 1  {Sp: Human} 5305 Arf1, ARF-1
adrenomedullin  {Sp: Human} Immunopharmacology Ligand 683 AM
adrenomedullin  {Sp: Mouse} 3589 AM, mouse adrenomedullin
adrenomedullin  {Sp: Rat} 697 AM
[125I]adrenomedullin Ligand is labelled Ligand is radioactive 3768 [125I]-adrenomedullin, [125I]-AM
adrenomedullin-(22-52) (human) 706 AM (22-52), AM-(22-52) (human), human adrenomedullin (22-52)
adrenomedullin 2/intermedin  {Sp: Human} 684 AM2/IMD
adrenomedullin 2/intermedin  {Sp: Mouse} 3590
adrenomedullin 2/intermedin  {Sp: Rat} 3591
adrenomedullin-(11-50) (rat) 704 AM (11-50), rat adrenomedullin (11-50)
adrenomedullin-(20-50) (rat) 705 rat adrenomedullin (20-50)
adropin  {Sp: Human} 9573
AF12198 Immunopharmacology Ligand 4861 AF 12198, AF-12198
A(4-24)(F23A)H2 8349
afamelanotide Approved drug 1324 α-NDP-MSH, [Nle4,dPhe7]α-MSH, CUV-1647, CUV1647, NDP-MSH, Scenesse®
aflibercept Approved drug 6786 AVE0005, Eylea®, VEGF Trap, Zaltrap®, ziv-aflibercept
AFT-II 2613 neurotoxin-2, Toxin AFII, Toxin AFT-II
ω-agatoxin IIIA 2528 omega-Aga-IIIA, Omega-agatoxin-Aa3a
ω-agatoxin IVA 2529 omega-Aga-IVA, Omega-agatoxin-Aa4a
ω-agatoxin IVB 2530 Omega-agatoxin-Aa4b
agouti  {Sp: Human} 3609
agouti  {Sp: Mouse} 1329 ASIP
agouti  {Sp: Rat} 3610
agouti-related protein  {Sp: Human} 1335 AGRP, agouti-related peptide
agouti-related protein  {Sp: Mouse} 3611 AGRP, agouti-related peptide
agrin  {Sp: Human} 5319
A(10-24)INSL3 8330
A(9-26)INSL3 8329
AL-78898A Immunopharmacology Ligand 9219 4(1MeW), POT-4
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2 5573 [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-34-NH2, M-PTH(1-34)
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-21)-NH2 (human) 5575 [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]hPTH-(1-21)-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-21-NH2 (human), M-PTH(1-21)
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-28)-NH2 (human) 5574 [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-28-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-28-NH2 (human), M-PTH(1-28)
[Ala1,12,Aib3,Gln10,hArg11,Trp14]PTH-(1-14)-NH2 5576 [Ala1,12,Aib3,Gln10,hArg11,Trp14]-hPTH 1-14-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14]-PTH 1-14-NH2 (human), M-PTH(1-14)
[Ala31,Aib32]NPY 1560
[Ala31,Aib32]NPY (pig) 1522
[Ala11, D-Leu15]orexin-B 1700
[Ala6, D-Trp8]galanin-(1-15)-ol 6146
[Ala1,3,11,15]ET-1 3837 [Ala1,3,11,15]endothelin-1
[125I][Ala1,3,11,15]ET-1 Ligand is labelled Ligand is radioactive 3760 [125I]-[Ala1,3,11,15]endothelin-1, [125I][Ala1,3,11,15]endothelin-1
alafosfalin PDB Ligand 9503 alaphosphin
[2Ala]-galparan 6098
β-Ala-Lys-AMCA Ligand is labelled 9501 β-alanyl-lysyl-N-7-amino-4-methylcoumarin-3-acetic acid, Beta-Ala-Lys-N(epsilon)-AMCA
alamandine  {Sp: Human, Mouse, Rat} 6065
[βAla8]neurokinin A-(4-10) 2112 [βAla8]neurokinin A (4-10)
alarelin 9342
alarin  {Sp: Rat} 6123
[Ala11,22,28]VIP 2278 [Ala11,22,28]vasoactive intestinal peptide
albiglutide Approved drug 7386 Eperzan®, GSK716155, Tanzeum®
alboverticillin 14256 triculamin
albutensin A 10226
aldafermin 11546 M70, NGM-282, NGM282
alefacept Approved drug Immunopharmacology Ligand 6787 Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip
alglucosidase alfa Approved drug 7561 Lumizyme®, Myozyme®, rhGAA
ALM201 11485
alpha1-proteinase inhibitor Approved drug 7487 A1AT, A1PI, alpha 1-antitrypsin, Aralast®, Prolastin®, serum trypsin inhibitor
AlprolixTM Approved drug 7373
alunacedase alfa 11320 APN01, GSK-2586881, GSK2586881, rhsACE2
ALX40-4C 607 ALX 40-4C, N-alpha-acetyl-nona-D-arginine amide acetate
AM3 5635 DOTA-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-D-Trp-Lys-Thr-Cys)
AM-6120 Immunopharmacology Ligand 10119 AM6120, peptide 41 [PMID: 30346167]
amanitin 4632 α-amanitin
AMG3054 9587
amphiregulin  {Sp: Human} Immunopharmacology Ligand 4864 colorectal cell-derived growth factor (CRDGF)
AMT-101 Immunopharmacology Ligand 11645
AMY-101 11986 AMY101, Compstatin 40, Compstatin analog CP40, CP-40, peptide 14 [PMID: 22795972]
amylin  {Sp: Human} 687 AMY
amylin  {Sp: Mouse, Rat} 688 AMY
[125I]amylin Ligand is labelled Ligand is radioactive 3770 [125I]-BH-AMY, [125I]-Bolton Hunter amylin
amyloid β  {Sp: Human} 4865 amyloid β-peptide, beta-amyloid protein
amyloid β1-16 13243 Aβ(1-16), N-Aβ
anakinra Approved drug Immunopharmacology Ligand 6972 antril, Kineret®
analog 30 [PMID:18543899] 5647
analog 31 [PMID:18543899] 5648
analog 32 [PMID:18543899] 7763
analog 3 [PMID:18543899] 5646
analogue 13: B7-24 11918
anantin 4866
andexanet alfa Approved drug 7576 Andexxa®, coagulation factor Xa (recombinant), inactivated-zhzo, Ondexxya®, PRT064445, PRT4445, r-antidote
angiopoietin-1  {Sp: Human} 4867 ANG-1
angiopoietin-2  {Sp: Human} 5316 ANG-2
angiopoietin-4  {Sp: Human} 4868 ANG-4
angiopoietin-like 3  {Sp: Human} 8716 ANGPTL3
angiopoietin protein-like 1  {Sp: Human} 5317 ANG-3, angiopoietin 3, angiopoietin-like protein 1
angiopoietin-related protein 7  {Sp: Human} 5321 ANGPTL7, angiopoietin-like factor, angiopoietin-like protein 7, AngX, CDT6, cornea-derived transcript 6 protein
angiotensin-(1-7)  {Sp: Human, Mouse, Rat} 582 ang 1-7, angiotensin 1-7, TXA-127, TXA127
angiotensin-(1-9)  {Sp: Human, Mouse, Rat} 5138 ang 1-9, angiotensin 1-9
angiotensin A  {Sp: Human} 6894 ang A
[125I]angiotensin-(1-7) (human, mouse, rat) Ligand is labelled Ligand is radioactive 5578 [125I]ang-(1-7)
angiotensin I  {Sp: Human, Mouse, Rat} 583 ang I
angiotensin II  {Sp: Human, Mouse, Rat} Approved drug 2504 ang II, Giapreza®
angiotensin III  {Sp: Human, Mouse, Rat} 585 ang III
angiotensin IV  {Sp: Human, Mouse, Rat} 5368 AT II (3-8)
annexin A3  {Sp: Human} 13777 annexin III, calcimedin 35-alpha, inositol 1,2-cyclic phosphate 2-phosphohydrolase (EC 3.1.4.43), lipocortin III, placental anticoagulant protein III
annexin I  {Sp: Human} 1031 ANXA1, annexin 1, annexin A1
annexin I-(2-26)  {Sp: Human} 1044 annexin I, Ac2-26, annexin-derived peptide, ANXA1-derived peptide
annexin I  {Sp: Mouse} 3568
annexin I  {Sp: Rat} 3569
[125I]ANP (human) Ligand is labelled Ligand is radioactive 4845 [125I]-ANP
anrikefon Approved drug 14403 compound 8 [US11014964], HSK-21542, HSK21542, Si Shu Jing® (China)
antarelix 1189 D-23234, EP 24332
antisauvagine 931 [dPhe11,His12]Svg(11-40), antisauvagine-30
[125I]antisauvagine Ligand is labelled Ligand is radioactive 930
AP811 4870 AP 811, AP-811
apamin 2311
APB-R3 Immunopharmacology Ligand 13869
apelin-36  {Sp: Human} 606
apelin-13  {Sp: Human, Mouse, Rat} 605 [Pyr1]-Apelin-13
apelin-17  {Sp: Human, Mouse, Rat} 3556 K17F
apelin-36  {Sp: Mouse, Rat} 3555
[125I]apelin-13 Ligand is labelled Ligand is radioactive 602
apelin-13(F13A) 5354
apelin receptor early endogenous ligand  {Sp: Human} 7930 ELA, ELABELA, Ende, tdl, toddler
apelin receptor early endogenous ligand  {Sp: Mouse} 7931 Ende
APETx-1 2609 Toxin APETx1
APETx2 4135
aponermin Approved drug 13293 Shaite® (China)
apraglutide 10685 CVQ1IAY2G6, FE 203799, FE203799
APRIL  {Sp: Human} Immunopharmacology Ligand 5068 A proliferation-inducing ligand, TALL2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, ZTNF2
aprotinin  {Sp: Bovine} Approved drug 6570 basic protease inhibitor (BPI), BPTI, pancreatic trypsin inhibitor, Trasylol®
AR305352 7043
[Arg16]chicken secretin 3293 [R16]chicken secretin
arginine vasotocin 2169 AVT, [Arg8]vasotocin
[Arg14Lys15]N/OFQ 1689 [Arg14Lys15]nociceptin, [Arg14Lys15]nociceptin/orphanin FQ, [Arg14Lys15]orphanin FQ
[Arg19]PTH-(1-34) (human) 1792 [Arg19]-PTH 1-34 (human)
ARL-15849 859 AR-R 15849, ARL 15849XX, FPL 15849
artemin  {Sp: Human} 4871 ARTN
ASIP [90-132 (L89Y)] 1327 agouti-signaling protein [90-132 (L89Y)], agouti-signaling protein[90-132 (L89Y)]
aspartame PDB Ligand 13899 Canderel®, NutraSweet®, SC18862
asprosin  {Sp: Human} 9200
astressin 925
[125I]astressin Ligand is labelled Ligand is radioactive 924
astressin 2B 10335 Astressin2-B, astressin2-B, cyclo(31-34)[DPhe(11),His(12),C(alpha)MeLeu(13,39),Nle(17),Glu(31),Lys(34)]Ac-sauvagine(8-40), peptide 20 [PMID: 12361401]
[Asu7,23']β-ANP-(7-28) 4852 [Asu7,23']-β-ANP7-28
atacicept Approved drug Immunopharmacology Ligand 9517 atacicept-vymj, TACI-Fc, TACI-Ig, Trutakna®
ATN-161 14587 ATN161, N-acetyl-L-prolyl-L-histidyl-L-seryl-L-cysteinyl-L-asparaginamide
atosiban Approved drug 2213 Antocin®, d[D-Tyr(Et)2,Thr4,Orn8]vasotocin, d[D-Tyr(Et)2,Thr4]OVT, ORF22164, RWJ 22164, Tractocile®
atrial natriuretic peptide  {Sp: Human} 4869 ANP, atrial natriuretic factor (ANF)
ATX-II 2614 anemonia viridis toxin 2, Sea anemone toxin II (Anemonia sulcata), toxin ATX-II
ATXN2 degron 14454
aTyr 1940 8738 ATYR1940, HRS(1-506), Resolaris
AUNP-12 10117 Aur-012, Aurigene NP-12, Aurigene-012, compound #8 [WO2011161699A3]
Ava3 3855
Ava5 3856
[Ava9,10,Ava14,15]-Ac-hMCH6-16-NH2 1307 compound 30 [PMID:12009900]
avexitide 13444
aviptadil Approved drug 10891 Invicorp® (aviptadil + phentolamine), Vasoactive intestinal octacosapeptide
[3H]AVP (human, mouse, rat) Ligand is labelled Ligand is radioactive 2175 [3H]arginine vasopressin
AY77 9455 compound 14 [PMID: 26819675]
AYPGKF-NH2 4061 AY-NH2
azapro-3 Immunopharmacology Ligand 9221
 
B Back to top
B-10356 652
B1-27 11459 analog 2 [PMID: 32133341]
B-9430 653 B 9430, B9430, D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin
B-9858 654 B 9858, Lys-Lys-[Hyp3, Igl5, D-Igl7, Oic8]des-Arg9-BK
B-9958 655 B9958, des-Arg(9)-BK
BAFF  {Sp: Human} Immunopharmacology Ligand 5069 B cell-activating factor, CD257 antigen, dendritic cell-derived TNF-like molecule
balixafortide 11587 POL-6326, POL6326
B and T lymphocyte attenuator  {Sp: Human} Immunopharmacology Ligand 4891 BTLA, B- and T-lymphocyte attenuator , B- and T-lymphocyte-associated protein, CD272
barusiban 10890 C4.6,S1-cyclo[N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-L-ornithinol], FE 200 440, FE-200440
BASS antagonist 5644 BASS antagonist Analog 4
BAY 55-9837 2269
BAY86-7548 Ligand is labelled Ligand is radioactive 11260 [68Ga]D-Phe6, Stat13, Leu14 Bn(6-14), [68Ga]RM2, Ga-RM2
[125I]BAY 55-9837 Ligand is labelled Ligand is radioactive 2281
BBL-454 895 BBL 454, BBL454
4-1BB ligand  {Sp: Human} 5081 CDw137L
BC-254 896 BC 254, BC254
BC-264 897 BC 264, BC264
Bc-III 2615 major neurotoxin BcIII
BCY15291 12820
BDNF  {Sp: Human} 4872
[125I]BDNF (human) Ligand is labelled Ligand is radioactive 4846 [125I]-BDNF, [125I]-brain-derived neurotrophic factor
beinaglutide Approved drug 12863 Feisumei®
BeKm-1 2610 neurotoxin BeKm-1, potassium channel toxin γ-KTx 2.1
belatacept Approved drug Immunopharmacology Ligand 6892 BMS-224818, LEA29Y, Nulojix®
bempegaldesleukin Immunopharmacology Ligand 10659 NKTR-214, NKTR214
berobenatide 14570 MET-097, MET-097i, MET097, PF'3944, PF-08653944, PF08653944
bestrophin-3  {Sp: Human} 5377 vitelliform macular dystrophy 2-like protein 3
betacellulin  {Sp: Human} 4873
beta-defensin 4A  {Sp: Human} 3648 beta-defensin 2, HBD2, skin-antimicrobial peptide 1 (SAP1)
bevemipretide 13258 SBT-272, SBT272
bevifibatide Approved drug 13953 BAT-2094, batifiban, Beitaning, Betagrin®, Compound I [CN101085809A]
BgK 2551 Potassium channel toxin Bgk
[125I]BgK (W5Y / Y26F) Ligand is labelled Ligand is radioactive 2565
(B7-33)H2 9321
BH3 interacting-domain death agonist  {Sp: Human} 5152 BID
[125I]BH-MIT1 Ligand is labelled Ligand is radioactive 8522
[125I]BH-NMB (human, mouse, rat) Ligand is labelled Ligand is radioactive 3771 [125I]-BH-NMB, [125I]-Bolton Hunter neuromedin B
[125I]BH-[Sar9,Met(O2)11]SP Ligand is labelled Ligand is radioactive 3769 [125I]-BH-[Sar9,Met(O2)11]SP, [125I]-Bolton Hunter-[Sar9,Met(O2)11]substance P
[3H]BH-[Sar9,Met(O2)11]SP Ligand is labelled Ligand is radioactive 3811 [3H]-Bolton Hunter-[Sar9,Met(O2)11]substance P, [3H]-BH-[Sar9,Met(O2)11]SP
big dynorphin  {Sp: Human, Mouse, Rat} 3669 big dyn
BigLEN  {Sp: Mouse} 6704 b-LEN, Big LEN, SAAS CT(25-40)
bihelical apoA-I mimetic peptide 5A Immunopharmacology Ligand 9183 5A peptide
BIM 23023 2032
BIM 23027 2033 BIM23027
BIM 23030 2034
BIM 23034 2035 DC 13-212
BIM 23050 2003 BIM-23050
BIM 23052 2004 BIM-23052, BIM23052, DC-(23-99)
BIM 23056 2036
BIM 23058 2068
BIM 23059 2037
BIM 23060 2038
BIM 23066 2039
BIM 23068 2040
BIM 23127 2162
BIM 23197 2041
BIM 23268 2083 BIM23268
BIM 23295 2069
BIM 23313 2084
BIM 23454 2026
BIM 23627 2027 H-5886, MW 1164
BIM28011 3857 [D-Ala2,Ala8,9,15,27,D-Arg29]hGHRH(1-29)NH2, BIM 28011
BIM 28163 1101 BIM-28163
[125I]BIM23027 Ligand is labelled Ligand is radioactive 3772 [125I]-BIM 23027, [125I]-BIM23027
BIO1211 6589 BIO 1211, BIO-1211
bivalirudin Approved drug 6470 Angiomax®
BJP-06-005-3 11401 compound 1 [PMID: 32483379], N-(chloroacetyl)-N-methyl-L-phenylalanyl-L-homoprolyl-L-tryptophyl-L-citrulline ethyl ester
[3H]BK (human, mouse, rat) Ligand is labelled Ligand is radioactive 3812 [3H]-BK, [3H]-bradykinin
blisibimod Immunopharmacology Ligand 9518 A-623, AGP3 peptibody, AMG 623, Fc-Agp-3
BM213 12513
BM221 12514
BmP09 14028
BMP-10  {Sp: Human} 4875
BMP-15  {Sp: Human} 4880 GDF-9B, growth/differentiation factor 9B
BMP-2  {Sp: Human} 4881 BMP-2A, bone morphogenetic protein 2A
BMP-3  {Sp: Human} 4882 BMP-3A, bone morphogenetic protein 3A
BMP-4  {Sp: Human} 4883 BMP-2B, bone morphogenetic protein 2B
BMP-5  {Sp: Human} 4884
BMP-6  {Sp: Human} 4885 VG-1-R, VG-1-related protein, VGR-1
BMP-7  {Sp: Human} 4886
BMP-9  {Sp: Human} 4889 bone morphogenetic protein 9, GDF-2
BMP-8A  {Sp: Human} 4887 bone morphogenetic protein 8A
BMP-8B  {Sp: Human} 4888 BMP-8
BMS-986238 Immunopharmacology Ligand 13877 BMS 986238, BMS986238
BmTx1 14026
BmTx2 14025
BOC-ATE 2042
BODIPY® TMR-NMU 3858
bombesin 616
BOP 12045 compound 2 [PMID: 24363056], compound 3 [PMID: 12033947], N-(Benzenesulfonyl)-L-prolyl-L-O-(1-pyrrolidinylcarbonyl)tyrosine
bovine adrenal medulla peptide 8-22  {Sp: Human} 4058 BAM 8-22, BAM (8-22), BAM-15, BAM-22, BAM-22P (8-22)
[Bpa1,Ile13]motilin (human) 1452
[Bpa6,Tyr10]secretin-27 (rat) Ligand is labelled Ligand is radioactive 1154
BP-CCL3 752 BP-LD78α, BP-MIP-1α, photoactivatable macrophage inflammatory protein-1α
BPTI-K15R/R17G 7897
BQ123 997 BQ 123, BQ-123
BQ 3020 3859 BQ-3020, BQ3020
[125I]BQ3020 Ligand is labelled Ligand is radioactive 1005 [125I]-BQ3020
[3H]BQ123 Ligand is labelled Ligand is radioactive 1003 [3H]-BQ123, [3H]cyc(DTrp-DAsp-Pro-DVal-Leu
bradykinin  {Sp: Human, Mouse, Rat} 649 BK, kallidin I, kinin 9
brain natriuretic peptide  {Sp: Human} Approved drug 4890 BNP, BNP(1-32), BNP-32, brain natriuretic peptide 32, Natrecor®
bremelanotide Approved drug 10408 PT-141, PT141, Vyleesi®
B-R13HR H2 relaxin 14151 H2 B-R13HR
brimapitide Immunopharmacology Ligand 9101 AM-111, D-JNKI-1, XG-102
BRINP2-related peptide  {Sp: Human} 13788 BRP
B-R13/17K H2 relaxin 4371 AT-001, B13/17K H2 relaxin
BT7480 Immunopharmacology Ligand 12060 BCY11863, BT-7480
bulevirtide Approved drug 12775 BLV, bulevirtide-gmod, formerly Myrcludex B, Hepcludex®
α-bungarotoxin 3964
[125I]α-bungarotoxin Ligand is labelled Ligand is radioactive 3972
[3H]α-bungarotoxin Ligand is labelled Ligand is radioactive 3981
buserelin Approved drug 3860 buserelin acetate, HOE 766, HOE 766A, ICI 123215, Metrelef®, Suprefact®
[125I]buserelin Ligand is labelled Ligand is radioactive 1167 [125I]-buserelin
butantoxin 14031 α-KTx12.1
Bv8 5362 Bombina variegata protein
[Bz-Phe6]U-II (human) 2159 human [Bz-Phe6] urotensin-II
 
C Back to top
C089 5779
C21 7037
C3 1291
C7 3861 galanin(1-13)spantide
C3a  {Sp: Human} 3640 C3a anaphylatoxin, C3a anaphylatoxin polypeptide, complement component C3a
C4a  {Sp: Human} 6547 C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2
C5a  {Sp: Human} Immunopharmacology Ligand 573 C5a anaphylatoxin, complement component C5a, human complement protein
C3a  {Sp: Mouse} 3641 C3a anaphylatoxin, complement component C3a
C5a  {Sp: Mouse} 3576 C5a anaphylatoxin, complement component C5a
C3a  {Sp: Rat} 3642 C3a anaphylatoxin, C3a anaphylatoxin polypeptide
C5a  {Sp: Rat} 3577 C5a anaphylatoxin, complement component C5a
C3a des Arg  {Sp: Human} 5367
C5a des-Arg  {Sp: Human} 574 C5a des-Arg74
cagrilintide 13768 AM-833, AM833, analogue 23 [PMID: 34288673], NN0174-0833
C5a hexapeptide analogue 5768 Phe-Lys-Ala-dCha-Cha-dArg
[125I]C3a (human) Ligand is labelled Ligand is radioactive 3773 [125I]-C3a
[125I]C5a (human) Ligand is labelled Ligand is radioactive 3774 [125I]-C5a
calciseptine 4149
calcitonin  {Sp: Human} Approved drug 685 CT, LS-173874, Miacalcin Nasal®, thyrocalcitonin
calcitonin  {Sp: Mouse, Rat} 3586 CT
[125I]calcitonin Ligand is labelled Ligand is radioactive 3776 [125I]-calcitonin (Human), [125I]-CT (Human)
calcitonin-(8-32) (salmon) 690 CT (8-32) (salmon), CT-(8-32) (salmon), salmon calcitonin (8-32)
calcitonin (salmon) Approved drug 6973 CT (salmon), Miacalcin®
[125I]calcitonin (salmon) Ligand is labelled Ligand is radioactive 3777 [125I]-calcitonin (Salmon), [125I]-CT (Salmon)
calmodulin  {Sp: Human} 2351 Ca2+/calmodulin, Ca2+/CaM, calcium-calmodulin, CaM
calpeptin 11643 benzylcarbonyl-Leu-nLeu-H, N-benzyloxycarbonyl-L-leucyl-L-norleucinal
cANF4-23 4892 des[Gln18,Ser19,Gly20,Leu21,Gly22]ANP4ï¾–23-NH2
cangitoxin II 7568 cangitoxin-2, cangitoxin-II, CGTX-II
C5apep 11344
carbetocin Approved drug 11169 Pabal®
cardiotrophin-1  {Sp: Human} 4906 CTF1, B-cell stimulatory factor 3, BSF3
cardiotrophin-like cytokine factor 1  {Sp: Human} 4895 CLCF1
CART(55-102)  {Sp: Human} 13185
CARTPT (76-96)  {Sp: Human} 10571
casoxin C 10224
β-catenin  {Sp: Human} 5371 catenin beta-1
cathepsin G  {Sp: Human} 3570
cathepsin G  {Sp: Mouse} 3571
cathepsin G  {Sp: Rat} 3572
[125I]cathepsin G (human) Ligand is labelled Ligand is radioactive 1017 [125I]cathepsin G
CB-182804 11003 CB-182,804, CB182804
CCK-58  {Sp: Dog} 862
CCK-33  {Sp: Human} 860 CCRIS 3307, cholecystokinin 33
CCK-39  {Sp: Human} 10221
CCK-4  {Sp: Human} 861 cholecystokinin fragment 30-33 amide, tetragastrin
CCK-58  {Sp: Human} 3552
CCK-8  {Sp: Human, Mouse, Rat} 864 CCK-8 (sulphated), cholecystokinin 8, cholecystokinin fragment 26-33 amide (sulphated)
CCK-33  {Sp: Mouse} 3550
CCK-58  {Sp: Mouse} 3553
CCK-33  {Sp: Rat} 3551
CCK-58  {Sp: Rat} 3554
[3H]CCK-8 (human, mouse, rat) Ligand is labelled Ligand is radioactive 4765 [3H]-CCK-8
CCL1  {Sp: Human} Immunopharmacology Ligand 812 I309, TCA-3
CCL11  {Sp: Human} Immunopharmacology Ligand 769 eotaxin
CCL13  {Sp: Human} Immunopharmacology Ligand 770 monocyte chemotactic protein-4
CCL14  {Sp: Human} Immunopharmacology Ligand 753 CCL14a, CKβ1, haemofiltrate CC chemokine 1 (HCC-1), HCC-1(1-74)
CCL15  {Sp: Human} Immunopharmacology Ligand 754 Lkn-1 [Leukotactin-1], macrophage inflammatory protein-1δ, MIP-1δ
CCL16  {Sp: Human} Immunopharmacology Ligand 1272
CCL17  {Sp: Human} Immunopharmacology Ligand 797 TARC, thymus- and activation-regulated chemokine
CCL18  {Sp: Human} Immunopharmacology Ligand 4382 macrophage inflammatory protein 4, small-inducible cytokine A18
CCL19  {Sp: Human} Immunopharmacology Ligand 810 β-chemokine exodus-3, ck β-11, ckβ11, MIP-3β
CCL2  {Sp: Human} Immunopharmacology Ligand 771
CCL20  {Sp: Human} Immunopharmacology Ligand 808 LARC, liver and activation-regulated chemokine, macrophage inflammatory protein-3α, MIP-3α
CCL21  {Sp: Human} Immunopharmacology Ligand 811 ckβ9, TCA-4
CCL22  {Sp: Human} Immunopharmacology Ligand 798 dc/β-ck, macrophage-derived chemokine, STCP1
CCL23  {Sp: Human} Immunopharmacology Ligand 755 ckβ8-1, myeloid progenitor inhibitor factor-1
CCL24  {Sp: Human} Immunopharmacology Ligand 775 eotaxin-2
CCL25  {Sp: Human} Immunopharmacology Ligand 817
CCL26  {Sp: Human} Immunopharmacology Ligand 776 MIP-4α, PTEC
CCL27  {Sp: Human} Immunopharmacology Ligand 3646
CCL28  {Sp: Human} Immunopharmacology Ligand 3649
CCL3  {Sp: Human} Immunopharmacology Ligand 756 macrophage inflammatory protein-1α, MIP-1α
CCL4  {Sp: Human} Immunopharmacology Ligand 757 HC21, macrophage inflammatory protein-1β, MIP-1β
CCL5  {Sp: Human} Immunopharmacology Ligand 758 eosinophil chemotactic cytokine [EoCP], regulated upon activation normal T cell expressed and secreted (RANTES)
CCL7  {Sp: Human} Immunopharmacology Ligand 759
CCL8  {Sp: Human} Immunopharmacology Ligand 772 monocyte chemotactic protein-2
CCL1  {Sp: Mouse} Immunopharmacology Ligand 4404
CCL11  {Sp: Mouse} Immunopharmacology Ligand 787 murine eotaxin
CCL12  {Sp: Mouse} Immunopharmacology Ligand 4435
CCL19  {Sp: Mouse} Immunopharmacology Ligand 4417
CCL2  {Sp: Mouse} Immunopharmacology Ligand 4406
CCL20  {Sp: Mouse} Immunopharmacology Ligand 4418
CCL22  {Sp: Mouse} Immunopharmacology Ligand 4420
CCL24  {Sp: Mouse} Immunopharmacology Ligand 4421
CCL25  {Sp: Mouse} Immunopharmacology Ligand 4422
CCL27  {Sp: Mouse} Immunopharmacology Ligand 4462
CCL28  {Sp: Mouse} Immunopharmacology Ligand 4463
CCL3  {Sp: Mouse} Immunopharmacology Ligand 4408
CCL4  {Sp: Mouse} Immunopharmacology Ligand 4410
CCL7  {Sp: Mouse} Immunopharmacology Ligand 4413
CCL8  {Sp: Mouse} Immunopharmacology Ligand 4415
CCL9  {Sp: Mouse} Immunopharmacology Ligand 4434
CCL5  {Sp: Mouse, Rat} Immunopharmacology Ligand 4412
CCL11  {Sp: Rat} Immunopharmacology Ligand 4416
CCL2  {Sp: Rat} Immunopharmacology Ligand 4407
CCL20  {Sp: Rat} Immunopharmacology Ligand 4419
CCL3  {Sp: Rat} Immunopharmacology Ligand 4409
CCL4  {Sp: Rat} Immunopharmacology Ligand 4411
CCL7  {Sp: Rat} Immunopharmacology Ligand 4414
Ccl21a  {Sp: Mouse} Immunopharmacology Ligand 8651 6Ckine-Ser, Exodus-2
Ccl21b  {Sp: Mouse} Immunopharmacology Ligand 8652 6Ckine-Leu, Exodus-2
[125I]CCL11 (human) Ligand is labelled Ligand is radioactive 794 [125I]eotaxin
[125I]CCL16 (human) Ligand is labelled Ligand is radioactive 1275 [125I]LEC
[125I]CCL17 (human) Ligand is labelled Ligand is radioactive 3652 [125I]TARC
[125I]CCL19 (human) Ligand is labelled Ligand is radioactive 3655 [125I]ELC
[125I]CCL1 (human) Ligand is labelled Ligand is radioactive 814 [125I]I-309, [125I]P500, [125I]TCA-3
[125I]CCL20 (human) Ligand is labelled Ligand is radioactive 3654 [125I]LARC, [125I]MIP-3α
[125I]CCL21 (human) Ligand is labelled Ligand is radioactive 3656 [125I]SLC
[125I]CCL25 (human) Ligand is labelled Ligand is radioactive 3657 [125I]TECK
[125I]CCL27 (human) Ligand is labelled Ligand is radioactive 3653 [125I]CTACK
[125I]CCL2 (human) Ligand is labelled Ligand is radioactive 762 [125I]MCAF, [125I]MCP-1, [125I]monocyte chemotactic protein-1
[125I]CCL3 (human) Ligand is labelled Ligand is radioactive 763 [125I]macrophage inflammatory protein-1α, [125I]MIP-1α
[125I]CCL4 (human) Ligand is labelled Ligand is radioactive 799 [125I]macrophage inflammatory protein-1β, [125I]MIP-1β
[125I]CCL5 (human) Ligand is labelled Ligand is radioactive 764 [125I]RANTES, [125I]regulated upon activation normal T cell expressed and secreted
[125I]CCL7 (human) Ligand is labelled Ligand is radioactive 765 [125I]MCP-3, [125I]monocyte chemotactic protein-3
[125I]CCL8 (human) Ligand is labelled Ligand is radioactive 766 [125I]MCP-2, [125I]monocyte chemotactic protein-2
[125I]CCL1 (mouse) Ligand is labelled Ligand is radioactive 5546
CCL20-SEAP(His)6 809 LARC fused with secreted alkaline phosphatase, LARC-SEAP(His)6, MIP-3α fused with secreted alkaline phosphatase
CD70  {Sp: Human} 5079 CD27 ligand, Ki-24, TNFSF7
Cdk5i 14459
CD30 ligand  {Sp: Human} 5080
CD40 ligand  {Sp: Human} Immunopharmacology Ligand 5077 CD40 ligand, membrane form
cellular communication network factor 3  {Sp: Human} 13454
cenderitide 9066 CD-NP
cerebral dopamine neurotrophic factor  {Sp: Human} 13048 arginine-rich, mutated in early stage tumors-like 1, ARMETL1
cetrorelix Approved drug Immunopharmacology Ligand 1190 Cetrotide®, SB-075
[125I]cetrorelix Ligand is labelled Ligand is radioactive 1186
CGEN-856 7041 P61
CGEN-857 7040 P33
CGEN-855A 6241
CGP 23996 2005 CGP-23996, CGP23996
CGP42112 3944 CGP 42112, CGP 42112A
[125I]CGP 23996 Ligand is labelled Ligand is radioactive 2022
[125I]CGP42112 Ligand is labelled Ligand is radioactive 594 [125I]-CGP42112, Cgp 42112B, Cgp-42112A
α-CGRP  {Sp: Human} 681 α-calcitonin gene-related peptide (αCGRP, human), calcitonin gene-related peptide 1 (CGRP)
β-CGRP  {Sp: Human} 682 β-calcitonin gene-related peptide, βCGRP, calcitonin gene-related peptide 2
β-CGRP  {Sp: Mouse} 3588 β-calcitonin gene-related peptide, βCGRP, calcitonin gene-related peptide 2
α-CGRP  {Sp: Mouse, Rat} 695 αCGRP, rat α-calcitonin gene-related peptide
β-CGRP  {Sp: Rat} 696 βCGRP, rat β-calcitonin gene-related peptide
[125I]αCGRP Ligand is labelled Ligand is radioactive 3766 [125I]-αcalcitonin gene-related peptide, [125I]-αCGRP
α-CGRP-(8-37) (human) 700 α-CGRP (8-37) (human), human α-calcitonin gene-related peptide (8-37)
[125I]αCGRP (mouse, rat) Ligand is labelled Ligand is radioactive 6567
α-CGRP-(8-37) (rat) 701 α-CGRP (8-37) (rat), rat α-calcitonin gene-related peptide (8-37)
CH 275 2006 CH-275, desAA1,2,5[D-Trp8,IAmp9]somatostatin-14
charybdotoxin 2328 ChTX, ChTX-Lql
charybdotoxin-GLU32 analog 2329 ChTX-GLU32
[Cha6]U-II-(4-11) 9439
chemerin  {Sp: Human} 2945 RARRES2, retinoic acid receptor responder protein 2, TIG2
chemerin C-terminal peptide 3422 bioactive chemerin peptide, chemerin 149-157, chemerin 9, chemerin-9
Chgb (511-532)  {Sp: Rat} 10540
CHIPS 3724 chemotaxis inhibitory protein of S. aureus
CHIPS-(28-149) 5770 CHIPS28-149
[125I]CHIPS Ligand is labelled Ligand is radioactive 1027 [125I]chemotaxis inhibitory protein of S. aureus
[(CH2NH)4,5]secretin 3755 [ψ4,5]secretin
chondroitin sulphate proteoglycan 3  {Sp: Human} 6616 CSPG3, neurocan
choriomammotropin  {Sp: Human} 4893
chorionic gonadotropin beta subunit  {Sp: Human} 4396 CG-beta, choriogonadotropin subunit beta, chorionic gonadotrophin chain beta
[125I]chorionic gonadotropin (human) Ligand is labelled Ligand is radioactive 3775 [125I]CG (human), [125I]-CG, [125I]-chorionic gonadotropin
chorionic somatomammotropin hormone-like 1  {Sp: Human} 4894 chorionic somatomammotropin-like, lactogen-like
chromogranin A  {Sp: Human} 5165 CgA, pituitary secretory protein I, SP-1
ChTX-Lq2 14030
cibinetide Immunopharmacology Ligand 9677 ARA 290, ARA-290, PH-BSP, PHBSP
CID-078 14495
C12-iE-DAP 9508
CIGB-552 13896 CIGB552
cilengitide 6597 EMD-12192, EMD-121974
ciliary neurotrophic factor  {Sp: Human} 4897 CNTF
citrocin 14236
4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide 2161
cloacaenodin 14251
CLUL1 (52-77)  {Sp: Human} 10543
[125I]CNP (human) Ligand is labelled Ligand is radioactive 4847 [125I]-CNP
C2-NPY (pig) 1534
COL1A1  {Sp: Human} 4898 alpha-1 type I collagen, collagen alpha-1(I) chain
COL2A1  {Sp: Human} 4899 alpha-1 type II collagen, collagen alpha-1(II) chain
COL3A1  {Sp: Human} 4900 collagen alpha-1(III) chain
COL4A1  {Sp: Human} 4901 collagen alpha-1(IV) chain
complement C3  {Sp: Human} Immunopharmacology Ligand 9414
complement C5  {Sp: Human} Immunopharmacology Ligand 8712
compound 54 11898
compound 5a [PMID: 41246830] 14288
compound 5b [PMID: 41246830] 14287
compound 6b [PMID: 24999562] 7927
compound 25c [PMID: 23747811] 11641
compound 3c [PMID: 30360354] Immunopharmacology Ligand 10591 [As(4-F)F4]-GHRP-6, azasulfuryl-p-fluorophenylalanine-4-[As(4-F)F4]-GHRP-6, H-His-D-Trp-Ala-(4-F)AsF-D-Phe-Lys-NH2
compound 5d [PMID: 25815150] 9008
compound 8d [PMID: 24999562] 7926
compound 1 [PMID: 25241924] 7801
compound 2 [PMID: 11375253] 1292
compound 3 [PMID: 16884309] 11640
compound 18-S4 [PMID: 31413801] 14157
compstatin Immunopharmacology Ligand 9218
conantokin-G 4161 conotoxin GV
conbercept Approved drug 14582 KH902, KH903, Lumitin® (China)
concanavalin A 4162
conestat alfa Approved drug 7627 rhC1INH, Ruconest®
conkunitzin-S1 toxin 7758 conk-S1, Kunitz-type conkunitzin-S1
connective tissue growth factor  {Sp: Human} 8927 CTGF
conopeptide Y-PI1 7742
α-conotoxin ArIB 4007
α-conotoxin AuIB 3973
ω-conotoxin CVIA 2531
ω-conotoxin CVIB 2532
ω-conotoxin CVIC 2533
ω-conotoxin CVID 2534 AM-336, AM336, CNSB004, leconotide
α-conotoxin GI 3983 G1
α-conotoxin-GIC 4009
μ-conotoxin GIIIA 2630 Geographutoxin I, GTx-I, Myotoxin I
ω-conotoxin GVIA 2535
α-conotoxin ImI 3965 α-CTx ImI
μ-conotoxin KIIIA 14461 μ-KIIIA, mu-KIIIA
α-conotoxin MI 3999
α-conotoxin MII 3970
[125I]α-conotoxin MII Ligand is labelled Ligand is radioactive 3975
α-conotoxin MII [H9A, L15A] 4010
ω-conotoxin MVIIC 2537 ω-CTx-MVIIC, SNX-230
ω-conotoxin MVIID 2538 SNX-238
α-conotoxin PIA 3985
μ-conotoxin PIIIA 2631 μ-conotoxin P3.7
α-conotoxin PnIA 3982
α-conotoxin RgIA 4008
μ-conotoxin SmIIIA 7567
α-conotoxin TxIA 4011
consomatin Fj1 13681
contactin-1  {Sp: Human} 6617
contactin-3  {Sp: Human} 6609 BIG-1, PANG
contactin-4  {Sp: Human} 6612 BIG-2
contactin-5  {Sp: Human} 6613 hNB-2, NB-2
contactin-6  {Sp: Human} 6614 NB-3, neural adhesion molecule
contulakin-G 1575 CGX-1160
corticotrophin-releasing hormone  {Sp: Human, Mouse, Rat} 912 CRF
corticotropin-releasing factor  {Sp: Sheep} 913 CRF, corticoliberin, endorpholiberin
corticotropin zinc hydroxide Approved drug Immunopharmacology Ligand 6967
cortistatin-14  {Sp: Mouse, Rat} 2007 CST-14, cortistatin
cosyntropin Approved drug 6965 Cortrosyn®
C4Pen 14460
CPN-116 11490 peptide 6b [PMID: 24999562]
CPN-219 11491
CPN-223 11492 analogue 8 [PMID: 32721452]
CPN-267 10380 analogue 7b [PMID: 28548497], C-terminal core peptide derivative of neuromedin U, bearing (α-Me)Trp2, NMUR1 agonist C7b
[125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP Ligand is labelled Ligand is radioactive 3921 [125I]-[cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP
CPS4 11603
CRAMP  {Sp: Mouse} Immunopharmacology Ligand 6266
CRCF1/CLCF1 heterodimer  {Sp: Human} 6150
[125I]CRF (ovine) Ligand is labelled Ligand is radioactive 915 [125I]corticotropin
crisantaspase Approved drug 7347 asparaginase, Elspar®, Enrylaze®, L-asparaginase, L-asparagine amidohydrolase
CST-17  {Sp: Human} 2008 cortistatin-17
CTAP 1635
CTOP 1674 Ctop-NH2, CTOPA
[3H]CTOP Ligand is labelled Ligand is radioactive 12512
CTR-stimulating peptide  {Sp: Pig} 5369 calcitonin-receptor stimulating peptide, CRSP-1
C-type lectin domain family 2 member D  {Sp: Human} Immunopharmacology Ligand 14522
C-type natriuretic peptide  {Sp: Human} 4896 CNP, CNP-22
CXCL1  {Sp: Human} Immunopharmacology Ligand 819 GROα, melanocyte growth-stimulatory activity, MIP-2
CXCL10  {Sp: Human} Immunopharmacology Ligand 835
CXCL11  {Sp: Human} Immunopharmacology Ligand 836 IP9, ITAC
CXCL12α  {Sp: Human} Immunopharmacology Ligand 4358 CXCL12 α, SDF-1α, stromal cell-derived factor-1α
CXCL12β  {Sp: Human} Immunopharmacology Ligand 845 SDF-1β, stromal cell-derived factor-1 (SDF-1), stromal cell-derived factor-1β
CXCL12δ  {Sp: Human} Immunopharmacology Ligand 8531
CXCL12ε  {Sp: Human} Immunopharmacology Ligand 8532
CXCL12γ  {Sp: Human} Immunopharmacology Ligand 8530
CXCL12φ  {Sp: Human} Immunopharmacology Ligand 8533
CXCL13  {Sp: Human} Immunopharmacology Ligand 3645 BCA-1
CXCL1  {Sp: Mouse} Immunopharmacology Ligand 4423
CXCL10  {Sp: Mouse} Immunopharmacology Ligand 4430
CXCL11  {Sp: Mouse} Immunopharmacology Ligand 4432
CXCL12  {Sp: Mouse} Immunopharmacology Ligand 4465
CXCL1  {Sp: Rat} Immunopharmacology Ligand 826 CINC, GROα, macrophage inflammatory protein-2
CXCL10  {Sp: Rat} Immunopharmacology Ligand 4431
CXCL12-(1-17) 846 CXCL12, 1-17, SDF-1, 1-17, stromal cell-derived factor-1, N-terminal fragment
CXCL12-(1-9) 847 CXCL12, 1-9
CXCL14  {Sp: Human} Immunopharmacology Ligand 3680 BMAC
CXCL16  {Sp: Human} Immunopharmacology Ligand 855
CXCL17  {Sp: Human} Immunopharmacology Ligand 6479 C-X-C motif chemokine 17, dendritic cell and monocyte chemokine-like protein
CXCL2  {Sp: Human} Immunopharmacology Ligand 827 GROβ, MIP-2α
CXCL3  {Sp: Human} Immunopharmacology Ligand 828 GROγ, MIP-2β
CXCL4  {Sp: Human} Immunopharmacology Ligand 3685 platelet factor 4 (PF4)
CXCL5  {Sp: Human} Immunopharmacology Ligand 829 ENA-78
CXCL6  {Sp: Human} Immunopharmacology Ligand 820
CXCL7  {Sp: Human} Immunopharmacology Ligand 830 PPBP
CXCL8  {Sp: Human} Immunopharmacology Ligand 821 interleukin-8
CXCL9  {Sp: Human} Immunopharmacology Ligand 837 MIG, monokine induced by gamma-interferon
CX3CL1  {Sp: Human} Immunopharmacology Ligand 856 fractalkine, neurotactin
CXCL13  {Sp: Mouse} Immunopharmacology Ligand 4466
CXCL15  {Sp: Mouse} Immunopharmacology Ligand 3862 lungkine (mouse)
CXCL16  {Sp: Mouse} Immunopharmacology Ligand 4433
CXCL2  {Sp: Mouse} Immunopharmacology Ligand 4424 macrophage inflammatory protein 2 (MIP-2)
CXCL3  {Sp: Mouse} Immunopharmacology Ligand 4426
CXCL5  {Sp: Mouse} Immunopharmacology Ligand 4428
CXCL9  {Sp: Mouse} Immunopharmacology Ligand 4429
CX3CL1  {Sp: Mouse} Immunopharmacology Ligand 4468
CXCL16  {Sp: Rat} Immunopharmacology Ligand 4467
CXCL2  {Sp: Rat} Immunopharmacology Ligand 4425
CXCL3  {Sp: Rat} Immunopharmacology Ligand 4427
CXCL5  {Sp: Rat} Immunopharmacology Ligand 4464
CX3CL1  {Sp: Rat} Immunopharmacology Ligand 4469
CXCL12-(1-9) dimer 848 CXCL12, 1-9 dimer, stromal cell-derived factor-1, N-terminal fragment dimer
CXCL122 (dimer) 8535
CXCL12H25R (monomer) 8534
[125I]CXCL10 (human) Ligand is labelled Ligand is radioactive 3660 [125I]IP-10
[125I]CXCL11 (human) Ligand is labelled Ligand is radioactive 3661 [125I]I-TAC
[125I]CXCL12α (human) Ligand is labelled Ligand is radioactive 849 [125I]SDF-1α (human), [125I]stromal cell-derived factor-1α
[125I]CXCL12β (human) Ligand is labelled Ligand is radioactive 850 [125I]SDF-1β (human), [125I]stromal cell-derived factor-1β
[125I]CXCL16 (human) Ligand is labelled Ligand is radioactive 3662
[125I]CXCL1 (human) Ligand is labelled Ligand is radioactive 3677 [125I]GROα
[125I]CXCL5 (human) Ligand is labelled Ligand is radioactive 3659 [125I]ENA-78
[125I]CXCL7 (human) Ligand is labelled Ligand is radioactive 3658 [125I]NAP-2
[125I]CXCL8 (human) Ligand is labelled Ligand is radioactive 822 [125I]IL-8, [125I]interleukin-8
[125I]CX3CL1 (human) Ligand is labelled Ligand is radioactive 3664 [125I]Fractalkine
[125I]CXCL13 (mouse) Ligand is labelled Ligand is radioactive 8631
Cy3B-NMU-8 Ligand is labelled 3863
cyclic INSL3 B-chain analogue 6 8333
cyclo apelin-12 (1-12) 6313 C1
cyclo apelin-12 (7-12) 6311 C4
cyclo(7-12) Des-AA1,2,5-[Glu7,D-Trp8,IAmp9,m-I-Tyr11,hhLys12]SRIF 2025
cyclohexylgriselimycin 13756 cyclohexyl-griselimycin
Cyclolinopeptide 1-Mso,3-Met-CL6 12467
cyclorelix 1191 D-23620
cyclosporin A Approved drug Immunopharmacology Ligand 1024 ciclosporin, cyclosporine, cyclosporine A, Ikervis® (opthalmic solution), Neoral®, Sandimmun®, Verkazia® (opthalmic solution)
cyclosporin H 1025
cyclotide kalata B1 13238
cyclourea apelin-12 (1-7) 6312 C3
[Cy5-Lys19]NPS Ligand is labelled 9166 Cy5-hNPS
[Cys(ACM)2,7]CGRP 698 [Cys(ACM)2,7]-calcitonin gene-related peptide, Cys(Acm)2,7-h-αCGRP
[Cys(Et)2,7]α-CGRP (human) 693 [cys(Et)2,7]α-calcitonin gene-related peptide (human)
cytokine domain of tyrosyl tRNA synthetase  {Sp: Human} 3729
cytokine receptor-like factor 1  {Sp: Human} 4904 CRLF1, NR6
 
D Back to top
D-23487 1180 D 23487
D-24710 1181 D 24710
ρ-Da1a 6663 toxin AdTx1
DADLE 1607 [D-Ala2, D-Leu5]-enkephalin, DADL, leucine enkephalin-2-alanine
[D-Ala7]-angiotensin(1-7) 6081 A-779, A779
(D-Ala11]bombesin 6179
[D-Ala2]deltorphin I 3838
[3H][D-Ala2]deltorphin I Ligand is labelled Ligand is radioactive 9065
[D-Ala2]deltorphin II 4060
[D-Ala2,F5,Phe4]dynorphin-(1-13)-NH2 1657 [D-Ala2,F5,Phe4]-dynorphin 1-13-NH2
[D-Ala2,F5,Phe4]dynorphin-(1-17)-NH2 1658 [D-Ala2,F5,Phe4]-dynorphin 1-17-NH2
D-Ala-Lys-AMCA Ligand is labelled 5421 (D)-Ala-(L)-Lys-Nε-AMCA, D-Ala-Lys-N(epsilon)-7-amino-4-methylcoumarin-3-acetic acid
DAMGO 1647 2-Ala-4-mephe-5-gly-enkephalin, DAGO, glyol
[3H]DAMGO Ligand is labelled Ligand is radioactive 3815 [3H]-DAMGO, [tyrosyl 3,5-3H]DAMGO
dapiglutide 14279 ZP-7570, ZP7570
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P 1102
[D-Arg1,D-Trp7,9,Leu11]substance P 6184
[D-Arg8]inotocin 14174
davalintide 10684 DACRA
dAVP 2181 [deamino-Cys1]AVP, [deamino1]AVP, deamino-vasopressin
DAVP 2170 [D-Arg8]vasopressin, [D-Arg8]VP
dazodalibep Immunopharmacology Ligand 13453 MEDI-4920, MEDI4920, VIB 4920, VIB-4920, VIB4920
[D-Bpa5,Ile13]motilin (human) 1450
dC2_049 14548
DC 23-60 2043
d[Cha4]AVP 2187 [1-deamino-4-cyclohexylalanine]AVP, [deamino-Cys1,Cha4]AVP
[3H]d[Cha4]AVP Ligand is labelled Ligand is radioactive 2227 [3H][1-deamino-4-cyclohexylalanine]AVP, [3H][deamino-Cys1,Cha4]AVP
d[Cha4,Dab8]VP 2186 [deamino-Cys1,Cha4,Dab8]vasopressin
d[Cha4]LVP 2188 [1-deamino-4-cyclohexylalanine]LVP, [deamino-Cys1,Cha4,Lys8]vasopressin
d(CH2)5[D-Ile2,Ile4,Ala-NH2]AVP 2215 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Ala-NH2]AVP
d(CH2)5[D-Ile2,Ile4,Ala-NH29]AVP 2214 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Ala-NH29]AVP, Pmp[D-Ile2,Ile4,Ala-NH2]AVP
d(CH2)5[D-Ile2,Ile4]AVP 2236 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4]AVP, d(CH2)5[D-Ile2,Ile4]VP
d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP 2235 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP
[125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP Ligand is labelled Ligand is radioactive 2230 [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP
d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP 2237 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP
[125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP Ligand is labelled Ligand is radioactive 2231 [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP
[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP Ligand is labelled Ligand is radioactive 2232 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP
d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP 2216 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP
[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP Ligand is labelled Ligand is radioactive 2233 [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP 2217 dGTyr(Et)VAVP, Mcp-tva-argipressin, SK&F 101926, SK&F 10196
d(CH2)5[Tyr(Me)2,Arg8]VP 3867
d(CH2)5[Tyr(Me)2]AVP 2223 CGP-25838, d(CH2)5Tyr(Me)AVP, d(CH2)5[O-methyl-Tyr2]AVP, Pmp[Tyr(Me)2]AVP, SKF-100273, SKF100273
[3H]d(CH2)5[Tyr(Me)2]AVP Ligand is labelled Ligand is radioactive 3813 [3H]-d(CH2)5[Tyr(Me)2,Arg8]AVP
[125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT Ligand is labelled Ligand is radioactive 3778 [125I]-d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT
d(CH2)5[Tyr(Me)2,Thr4]OVT 2222 d(CH2)5[O-Me-Tyr2,Thr4,Orn8]vasotocin, d(CH2)5[O-Me-Tyr2,Thr4]ornithine vasotocin, d(CH2)5[O-Me-Tyr2-The4-Orn8]vasotocin
d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT 2219 d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3I,4N3)-NH29]vasotocin, I-ZOTA
d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT Ligand is labelled Ligand is radioactive 2218 β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT, [125I]ZOTA, d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3125I,4N3)-NH29]vasotocin
d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT Ligand is labelled Ligand is radioactive 2220 [125I]D-(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin, [125I]OTA
d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT 2221 β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Tyr-NH29]OVT, d(CH2)5[O-Me-Tyr2-Thr4-Orn8-Tyr9-NH2]vasotocin, Pmp[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin
dCX1_001 14549
[D-Cys(tBu)5]NPS 5810
[3H]d[D-Arg8]VP Ligand is labelled Ligand is radioactive 5403 [3H]-d[D-Arg8]VP, [3H][D-Arg8]vasopressin, [3H]DAVP
[3H]dDAVP Ligand is labelled Ligand is radioactive 2228 [3H]deamino arginine vasopressin, [3H]desmopressin
d[D-Pal2]AVP 2184 d[D-3-Pal2]AVP, Schwartz compound
d[D-Phe2]AVP 2185 [deamino-Cys1,D-Phe2]AVP
degarelix Approved drug 5585 FE200486, Firmagon®
delcasertib 7840 BMS-875944, CS-9803, KAI-9803
delta like canonical Notch ligand 3  {Sp: Human} 10560 DLL3, SCDO1
delta like canonical Notch ligand 4  {Sp: Human} 8452 DLL4
deltorphin II 1615 (Ala(2))deltorphin II, (Ala(2),glu(4))deltorphin, Delt II, Delt-II
[3H]deltorphin II Ligand is labelled Ligand is radioactive 3816 [3H]-deltorphin II
demotate 2 5636 N(4) (0-1),Asp0,Tyr3-octreotate
Dendroaspis natriuretic peptide 9070 DNP
α-dendrotoxin 2563 α-DTX
dendrotoxin-I 2544 dendrotoxin, dendrotoxin I, venom basic protease inhibitor 1
dendrotoxin-k 7738 DTX-K, Kunitz-type serine protease inhibitor homolog dendrotoxin K, venom basic protease inhibitor K
denileukin diftitox Approved drug Immunopharmacology Ligand 7044 DAB389 IL2, denileukin diftitox-cxdl, LY 335348, Lymphir®, Ontak®
Des-AA1,2,5,12,13-[D-Trp8]SRIF 2009
Des-AA5-[D-Trp8]SRIF 2012
Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF 2011 CH-288
(des 1-8) A-chain INSL3 analogue 3754
Des-Ala1,2,5-[D-Trp8,IAmp9]SRIF 2010
[des-Arg9]bradykinin  {Sp: Human, Mouse, Rat} 646 [des-Arg9]BK
[des-Arg10]icatibant 663 [D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]-des-Arg9]bradykinin, [des-Arg10]HOE140
[des-Arg10]kallidin  {Sp: Human} 644 [Lys,des-Arg9]bradykinin, kallidin1-9, Lys-[des-Arg9]-bradykinin, Lys-[des-Arg9]BK
[des-Arg11]T-kinin 645 [Ile,Ser,des-Arg9]bradykinin
des-Br-neuropeptide B-23  {Sp: Human} 1499 des-Br-NPB-23
des-Br-neuropeptide B-29  {Sp: Human} 1500 des-Br-NPB-29
[des-Gln14]ghrelin  {Sp: Human} 3600 des-Gln14-ghrelin
[des-Gln14]ghrelin  {Sp: Mouse, Rat} 3601
[des-Gly10,D-Ala6]GnRH N-ethylamide 1174
[125I][des-Gly10,D-Ala6]GnRH N-ethylamide Ligand is labelled Ligand is radioactive 1166
desGlyNH2-d(CH2)5[Tyr(Me)2,Thr4,Orn8]OT 3870
[3H]desGly-NH2[D-Ile2,Ile4]VP Ligand is labelled Ligand is radioactive 3817 [3H]-desGly-NH2[D-Ile2,Ile4]AVP
des-His1-[Glu9]glucagon-NH2 1150 des-His(1)-[Glu9]-glucagon-NH2
des-His1-[Leu4-Glu9]glucagon-NH2 1151 des-His(1)-[Leu4-Glu9]-glucagon-NH2
desirudin Approved drug 6458 CGP 39393, CGP-39393, CGP39393
deslorelin 9343
desmopressin Approved drug 2182 1-deamino,D-AVP, [deamino-Cys1,D-Arg8]vasopressin, dDAVP, Noctiva®
[des-octanoyl]ghrelin  {Sp: Human} 1098 [des-octanoyl] ghrelin, des-octanoyl ghrelin
[des-octanoyl]ghrelin  {Sp: Mouse, Rat} 3599 des-octanoyl ghrelin
[des-Phe9,des-Arg10]kallidin 647 [Lys,des-Phe8,Arg9]bradykinin
[des-Pro8,des-Phe9,des-Arg10]kallidin 648 [des-Pro7,Phe8,Arg9]Lys-bradykinin
desulfated cholecystokinin-8 3725 CCK-8 (desulphated), des-CCK-8, desulfated sincalide
desulfated gastrin-14  {Sp: Human} 3558 minigastrin
desulfated gastrin-17  {Sp: Human} 8408 little gastrin I
desulfated gastrin-34  {Sp: Human} 8409
desulfated gastrin-71  {Sp: Human} 8410
DFGYVAE 3023
D-GL13K 14298 DGL13K
dGP1_035 14551
Dickkopf 1  {Sp: Human} 3701 Dickkopf-related protein 1, DKK 1
difelikefalin Approved drug Immunopharmacology Ligand 9044 CR845, D-Phe-D-Phe-D-Leu-D-Lys-[γ-(4-N-piperidinyl)amino carboxylic acid], FE-202845, Kapruvia®, Korsuva®, SEQ ID NO: 2
DkTx 4178 Double-knot toxin
d[Leu4]AVP 2190 [deamino-Cys1,Leu4,Arg8]vasopressin
d[Leu4,Dap8]VP 2189 [deamino-Cys1,Leu4,Dap8]vasopressin
d[Leu4Lys8]VP 2191 [deamino-Cys1,Leu4,Lys8]vasopressin, d[Leu4,Lys8]VP, d[Leu4]LVP, d[Leu4]lysine vasopressin
D-Lys0-[des-Arg10]kallidin 636 D-[Lys,Lys,des-Arg9]bradykinin
[D-Lys1,des-Arg10]kallidin 640 D-[Lys,des-Arg9]bradykinin
[D-Lys3]-GHRP-6 11814 [D-Lys] GHRP-6
[D-Lys6]GnRH-II 5581
1DMe 1477 [D-Tyr1,(NMe)Phe3]neuropeptide FF, [D.Tyr1,(N.Me)Phe3]NPFF
[125I]1DMe Ligand is labelled Ligand is radioactive 1483
dNal-cyc(Cys-Tyr-dTrp-Orn-Val)-Nal-NH2 3871
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2 635 analogue #30 [PMID: 19463875]
D-Nal,Cys,Tyr,D-Trp,Orn,Val,Cys,Nal-NH2 6172
dNK1_070 14547
dNPA 1489
dolcanatide 10011
DOTA-BASS 5645 DOTA-BASS analog 2
[111In]DOTA-BOC-ATE Ligand is labelled Ligand is radioactive 2063 [111In-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE
[111In]DOTA-dLVT Ligand is labelled Ligand is radioactive 3756 [111In]-DOTA-dLVT, [111In]-DOTA-Lys8-deamino-vasotocin, [111indium]DOTA-dLVT
DOTA/Eu relaxin-3 Ligand is labelled 11912
DOTA-JR11 10113
[111In,90Y]DOTA-LAN Ligand is labelled Ligand is radioactive 2056 DOTA-conjugated peptide, YIII-DOTA-LAN
[111In]DOTA-NOC Ligand is labelled Ligand is radioactive 2045 [111In-DOTA]-NOC, [InIII-DOTA]-NOC, [InIII-DOTA]-NOC
[111In,90Y]DOTA-NOC Ligand is labelled Ligand is radioactive 2057 90Y-DOTA-NOC, [90Y-DOTA]-1-Nal3-octreotide, YIII-DOTA-NOC
[111In]DOTA-NOC-ATE Ligand is labelled Ligand is radioactive 2064 [111In-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE
[111In,90Y]DOTA-OC Ligand is labelled Ligand is radioactive 2058 [3Y]DOTA-OC, [3Y]DOTA-octreotide, YIII-DOTA-OC
[111In,90Y]DOTA-TOC Ligand is labelled Ligand is radioactive 2059 YIII-DOTA-TOC, YIII-DOTA-Tyr3-octreotide, YIII-DOTA-TOC
dOX1_003 14550
DPDPE 1608 2,5-pen-enkephalin, D-penicillamine (2,5)-enkephalin, DPLPE
[3H]DPDPE Ligand is labelled Ligand is radioactive 3819 [3H]-[d-Pen2,d-Pen5]-Enkephalin, [3H]-DPDPE
d[Pen1,Tyr(Me)2]AVP 2225 1-deaminopenicillamine-2-(O-methyl-tyr)-argipressin, dPTyr(Me)AVP
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14) 632 [D-Phe6,β-Ala11,Phe13,Nle14]bombesin(6-14)
[D-Phe12]bombesin 6181
[D-Phe6]bombesin(6-13)methyl ester 6180
[D-Phe6]bombesin(6-13)propylamide 6182
D-Phe-CRF-(12-41) 3865 D-Phe-corticotropin-releasing factor(12-41), D-Phe-CRF(12-41), D-Phe12,Nle21,38,αMeLeu37-CRF
[D-Phe6, Leu13, Cpa14,ψ13-14]bombesin-(6-14) 3840 [D-Phe6,Cpa14,ψ13-14]bombesin6-14, [D-Phe6,Leu13,Cpa14,ψ13-14]bombesin-(6-14), analogue #7 [PMID: 19463875]
[D-Phe6, Stat13, Leu14]Bn(6-14) 12494 RM-2, RM2
DPK-060 14113 GKH17-WWW
[D-Pro4,D-Trp7,9,10]substance P (4-11) 6185
drotrecogin alfa Approved drug 6788 drotrecogin alfa (activated), HSDB 7366, Xigris®
DSLET 1609 [D-Ser2, Leu5, Thr6]-enkephalin, Dislet, DSTLE
D1SP 13660
DSTBULET 3873
(D-Thr6, D-Trp8,9)galanin(1-15)ol 6133 (D-THR6,D-TRP8,9,L-ALANINOL15)-GALANIN (1-15)
[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14) 6183 (D-Tpi6, Leu13ψ(CH2-NH)-Leu14)bombesin (6-14), D-Tpi-Gln-Trp-Ala-Val-Gly-His-Leu-Y(CH2-NH)-Leu-NH2 trifluoroacetate salt, RC-3095
[D-Trp2]galanin-(1-29) 3866 [D-Trp2]galanin(1-29)
[D-Trp8]γ-MSH 1334 D-Trp8 γ-melanocyte stimulating hormone, D-Trp8 γ-MSH, D-Trp8-y-MSH
[D-Trp11]neurotensin 1584 D-Trp11-neurotensin
[D-Trp32]NPY 1544 [D-Trp32] neuropeptide Y, [D-Trp32]-NPY
[D-Trp12]PTH-(7-34) (bovine) 1820 [D-Trp12]-PTH 7-34 (bovine)
[D-Trp12,Tyr34]PTH-(7-34) (bovine) 1819 [D-Trp12,Tyr34]-PTH 7-34 (bovine)
[125I]α-DTX Ligand is labelled Ligand is radioactive 2564
[D-Tyr6,β-Ala11,N-Me-Ala13,Nle14]bombesin-(6-14) 11434
[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14) Ligand is labelled Ligand is radioactive 631 [125I]-[Tyr6,βAla11,Phe13,Nle14] bombasin-6-14, [125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin(6-14)
[D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin-(6-14) 3946 [D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin6-14
[D-Tyr6,(R)-APA11,Phe13,Nle14]bombesin-(6-14) 633 [D-Phe6,(R)-APA11,Phe13,Nle14]bombesin(6-14)
[125I][D-Tyr6]bombesin-(6-13)-methyl ester Ligand is labelled Ligand is radioactive 628
[D-Tyr8]CYN 154806 2028 cyanamid 154806, CYN 154806, D-Tyr8-CYN 154806
[125I]DTyr-Gly-[(Nle28,31)CCK-26-33 Ligand is labelled Ligand is radioactive 6666
dulaglutide Approved drug 7638 GLP-1Fc, LY2189265, Trulicity®
duramycin 841
dusquetide 14001 IMX942, SGX942
d[Val4,DArg8]VP 3869
[D-Val5]NPS 5811
dVDAVP 2183 1-deamino-4-val-8-arg-vasopressin, [deamino-Cys1,Val4,D-Arg8]AVP, d[Val4]AVP
DW13.3 2527 ω-filistatoxin-Kh1a, ω-FLTX-Kh1a, DW13.3 toxin
DX600 11602 DX-600
[dY]1KP-10 4015
dynorphin-(1-11) 1618 dynorphin 1-11, dynorphin A (1-11)
dynorphin A  {Sp: Human, Mouse, Rat} 1620 dynA, dynorphin 1-17, dynorphin A (1-17)
dynorphin A-(1-13)  {Sp: Human, Mouse, Rat} 1619 dynorphin 1-13, dynorphin A (1-13)
dynorphin A-(1-8)  {Sp: Human, Mouse, Rat} 1621 dynorphin A (1-8)
dynorphin B  {Sp: Human, Mouse, Rat} 1622 rimorphin
dynorphin-(1-17)-NH2 1661 dynorphin 1-17-NH2
 
E Back to top
E2078 1648 E 2078, E-2078, N-Me-tyr(1)-N-Me-arg(7)-N-Et-leunh2(8)-dynorphin (1-8), N-methyl-Tyr1,N-methyl-Arg7,D-leu8-dynorphin-A(1-8)
E7 3915 (Trp63-Trp64)-C3a-(63-77), C3a receptor superagonist, EP141
EB1002 14664 compound ID 344 [ WO2023118263], neurokinin A (4-10)-S5K/F6Y/L9mL/M10Mox, SEQ ID NO: 23 [WO2023118263]
EC 5-21 2044
ecallantide Approved drug Immunopharmacology Ligand 6955 DX-88, FOV2302, Kalbitor®
echistatin 6594
ecnoglutide 13970 XW-003, XW003
E. coli heat-stable enterotoxin (STa) 4854
ectodysplasin A1  {Sp: Human} 6144 ectodysplasin-A isoform 1, ectodysplasin-A, membrane form, membrane isoform of ectodysplasin-A
ectodysplasin A2  {Sp: Human} 6143 ectodysplasin-A, secreted form, secreted form of ectodysplasin-A
edotreotide Approved drug 5638 DOTA-Tyr3-octreotide, DOTA0-Phe1-Tyr3-octreotide, Ga-DOTA-TOC, Ga-DOTATOC, SMT487, SomaKit TOC®
efanesoctocog alfa Approved drug 13086 ALTUVIIIO®, Altuvoct®, BIVV-001, BIVV001, Fc-VWF-XTEN
efineptakin alfa Immunopharmacology Ligand 11097 GX-I7, Hyleukin-7, Il-7 hybrid Fc, NT-I7, rhIL-7-hyFc, TJ-107
efinopegdutide 14750 HM-12525A, HM12525A, JNJ-64565111, JNJ64565111, LAPS-GLP-1/GCG, MK-6024, MK6024
eflapegrastim Approved drug 12180 eflapegrastim-xnst, HM-10460A, HM10460A, rolontis, Rolvedon®, SPI-2012, SPI2012
EFWSLAAPQRF-NH2 1478 EFW-NPSF
efzofitimod Immunopharmacology Ligand 13199 ATYR-1923, ATYR1923, KRP-R120
EG3287 11290 VEGFA(138-165)
EGF  {Sp: Human} 4916 urogastrone
[125I]EGF (human) Ligand is labelled Ligand is radioactive 4848 [125I]-epidermal growth factor
EISAI-1 1566
EISAI-2 1567
EK-1 11500
EK-1-C4 11501 EK1C4
Elabela/Toddler-11  {Sp: Human} 8526 ELA-11
Elabela/Toddler-21  {Sp: Human} 8525 ELA-21
Elabela/Toddler-32  {Sp: Human} 8524 ELA-32
elafin  {Sp: Human} Immunopharmacology Ligand 12035 cementoin, trappin-2
elamipretide Approved drug 14276 bendavia, Forzinity®, MTP-131, MTP131, SS-31, SS31
eledoisin 2086 ELD 950, ELD-950, eledone peptide
elosulfase alfa Approved drug 7392 BMN 110, rhGALNS, Vimizim®
endomorphin-1  {Sp: Human} 1623
endomorphin-2  {Sp: Human} 3668
β-endorphin  {Sp: Human} 1643 β-end
β-endorphin  {Sp: Mouse} 3722 β-end
β-endorphin  {Sp: Rat} 3723 β-end
endothelin-2  {Sp: Human} 990 ET-2
endothelin-1  {Sp: Human, Mouse, Rat} 989 ET-1
endothelin-3  {Sp: Human, Mouse, Rat} 1004 ET-3
endothelin-2  {Sp: Mouse, Rat} 3546 ET-2
eneboparatide 13815 AZP-3601, AZP3601, LA-PTH
enicepatide 14700 CT-388, CT388, RO-7795068, RO7795068
enlicitide Approved drug 13944 Lipfendra®, MK-0616, MK0616
ensovibep 11470 MP-0420, MP0420
ephrin-A1  {Sp: Human} 4908 EFNA1, EPH-related receptor tyrosine kinase ligand 1, immediate early response protein B61, TNF alpha-induced protein 4, tumor necrosis factor alpha-induced protein 4 (TNFAIP4)
ephrin-A2  {Sp: Human} 4909 EFNA2, EPH-related receptor tyrosine kinase ligand 6, HEK7 ligand, HEK7-L
ephrin-A3  {Sp: Human} 4910 EFNA3, EFL-2, EHK1 ligand, EPH-related receptor tyrosine kinase ligand 3
ephrin-A4  {Sp: Human} 4911 EFNA4, EPH-related receptor tyrosine kinase ligand 4, LERK-4
ephrin-A5  {Sp: Human} 4912 EFNA5, AL-1, EPH-related receptor tyrosine kinase ligand 7, LERK-7
ephrin-B1  {Sp: Human} 4913 EFNB1, EFL-3, ELK ligand, EPH-related receptor tyrosine kinase ligand 2, LERK-2
ephrin-B2  {Sp: Human} 4914 EFNB2, LERK-5
ephrin-B3  {Sp: Human} 4915 EFNB3, EPH-related receptor transmembrane ligand ELK-L3, EPH-related receptor tyrosine kinase ligand 8
epigen  {Sp: Human} 4917 EPG, epithelial mitogen
epiregulin  {Sp: Human} 4918
ErgTx-1 2612 CnErg1, CnErgTx1, ergtoxin, ergtoxin-like protein 1, ErgTx, ErgTx1, potassium channel toxin gamma-KTx 1.1
erythropoietin  {Sp: Human} Approved drug 4921 Epogen®, Procrit®
etanercept Approved drug Immunopharmacology Ligand 6789 Enbrel®, Rhu Tnfr:Fc, TNFR-Fc, TNR 001
etelcalcetide Approved drug 8375 AMG 416, AMG-416, KAI-4169, Parsabiv®, velcalcetide
[125I]ET-2 (human) Ligand is labelled Ligand is radioactive 992 [125I]endothelin-2
[125I]ET-1 (human, mouse, rat) Ligand is labelled Ligand is radioactive 991 [125I]endothelin-1
[18F]ET-1 (human, mouse, rat) Ligand is labelled Ligand is radioactive 994 [18F]endothelin-1
ETN029 14192 ETN-029, MC339
Eu-DTPA-hC3a Ligand is labelled 11286
Eu-DTPA-[Ser27, Nle70]hC5a Ligand is labelled 12516
europium-labelled INSL3 Ligand is labelled 3875
europium-labelled INSL5 Ligand is labelled 4375
europium-labelled mouse INSL5 Ligand is labelled 6522
europium-labelled R3(B1-22R) Ligand is labelled 8342 Eu R3(B1-22R)
europium-labelled relaxin Ligand is labelled 3874 europium-labelled H2 relaxin
europium-labelled relaxin-3-B/INSL5 A chimera Ligand is labelled 4374 Eu-R3/I5, europium-labelled H3-B/INSL5 A chimera
evorpacept 11592 ALX-148, ALX148
examorelin 1100 EP-23905, hexarelin, MF-6003
exendin-3 3730
exendin-4 Approved drug 1135 AC 2993, AC002993, AC2993A, Bydureon®, Byetta®
exendin-(9-39) 1138 exendin (9-39), exendin 3 [Heloderma horridum horridum (Mexican beaded lizard)] (9-39)-peptide 39-amide (from INN record), exendin(9-39), exendin-(9-39) amide, Exendin-3-(9-39) amide
[125I]exendin-(9-39) Ligand is labelled Ligand is radioactive 1137 [125I]exendin (9-39)
[125I]EYF Ligand is labelled Ligand is radioactive 1488 [125I]-EYF
[3H]EYF Ligand is labelled Ligand is radioactive 4021 [3H]-EYF
 
F Back to top
F180 2171 [2-hydroxy-3-mercaptopropionic acid-1, Phe-2, Hgn-4. Dab(Abu)-8]OT, F 180
FAM150A  {Sp: Human} 14203 AUG-β, augmentor-β, augmentor-beta
FAM237A  {Sp: Human} 14579 neurosecretory protein GL (NPGL)
FAM150B  {Sp: Human} 14204 ALKAL2, AUG-α, augmentor-α, augmentor-alpha
FAM237B  {Sp: Human} 14578 neurosecretory protein GM (NPGM)
Fas ligand  {Sp: Human} Immunopharmacology Ligand 5078 apoptosis antigen ligand, CD95L
fertirelin 9341
FGF-1  {Sp: Human} 4923 acidic fibroblast growth factor, beta-endothelial cell growth factor, heparin-binding growth factor 1 (HBGF-1)
FGF-10  {Sp: Human} 9641
FGF-18  {Sp: Human} 10974
FGF-19  {Sp: Human} 11545 fibroblast growth factor 19
FGF-2  {Sp: Human} 4924 basic fibroblast growth factor (bFGF), fibroblast growth factor 2 (FGF-2), heparin-binding growth factor 2 (HBGF-2)
FGF-21  {Sp: Human} 11721 fibroblast growth factor 21
FGF-23  {Sp: Human} 9291 fibroblast growth factor 23
FGF-3  {Sp: Human} 9629 fibroblast growth factor 3, HBGF-3, INT2
FGF-4  {Sp: Human} 4925 heparin secretory-transforming protein 1 (HST-1), heparin-binding growth factor 4 (HBGF-4), transforming protein KS3
FGF-5  {Sp: Human} 4926 HBGF-5, heparin-binding growth factor 5, Smag-82
FGF-6  {Sp: Human} 4927 heparin secretory-transforming protein 2 (HST-2), heparin-binding growth factor 6 (HBGF-6), HSTF-2
FGF-7  {Sp: Human} 4928 HBGF-7, heparin-binding growth factor 7
FGF-8  {Sp: Human} 4929 androgen-induced growth factor (AIGF), heparin-binding growth factor 8 (HBGF-8)
FGF-9  {Sp: Human} 4930 glia-activating factor (GAF), heparin-binding growth factor 9 (HBGF-9)
[F/G]N/OFQ-(1-13)-NH2 1690 [F/G]N/OFQ(1-13)NH2, [F/G]nociceptin(1-13)NH2, [F/G]nociceptin/orphanin FQ(1-13)NH2, [F/G]orphanin FQ(1-13)NH2
fibrinogen  {Sp: Human} 6749 coagulation factor I
fibrinogen alpha chain  {Sp: Human} 6750
fibrinogen beta chain  {Sp: Human} 6751
fibrinogen gamma chain  {Sp: Human} 6752
fibronectin  {Sp: Human} 6754
filgrastim Approved drug Immunopharmacology Ligand 6968 Filcad®, Imumax ®, R-METHUG-CSF
FK 224 2103 FK-224, FK224
F2L  {Sp: Human} 3935
F2L  {Sp: Mouse, Rat} 3574
FLICE-like inhibitory protein  {Sp: Human} 5186 FLIP, CASP8 and FADD-like apoptosis regulator
FLICE-like inhibitory protein subunit p12  {Sp: Human} 5187 FLIP subunit p12, CASP8 and FADD-like apoptosis regulator subunit p12
FLICE-like inhibitory protein subunit p43  {Sp: Human} 5188 FLIP subunit p43, CASP8 and FADD-like apoptosis regulator subunit p43
FLPLAR 5761
FLRT3  {Sp: Rat} 5900 fibronectin-like domain-containing leucine-rich transmembrane protein 3, leucine-rich repeat transmembrane protein FLRT3
FLTChaAR 5777
F2L-[125I]Tyr Ligand is labelled Ligand is radioactive 1045
Flu-CCL3 Ligand is labelled 760 Flu-LD78α, Flu-MIP-1α, fluorescent macrophage inflammatory protein-1α
4-fluorobenzoyl-FGLRW-NH2 4014
fMet-Ile-Phe-Leu 1021 fMet-Ile-Phe-Leu [S. aureus]
fMet-Ile-Val-Ile-Leu 5842 fMet-Ile-Val-Ile-Leu [L. monocytogenes]
fMet-Ile-Val-Thr-Leu-Phe 5841 fMet-Ile-Val-Thr-Leu-Phe [L. monocytogenes]
fMet-Leu-Phe 1022 fMLP, fMetLeuPhe, fMLF, formyl-Met-Leu-Phe
[3H]fMet-Leu-Phe Ligand is labelled Ligand is radioactive 1018 [3H]fMet-Leu-Phe, [3H]fMLP
fMet-Leu-Phe-Glu 5840 fMet-Leu-Phe-Glu [E. coli]
fMet-Leu-Phe-Ile-Ile 14145 fMLFII
fMet-Leu-Phe-Ile-Ile-Lys-FITC Ligand is labelled 5843
fMet-Met-Trp-Leu-Leu 5837
fMet-Met-Tyr-Ala-Leu-Phe 1023 fMet-Met-Tyr-Ala-Leu-Phe [Mitochondria]
FMRFamide 4195 Phe-Met-Arg-Phe-amide
Fms-related tyrosine kinase 3 ligand  {Sp: Human} 4932 FLT3L, Flt3 ligand, SL cytokine
follistatin  {Sp: Human} 4933 FS, activin-binding protein
FP-1039 11581 FGFR1:Fc, FP1039, GSK-3052230, GSK3052230, HGS1036
F peptide 6247
(3,5)-[19F]2-Phe-ψ-Ala Ligand is labelled Ligand is radioactive 11370 (3,5)-difluoro Phe-ψ-Ala
FPRL1-inhibitor protein 6264 FLIPr
FPYVAE peptide [PMID: 20494585] 3024
FSH  {Sp: Human} Approved drug 1157 follitropin, human follicle stimulating hormone
FSH  {Sp: Mouse} 4386 follicle stimulating hormone
FSH  {Sp: Rat} 4387 follicle stimulating hormone
FSH deglycosylated α/β 1158
[125I]FSH (human) Ligand is labelled Ligand is radioactive 3780 [125I]-follicle-stimulating hormone, [125I]-FSH
FSH β subunit  {Sp: Human} 3733 follitropin beta subunit, FSH beta subunit, FSHβ, FSH-B
FSH β subunit  {Sp: Mouse} 4384 follitropin beta subunit, FSHβ, FSH-B, FSHB
FSH β subunit  {Sp: Rat} 4385 FSH beta subunit, FSHβ
FSH α subunit-deglycosylated form 5536
FSH β subunit-deglycosylated form 5537
fulipiftide 14377 BR 21001, BR21001, BRM-421, BRM421, PSP 29-mer
furin inhibitor peptide 8668
2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH2 Ligand is labelled 4050 Alexa Fluor 594-2fLI
[3H]2-furoyl-LIGRL-NH2 Ligand is labelled Ligand is radioactive 6660
2-furoyl-LIGRL[N[3H]propionyl]-O-NH2 Ligand is labelled Ligand is radioactive 4049 [3H]propionyl-2fLI
2-furoyl-LIGRLO-amide 3851
Fz7-21 10324
 
G Back to top
G4120 6588 cyclic Arg-Gly-Asp-containing pentapeptide, cyclic RGD, G 4120, G-4120, L-cysteine, N-(mercaptoacetyl)-D-tyrosyl-L-arginylglycyl-L-alpha- aspartyl-cyclic(1-->5)-sulfide, 5-oxide
GA31 Immunopharmacology Ligand 14580
Ga-DOTA-NOC 5639
[Ga-DOTA,Tyr3,Thr8]octreotide 5632 Ga-DOTA-octreotate, Ga-DOTA-TATE, Ga-DOTATATE
Ga-KE88 5640
GAL-101 14214 D-Trp-Aib, GAL101, MRZ-99030
galanin  {Sp: Human} 3592
galanin  {Sp: Mouse, Rat} 3593
galanin  {Sp: Pig} 6129
galanin(1-10) 6140
galanin(1-11) 6084 AR-M1717
galanin-(1-11) 5356 galanin (1-11)
galanin(1-12) 6141
galanin(1-15) 6086
galanin(2-11) 5357 AR-M1896
galanin(1-13)amide 6085
galanin(D-Trp2) (pig) 6095
galanin(1-19) (human) 6088
galanin(1-20) (human) 6137
galanin(2-30) (human) 6090
galanin(3-30) (human) 6138
galanin-like peptide  {Sp: Human} 3594
galanin-like peptide  {Sp: Mouse} 3595
galanin-like peptide  {Sp: Pig} 6120
galanin-like peptide  {Sp: Rat} 3596
galanin(10-29) (pig) 6094
galanin(2-29) (pig) 6130
galanin(3-29) (pig) 6091
galanin(5-29) (pig) 5359 galanin (5-29) (pig)
galanin(7-29) (pig) 6083
galanin(10-29) (rat/mouse) 6093
galanin(1-19) (rat/mouse) 6139
galanin(2-29) (rat/mouse) 3876 galanin (2-29)
galanin(3-29) (rat/mouse) 6092
galanin(5-29) (rat/mouse) 6134
galanin(9-25) (rat/mouse) 6136
galanin(9-29) (rat/mouse) 6135
galanin(1-16) (rat/mouse/pig) 6087
Gal-B2 6105 NAX 5055
Gal-B5 6107
Gal-B2-C10 6112
Gal-B2-C12 6113
Gal-B2-C14 6114
Gal-B2-C18 6115
Gal-B2-C8 6111
Gal-B2-dPEG24 6106
Gal-B2-MPEG4 6116
galectin-1  {Sp: Human} Immunopharmacology Ligand 6603 GBP
galectin-3  {Sp: Human} Immunopharmacology Ligand 6619 galectin 3, GALIG, LGALS2, MAC-2
galectin 9  {Sp: Human} Immunopharmacology Ligand 9594 Ecalectin, Gal-9, Tumor antigen HOM-HD-21
galectin-3 binding protein  {Sp: Human} Immunopharmacology Ligand 6615 L3 antigen, Mac-2-binding protein, MAC-2-BP
Gal-(K)4 6110
galparan 6096
GALP(1-32) (human) 6121
GALP(3-32) (human) 6122
Gal-R2-dPEG24 6108
ganirelix Approved drug 3877 D 24598, D-24598, Orgalutran®, RS 26306, RS-26306
Ga-NODAGA-LM3 5643
gastric inhibitory polypeptide  {Sp: Human} 3542 GIP, GIP(1-42)
gastric inhibitory polypeptide  {Sp: Mouse} 3543 GIP, gastric inhibitory peptide, glucose-dependent insulinotropic polypeptide
gastric inhibitory polypeptide  {Sp: Rat} 1126 GIP, gastric inhibitory peptide, glucose-dependent insulinotropic polypeptide
gastrin-14  {Sp: Human} 8411
gastrin-17  {Sp: Human} 3559 gastrin I
gastrin-34  {Sp: Human} 3562 big gastrin
gastrin-52  {Sp: Human} 3565 G52
gastrin-6  {Sp: Human} 3557
gastrin-71  {Sp: Human} 3566
gastrin-17  {Sp: Mouse} 3560
gastrin-34  {Sp: Mouse} 3563 big gastrin (mouse)
gastrin-17  {Sp: Rat} 3561
gastrin-34  {Sp: Rat} 3564 big gastrin (rat)
[125I]gastrin Ligand is labelled Ligand is radioactive 3781 [125I]-gastrin
[3H]gastrin Ligand is labelled Ligand is radioactive 3821 [3H]-gastrin
gastrin-releasing peptide  {Sp: Human} 612 GRP
gastrin-releasing peptide  {Sp: Mouse, Rat} 3579
gastrin-releasing peptide  {Sp: Pig} 3581
gastrin releasing peptide(14-27) (human)  {Sp: Human} 6175 GRP(14-27)
GaTx1 4198 Toxin GaTx1
GaTx2 4199
[G(B24)S]R3/I5 11909
GC-373 11635 GC373, N-benzyloxycarbonyl-L-leucyl-3-(2-oxopyrrolidin-3-yl)-L-alaninal
G-CSF  {Sp: Human} Approved drug Immunopharmacology Ligand 4934 Granocyte®
GDNF  {Sp: Human} 4940 astrocyte-derived trophic factor (ATF)
[125I]GDNF (rat) Ligand is labelled Ligand is radioactive 4851 [125I]-GDNF (rat)
GE-137 Ligand is labelled 8585
gG-2p20 5839
ghrelin  {Sp: Human} 1099
ghrelin  {Sp: Mouse, Rat} 3597
GHRH  {Sp: Human} 2270 growth hormone-releasing factor (GHRF), growth hormone-releasing hormone (GHRH), somatoliberin, somatorelin
GHRH  {Sp: Mouse} 3602 growth hormone-releasing factor, somatoliberin (mouse)
GHRH  {Sp: Rat} 3603
[125I]GHRH (human) Ligand is labelled Ligand is radioactive 3783 [125I]-GHRH, [125I]-growth hormone releasing hormone, [125I]-Tyr10-hGHRH(1-44)NH2, [125I]GHRH(1-44)NH2
GHRH-(1-29)-NH2 (human) 1103 GHRH (1-29)NH2 (human), human growth hormone releasing hormone (1-29)NH2
GHRH-(1-29)-NH2 (rat) 1104 GHRH(1-29)NH2 (rat), rat growth hormone releasing hormone (1-29)NH2
GHRH-(1-29)-OH (human) 1105 GHRH(1-29)OH (human), human growth hormone releasing hormone (1-29)OH
GHRP-6 1093 GH-releasing hexapeptide 6, growth hormone releasing hexapeptide, growth hormone releasing peptide-6, Skf 110679
GIP-(10-30) 1128 gastric inhibitory polypeptide10-30, GIP10-30
GIP-(7-30) 1130 gastric inhibitory polypeptide7-30, GIP7-30
GIP-(6-30)-amide 1129 gastric inhibitory polypeptide6-30 amide, GIP6-30 amide
[125I]GIP (human) Ligand is labelled Ligand is radioactive 1131 [125I]-GIP, [125I]gastric inhibitory polypeptide
glepaglutide 10885 Zeydovio®, ZP-1848, ZP1848
[Gln8]GnRH 1169 chicken GnRH
globular adiponectin  {Sp: Human} 3727 gAdipo, gelatin-binding protein
GLP-1-(9-36) 6524
[125I]GLP-1-(7-36)-amide Ligand is labelled Ligand is radioactive 1134 [125I]GLP-1, [125I]GLP-1(7-36)amide, [125I]glucagon-like peptide 1 (7-36)
GLP-2 analogue 10 Immunopharmacology Ligand 9896
GLPDGG peptide [PMID: 20494585] 2980
[125I]GLP-1-(7-37) (human) Ligand is labelled Ligand is radioactive 3784 [125I]-GLP-1(7-37), [125I]-glucagon-like peptide-1(7-37), [125I]GLP-1(7-37)
[125I][Glp65Nle75,Tyr77]apelin-13 Ligand is labelled Ligand is radioactive 3761 [125I](Pyr1)[Nle75,Tyr77]-apelin-13, [125I]-[Glp65Nle75,Tyr77]apelin-13, [125I][Glu65,Nle75,Tyr77]apelin-13
GLP-2-(1-29) (rat) 1139 GLP-2 (1-29) (rat), rat glucagon-like peptide 2 (1-29)
glucagon  {Sp: Human, Mouse, Rat} Approved drug 1136
glucagon-(1-21) 1146 glucagon 1-21
glucagon-(1-6) 1147 glucagon 1-6
[125I]glucagon (human, mouse, rat) Ligand is labelled Ligand is radioactive 3785 [125I]-glucagon
glucagon-like peptide 2  {Sp: Human} 1140 GLP-2, GLP-2 (1-33), glucagon-like peptide 2 (1-33)
glucagon-like peptide 2-(3-33)  {Sp: Human} 1143 GLP-2 (3-33)
glucagon-like peptide 1  {Sp: Human, Mouse, Rat} 5194 GLP-1
glucagon-like peptide 1-(7-37)  {Sp: Human, Mouse, Rat} 3544 GLP-1(7-37), GLP-1-(7-37)
glucagon-like peptide 2  {Sp: Mouse} 3540 GLP-2, GLP-2 (1-33)
glucagon-like peptide 2-(3-33)  {Sp: Mouse} 3541 GLP-2 (3-33)
glucagon-like peptide 2  {Sp: Rat} 1141 GLP-2, GLP-2 (1-33), glucagon-like peptide 2 (1-33)
glucagon-like peptide 2-(2-33)  {Sp: Rat} 1142 GLP-2 (2-33), rat glucagon-like peptide 2 (2-33)
glucagon-like peptide 2-(3-33)  {Sp: Rat} 1144 GLP-2 (3-33)
glucagon-like peptide 1-(7-36) amide  {Sp: Human, Mouse, Rat} 1132 GLP-1(7-36)amide
glucarpidase Approved drug 7450 Voraxaze®
glutathione PDB Ligand 6737 GSH
glycoprotein hormone common alpha subunit  {Sp: Human} 3731 chorionic gonadotropin alpha chain, FSHα, GPHα, HCGα, LHα, TSHα
glycoprotein hormone common alpha subunit  {Sp: Mouse} 4377 FSHα, glycoprotein hormones alpha polypeptide, GPHα, hCGα, HCGα, LHα, TSHα
glycoprotein hormone common alpha subunit  {Sp: Rat} 4378 chorionic gonadotropin alpha chain, FSHα, HCGα, LHα
glycyl-sarcosine 9505 Gly-Sar, glycylsarcosine
GM-109 1466 GM 109, GM109
GMAP(1-41)  {Sp: Pig} 6131 galanin message associated peptide fragment 1-41 amide, porcine, preprogalanin 65-105 amide
GMAP(44-59)  {Sp: Pig} 6132 galanin message associated peptide fragment 44-59 amide, preprogalanin 108-123 amide
GM-CSF  {Sp: Human} Immunopharmacology Ligand 4942 colony-stimulating factor, CSF
GnRH I  {Sp: Human, Mouse, Rat} 1162 GnRH, gonadoliberin, gonadotropin releasing hormone, LH-RH (LHRH)
[125I]GnRH I (human, mouse, rat) Ligand is labelled Ligand is radioactive 3786 [125I]-GnRH I, [125I]-gonadotropin-releasing hormone I
GnRH II  {Sp: Human} 1164 gonadoliberin II, gonadoliberin-2, gonadotropin-releasing hormone II, LH-RH II, luliberin II, luteinizing hormone-releasing hormone II
[125I]GnRH II (human) Ligand is labelled Ligand is radioactive 3787 [125I]-GnRH II, [125I]-gonadotropin-releasing hormone II
GnRH III 3878 gonadoliberin III, gonadoliberin-3, Gonadotropin-releasing hormone III, lamprey GnRH III, Luliberin III
goserelin Approved drug 3879 decapeptide I, ICI 118630, Zoladex®
gosicalcetide 14380 N-acetyl-S-(L-cystein-S-yl)-D-cysteinyl-D-arginyl-D-arginyl-(2R)-2-aminobutanoyl-D-arginyl-D-alanyl-D-argininamide
gosteganan 14105 HPRP-A1, PL-18
GPR15L  {Sp: Human} Immunopharmacology Ligand 10567 antimicrobial peptide-57, colon-derived SUSD2 binding factor
GPR15L (71-81)  {Sp: Human} 10568
GR100679 3880 GR 100679, GR-100679
GR138676 2128 GR 138676, GR-138676
GR1.4 14456
GR231118 1529 GR 231118, GR-231118, GW 1229, GW-1229, GW1229
GR3.1.2 14457
GR64349 3881 GR-64349, Lys-Asp-Ser-Phe-Val-Gly-(R-γ-lactam)
GR94800 3882 GR 94800, GR-94800
[125I]GR231118 Ligand is labelled Ligand is radioactive 1531 [125I]1229U91, [125I]GW1229
[3H]GR100679 Ligand is labelled Ligand is radioactive 3822 [3H]-GR100679
ω-grammotoxin SIA 2539 ω-GrTx SIA, omega-grammotoxin SIA, omega-GsTx SIA, omega-GTX SIA
GRASP 12844
gremlin 1  {Sp: Human} 11768
growth arrest specific protein 6  {Sp: Human} 4935 Gas6, AXL receptor tyrosine kinase ligand
growth/differentiation factor-1  {Sp: Human} 4936 GDF1, embryonic growth/differentiation factor 1, GDF-1
growth/differentiation factor-10  {Sp: Human} 4937 GDF10, bone morphogenetic protein 3B (BMP-3B), bone-inducing protein (BIP), GDF-10
growth/differentiation factor-11  {Sp: Human} 4876 BMP11, bone morphogenetic protein 11, GDF-11
growth differentiation factor 15  {Sp: Human} 9735 GDF15, macrophage inhibitory cytokine-1, MIC-1, MIC1, PTGFB
growth/differentiation factor-3  {Sp: Human} 4938 GDF3, GDF-3
growth/differentiation factor-5  {Sp: Human} 4879 GDF5, BMP-14, bone morphogenetic protein 14, cartilage-derived morphogenetic protein 1 (CDMP-1), growth/differentiation factor 5 (GDF-5), radotermin
growth/differentiation factor-6  {Sp: Human} 4878 GDF6, BMP13, bone morphogenetic protein 13, GDF-6, growth/differentiation factor 16
growth/differentiation factor-7  {Sp: Human} 4877 GDF7, BMP12, GDF-7
growth/differentiation factor-9  {Sp: Human} 4939 GDF9, GDF-9
growth hormone 1  {Sp: Human} Approved drug 4943 NutropinAq®, Omnitrope®, Saizen®, somatotropin
growth hormone 2  {Sp: Human} 4944 GH2
GRP-(18-27)  {Sp: Human, Pig} 3582 GRP (18-27), GRP(18-27), GRP-18-27
GRP-(18-27)  {Sp: Mouse, Rat} 3583 GRP (18-27), GRP(18-27), neuromedin C
[125I]GRP (human) Ligand is labelled Ligand is radioactive 3788 [125I]-gastrin-releasing peptide, [125I]-GRP
GsMTx-4 4206 M-theraphotoxin-Gr1a, M-TRTX-Gr1a, MTx4, Toxin GsMTx-4
guanylin  {Sp: Human} 4945
guanylyl cyclase-activating protein 1  {Sp: Human, Mouse, Rat} 9164 GCAP1
guanylyl cyclase-activating protein 2  {Sp: Human, Mouse, Rat} 9165 GCAP2
GxTx-1E 7760 κ-theraphotoxin-Pg1a, κ-TRTX-Pg1a, guangxitoxin-1E
GYPGKF-NH2 3883
GYPGQV-NH2 3739
 
H Back to top
H3 Ac-B10-27(13-17 HC) 11908
β-haemoglobin  {Sp: Human} 5370 hemoglobin beta chain, hemoglobin subunit beta
HAS-NMU 7925
[3H]haTRAP Ligand is labelled Ligand is radioactive 3823 [3H]-haTRAP, Ala-p-fluoroPhe-Ala-Arg-cyclohexylAla-homoArg-[3H]Tyr-amide
HaTx1 7762 κ-theraphotoxin-Gr1a, κ-TRTX-Gr1a, hanatoxin-1
HB-EGF  {Sp: Human} 4948 DT-R
H3B10-27(13/17αF) 14152
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH 2079
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH 2080
H-c[DCys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH 2081
hCG  {Sp: Human} 1160 CG, human chorionic gonadotropin
H3-CoA-20 7035
HelaTx1 7737 HL15-1-1, potassium channel toxin kappa-KTx 5.1
α-helical CRF 923 α-helical corticotropin, α-helical CRF (9-41), alpha-helical CRF (9-41)
helodermin 2280 Exendin 2
hemokinin 1  {Sp: Mouse} 2087 HK-1, HEK-1
hepatocyte growth factor  {Sp: Human} 4949 HGF, hepapoietin A, scatter factor (SF)
hepatocyte growth factor alpha chain  {Sp: Human} 4950 HGF alpha chain
hepatocyte growth factor beta chain  {Sp: Human} 4951 HGF beta chain
hepcidin-20  {Sp: Human} 5379 Hepc20
hepcidin-25  {Sp: Human} 5378 Hepc25
HER-096 13049 HER096
heteropodatoxin-2 2581 κ-sparatoxin-Hv1b, κ-SPRTX-Hv1b, HpTX2, HpTx2, Toxin KJ6
δ-hexatoxin-Mg1a 7569 Delta-HXTX-Mg1a, neurotoxin magi-4
HGF-inhibitor 1  {Sp: Human} 5315 HAI-1, hepatocyte growth factor activator inhibitor type 1, Kunitz-type protease inhibitor 1
hGLP-2(1-33,M10Y) 11804
hGLP-2(3-33,M10Y) 11805
hINSL5: A8-21 (T15K) 12504 analogue 13 [PMID: 26824523]
hINSL5: A8-21 (T9R) 9324
Hip-His Leu 5197 Hippuryl-His-Leu
[His5,Arg19]PTH-(1-34) (human) 1793 [His5,Arg19]-PTH 1-34 (human)
[His5,D-Tyr6]GnRH 1170
[125I][His9]ghrelin (human) Ligand is labelled Ligand is radioactive 1094 [125I-His9]ghrelin, [125I] His9-ghrelin (human)
[His5]PTH-(1-34) (human) 1794 [His5]-PTH 1-34 (human)
histatin 1  {Sp: Human} 14556
histerelin 9344
histidyl-leucine 9485 His-leu, Histidylleucine, L-histidyl-L-leucine
histrelin Approved drug 3884 ORF 17070, RWJ 17070, Vantas®
[His4, Tyr5, Trp6, His7]TIP39 (human) 5572 [His4, Tyr5, Trp6, His7]-hTIP39, [His4, Tyr5, Trp6, His7]-TIP39 (human), HYWH-TIP39
HIV-1 matrix protein p17 8495
HIV-Tat 773 Tat1-86
hK2p01 derivative KLK2 inhibitor 8672
Hm1a 9553 δ-theraphotoxin-Hm1a
HmTx1 2580 κ-theraphotoxin-Hm1a, κ-TRTX-Hm1a, Heteroscodratoxin-1
hongotoxin-1 2545 HgTX1, potassium channel toxin α-KTx 2.5
Hp(2-20) 1046
HpARI Immunopharmacology Ligand 9685 H. polygyrus Alarmin Release Inhibitor
H. polygyrus TGF-β mimic Immunopharmacology Ligand 9713 Hp-TGM
[125I]Hpp-desArg10HOE140 Ligand is labelled Ligand is radioactive 3791 [125I]-Hpp-desArg9HOE140
[125I]HPP-HOE140 Ligand is labelled Ligand is radioactive 11436 [125I]-3-4-hydroxyphenyl-propionyl-d-Arg0-[Hyp3,Thi5,d-Tic7,Oic8]bradykinin
[125I]-HPP-icatibant Ligand is labelled Ligand is radioactive 11158 [(125)I]-HPP-Hoe 140, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-BK, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin, [125I]3-4 hydroxyphenyl-propionyl-icatibant
H3 relaxin (A chain)  {Sp: Rat} 11924
H3 relaxin (B chain)  {Sp: Rat} 11925
HS014 1321 HS 014
HS024 1328 cyclic[AcCys3,Nle4,Arg5,D-Nal7,Cys-NH2(11)]alpha-MSH-(3-11), HS 024
hsp60  {Sp: Human} Immunopharmacology Ligand 4953 heat shock 60kD protein 1 (chaperonin), HSP-60, mitochondrial matrix protein P1
hsp90α1  {Sp: Human} 7752 HSP90A, HSPC1, HSPCA
hsp90β  {Sp: Human} 5365 heat shock 84 kDa, heat shock protein HSP 90-beta, HSP 84, HSP84
H3 14s18 stapled B-chain 11910
HsTX1[R14A] Immunopharmacology Ligand 9582 KTx 6.3
5-HT-moduline 137 PEPTIDE1{L.S.A.L}$$$$
human GIP(1-30)NH2 8973
human GIP(3-30)NH2 8971
human GIP(3-42)NH2 8970
human GIP(5-30)NH2 8972
humanin  {Sp: Human} 1047 formyl humanin
huntingtin  {Sp: Human} 5199 huntingtin protein
huwentoxin IV 7570 huwentoxin-4, HwTx-IV
[Hyp3]bradykinin  {Sp: Human} 3578 [Hyp3]-BK, [hydroxyproline3]-bradykinin, [Hyp3]-bradykinin
[Hyp3,Tyr(Me)8]BK 3841 [Hyp3,Tyr(Me)8]bradykinin
 
I Back to top
iberiotoxin Immunopharmacology Ligand 4218 IbTX
i-Boc-Met-Leu-Phe 1028
ICAM-1  {Sp: Human} 6757
ICAM-2  {Sp: Human} 6756
icatibant Approved drug Immunopharmacology Ligand 667 D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK, Firazyr®, HOE 140, HOE140
ICI 174,864 1636 ICI-174,864, ICI-174864
ICOS ligand  {Sp: Human} Immunopharmacology Ligand 9593 CD275, B7 homolog 2, B7-H2, B7-related protein 1, B7RP-1, ICOS-L
icotrokinra Approved drug Immunopharmacology Ligand 14181 Icotyde®, JNJ-2113, JNJ-77242113, JNJ77242113
IDR-1 14525 innate defense regulator peptide-1
γ-iE-DAP 9504 γ-D-glutamyl-meso-diaminopimelic acid, Gamma-D-Glu-mDAP, Gamma-d-glutamyl-meso-diaminopimelic acid, iE-DAP
IFN-α10  {Sp: Human} Immunopharmacology Ligand 4956 IFN alpha-10, interferon alpha-10, interferon alpha-6L, interferon alpha-C
IFN-α1/13  {Sp: Human} Immunopharmacology Ligand 4955 IFN-α1, IFN-α13, IFN-alpha 1/13, interferon alpha-1/13, interferon alpha-D
IFN-α14  {Sp: Human} Immunopharmacology Ligand 4957 IFN alpha-14, interferon alpha-14, interferon alpha-H, interferon lambda-2-H
IFN-α16  {Sp: Human} Immunopharmacology Ligand 4958 IFN alpha-16, interferon alpha-16, interferon alpha-WA
IFN-α17  {Sp: Human} Immunopharmacology Ligand 4959 IFN alpha-17, interferon alpha-17, interferon alpha-88, interferon alpha-T
IFN-α2  {Sp: Human} Approved drug Immunopharmacology Ligand 4960 IFN-alpha-2, interferon alpha-2, Roferon A®
IFN-α21  {Sp: Human} Immunopharmacology Ligand 4961 IFN-alpha 21, interferon alpha-21, interferon alpha-F
IFN-α4  {Sp: Human} Immunopharmacology Ligand 4962 IFN-alpha-4, interferon alpha-4 , interferon alpha-4B, interferon alpha-76, interferon alpha-M1
IFN-α5  {Sp: Human} Immunopharmacology Ligand 4963 IFN-alpha-5, interferon alpha-5, interferon alpha-61, interferon alpha-G
IFN-α6  {Sp: Human} Immunopharmacology Ligand 4964 IFN-alpha-6, interferon alpha-54, interferon alpha-6, interferon alpha-K
IFN-α7  {Sp: Human} Immunopharmacology Ligand 4965 IFN-alpha-7, interferon alpha-7, interferon alpha-J, interferon alpha-J1
IFN-α8  {Sp: Human} Immunopharmacology Ligand 4966 IFN-alpha-8, interferon alpha-8, interferon alpha-B, interferon alpha-B2
IFN-β  {Sp: Human} Immunopharmacology Ligand 4967 Avonex® (recombinant IFN-beta-1a), fibroblast interferon, interferon beta
IFN-γ  {Sp: Human} Approved drug Immunopharmacology Ligand 4968 Actimmune®, immune interferon, interferon gamma
IFN-κ  {Sp: Human} Immunopharmacology Ligand 4969 interferon kappa
IFN-λ1  {Sp: Human} Immunopharmacology Ligand 4993 IFN-lambda-1, interferon lambda-1, interferon-λ1, interleukin-29
IFN-λ2  {Sp: Human} Immunopharmacology Ligand 4991 cytokine Zcyto20, IFN-lambda-2, interferon lambda-2, interferon-λ2, interleukin-28A
IFN-λ3  {Sp: Human} Immunopharmacology Ligand 4992 cytokine Zcyto22, IFN-lambda-3, IFN-lambda-4, interleukin-28B (IL-28B), interleukin-28C (IL-28C)
IFN-ω  {Sp: Human} Immunopharmacology Ligand 4970 interferon alpha-II-1, interferon omega-1
IFN-β1a (recombinant human) Approved drug 8339 Avonex®, Rebif®
IFN-γ1b (human recombinant) Approved drug 8341 Actimmune®., IFNγ2a
IFN-α2b (recombinant human) Approved drug 8338 Intron A®, intronA
IFN-β1b (recombinant human) Approved drug Immunopharmacology Ligand 8340 Betaferon®, Betaseron®, Extavia®, IFNb1b
IgE heavy chain Immunopharmacology Ligand 9557
IL-10  {Sp: Human} Immunopharmacology Ligand 4975 interleukin-10
IL-11  {Sp: Human} Immunopharmacology Ligand 4976 interleukin-11
IL-12  {Sp: Human} Immunopharmacology Ligand 4977 IL-12 p70
IL-13  {Sp: Human} Immunopharmacology Ligand 4980 hematopoietic growth factor, interleukin-13, mast cell growth factor, multipotential colony-stimulating factor, P-cell-stimulating factor
IL-15  {Sp: Human} Immunopharmacology Ligand 4981 interleukin-15
IL-16  {Sp: Human} Immunopharmacology Ligand 14695 lymphocyte chemoattractant factor (LCF)
IL-18  {Sp: Human} Immunopharmacology Ligand 4983 ibocatdekin, interferon-γ-inducing factor, interleukin-1 gamma (IL-1 gamma), interleukin-18
IL-19  {Sp: Human} Immunopharmacology Ligand 4984 interleukin-19, melanoma differentiation-associated protein-like protein
IL-1α  {Sp: Human} Immunopharmacology Ligand 4973 hematopoietin-1, interleukin-1 alpha
IL-1β  {Sp: Human} Immunopharmacology Ligand 4974 catabolin, interleukin-1 beta
IL-2  {Sp: Human} Approved drug Immunopharmacology Ligand 4985 aldesleukin, interleukin-2, Proleukin®
IL-20  {Sp: Human} Immunopharmacology Ligand 4986 cytokine Zcyto10, interleukin-20
IL-21  {Sp: Human} Immunopharmacology Ligand 4987 interleukin-21, ZA11
IL-22  {Sp: Human} Immunopharmacology Ligand 4988 cytokine Zcyto18, interleukin-22
IL-23  {Sp: Human} Immunopharmacology Ligand 4978
IL-24  {Sp: Human} Immunopharmacology Ligand 4990 interleukin-24, MDA-7, melanoma differentiation-associated gene 7 protein
IL-25  {Sp: Human} Immunopharmacology Ligand 5876 IL-17E, interleukin-17E, interleukin-25
IL-27  {Sp: Human} Immunopharmacology Ligand 6151
IL-3  {Sp: Human} Immunopharmacology Ligand 4994 interleukin-3 (IL-3), multilineage-colony-stimulating factor (mCSF)
IL-31  {Sp: Human} Immunopharmacology Ligand 4995 interleukin-31
IL-33  {Sp: Human} Immunopharmacology Ligand 5880 IL-1F11
IL-34  {Sp: Human} Immunopharmacology Ligand 8975
IL-36α  {Sp: Human} Immunopharmacology Ligand 5881 FIL1 epsilon, interleukin-1 epsilon (IL-1 epsilon)
IL-36β  {Sp: Human} Immunopharmacology Ligand 5882 FIL1 eta, IL-1 eta, interleukin-1 eta
IL-36γ  {Sp: Human} Immunopharmacology Ligand 5883 IL-1-related protein 2 (IL-1RP2), interleukin-1 epsilon (IL-1E), interleukin-1 family member 9, interleukin-36 gamma
IL-37  {Sp: Human} Immunopharmacology Ligand 6149 IL-1ζ, IL-23, interleukin-1ζ, interleukin-1-related protein (IL1RP), interleukin-23
IL-4  {Sp: Human} Immunopharmacology Ligand 4996 B-cell stimulatory factor 1, binetrakin, interleukin-4, pitrakinra
IL-5  {Sp: Human} Immunopharmacology Ligand 4997
IL-6  {Sp: Human} Immunopharmacology Ligand 4998 B-cell stimulatory factor 2, CTL differentiation factor, hybridoma growth factor, interferon β2, interleukin-6
IL-7  {Sp: Human} Immunopharmacology Ligand 4999 interleukin-7
IL-9  {Sp: Human} Immunopharmacology Ligand 5000 interleukin-9
IL-12A  {Sp: Human} Immunopharmacology Ligand 5001 IL-12 p35, interleukin-12A, NKSF1
IL-17A  {Sp: Human} Immunopharmacology Ligand 4982 CTLA-8, interleukin-17 alpha
IL-23A  {Sp: Human} Immunopharmacology Ligand 4989 IL-23p19, IL23A, interleukin-23 subunit alpha, interleukin-23A
IL-17A/IL-17F  {Sp: Human} Immunopharmacology Ligand 5874
IL-12B  {Sp: Human} Immunopharmacology Ligand 5002 IL-12 p40, IL-12B monomer, interleukin-12β, interleukin-12B, natural killer cell stimulatory factor 2
IL-17B  {Sp: Human} Immunopharmacology Ligand 5877
IL-17C  {Sp: Human} Immunopharmacology Ligand 5875 cytokine CX2, interleukin-17C
[Ile31,Gln34]PP (human) 1555 [Ile31,Gln34]-PP (human), human [Ile31,Gln34] pancreatic peptide
[Ile5,Glu19]PTHrP-(1-34) (human) 1796
[Ile5,Glu19,Val21]PTHrP-(1-34) (human) 1795 [Ile5,Glu19,Val21]-PTHrP 1-34 (human)
[Ile5]PTHrP-(1-36) 1825 [Ile5]-PTHrP 1-36
[Ile5]PTHrP-(1-34) (human) 1803 [Ile5]-PTHrP 1-34 (human)
[Ile5]PTHrP-(1-36) (human) 1804 [Ile5]-PTHrP 1-36 (human)
[Ile5,Trp23]PTHrP-(5-36) 1821 [Ile5,Trp23]-PTHrP 5-36
[Ile5,Trp23]PTHrP-(1-36) (human) 1798 [Ile5,Trp23]-PTHrP 1-36 (human)
[Ile5,Trp23]PTHrP-(2-36) (human) 1799 [Ile5,Trp23]-PTHrP 2-36 (human)
[Ile5,Trp23]PTHrP-(3-36) (human) 1800 [Ile5,Trp23]-PTHrP 3-36 (human)
[Ile5,Trp23]PTHrP-(4-36) (human) 1801 [Ile5,Trp23]-PTHrP 4-36 (human)
[Ile5,Trp23]PTHrP-(5-36) (human) 1824 [Ile5,Trp23]-PTHrP 5-36 (human)
[Ile5,Trp23,Tyr36]PTHrP-(1-36)-NH2 (human) 1797 [Ile5,Trp23,Tyr36]-PTHrP 1-36-NH2 (human)
[Ile5,Val21]PTHrP-(1-34) (human) 1802 [Ile5,Val21]-PTHrP 1-34 (human)
IL-17F  {Sp: Human} Immunopharmacology Ligand 5873 cytokine ML-1, Interleukin-17F
IL-1 receptor antagonist  {Sp: Human} Immunopharmacology Ligand 5878 IL-1ra, interleukin-1 receptor antagonist protein, IRAP
IL-36 receptor antagonist  {Sp: Human} Immunopharmacology Ligand 5879 IL-1 related protein 3 (IL1RP3), IL-1F5, IL-36ra, IL1F5, interleukin 1 family member 5 (delta)
IL-27 subunit α  {Sp: Human} Immunopharmacology Ligand 6152 IL-27 subunit alpha, interleukin-27 subunit alpha, p28
IL-27 subunit β  {Sp: Human} Immunopharmacology Ligand 6153 EBV-induced gene 3 protein, Epstein-Barr virus-induced gene 3 protein, IL-27 subunit beta, IL-27B, interleukin-27 subunit beta
inbakicept 11593 15RalphaSu-Fc, Anktiva®: nogapendekin alfa + inbakicept-pmln, inbakicept-pmln
inhibin α  {Sp: Human} 5005 inhibin alpha chain
inhibin A  {Sp: Human} 5010
inhibin βA  {Sp: Human} 5006 activin βA, activin beta-A chain, erythroid differentiation factor (EDF), follicle-stimulating hormone-releasing protein
inhibin B  {Sp: Human} 5011
inhibin βB  {Sp: Human} 5007 activin beta-B chain, inhibin beta B chain
inhibin βC  {Sp: Human} 5008 activin beta-C chain, inhibin beta C chain
inhibin βE  {Sp: Human} 5009 activin beta-E chain, inhibin beta E chain
In-NODAGATOC 5642 In-NODAGA-Tyr3-octreotide
INSL3  {Sp: Human} 1995 insulin-like peptide 3
INSL5  {Sp: Human} 2000 insulin-like peptide 5
INSL5  {Sp: Mouse} 6519
INSL3 [A(5-26):B(7-27)] 11914
INSL3 (A chain)  {Sp: Human} 3750 insulin-like peptide 3 (A chain)
INSL5 (A chain)  {Sp: Human} 3752 insulin-like peptide 5 (A chain)
INSL5 (A chain)  {Sp: Mouse} 6520
INSL5 amide (human) 8350
INSL5 amide (mouse) 8351
INSL5 analogue 13 11915
INSL5-A13NR 11919
INSL5-A13nRbW 14154 A13-nRbW
INSL3 (B chain)  {Sp: Human} 3749 insulin-like peptide 3 B chain
INSL5 (B chain)  {Sp: Human} 3751 insulin-like peptide 5 (B chain)
INSL5 (B chain)  {Sp: Mouse} 6521
INSL3 B-chain analogue 3885
INSL3 B chain dimer analogue 8 4372
[125I]INSL3 (human) Ligand is labelled Ligand is radioactive 1996
[125I]INSL5 (human) Ligand is labelled Ligand is radioactive 2001 [125I]insulin-like peptide 5
insulin  {Sp: Human} Approved drug 5012
insulin A chain  {Sp: Human} 5013
insulin B chain  {Sp: Human} 5014
insulin glargine Approved drug 7572 HOE-901, HOE901, Lantus®
insulin-like growth factor 1  {Sp: Human} Approved drug 4971 IGF-1, CEP-151, mechano growth factor (MGF), myotrophin
insulin-like growth factor 2  {Sp: Human} 4972 IGF2, insulin-like growth factor II, somatomedin-A
insulin-like growth factor 1  {Sp: Mouse} 2495 IGF1, somatomedin
interleukin 18 binding protein  {Sp: Human} Immunopharmacology Ligand 13868
interleukin-17D  {Sp: Human} Immunopharmacology Ligand 14474 IL-17D
[125I](3-iodo-Tyr13)-MCH Ligand is labelled Ligand is radioactive 1316
[3-iodo-Tyr6]U-II-(4-11) (human) 9436
ipafricept 10325 FZD8-Fc, OMP-54F28, OMP54F28
iPep-SARS2-E 13253 TAT-MY18-2ED
IPL344 13268 IPL-344
[3H]-IPP Ligand is labelled Ligand is radioactive 11368
IRL 2500 PDB Ligand 3887 IRL-2500, IRL2500
[125I]IRL1620 Ligand is labelled Ligand is radioactive 1007 [125I]-IRL1620, [125I]IRL 1620
iseganan 10822 IB-367, IB-367-03
isopropylureido-FLFLF 1041
Isox-Cha-Chg-Ala-Arg-Dpr(4FB)-NH2 12492
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 Ligand is labelled 12493
isunakinra Immunopharmacology Ligand 9704 EBI-005
iturelix 3854 antide, D 21074, ORF 23541
[125I-Tyr]Ac2-26 Ligand is labelled Ligand is radioactive 6198 [125I]ANXA1-derived peptide
 
J Back to top
Jagged2  {Sp: Human} 13352
J18 (galanin analogue) 6075
J20 (galanin analogue) 6076
JI-38 6523 [Dat1,Gln8,Orn12,21,Abu15,Nle27Asp28,Agm29]hGH-RH-(1-29)
jingzhaotoxin-III 2574 β-theraphotoxin-Cj1a, β-TRTX-Cj1a, Jingzhaotoxin-3, JZTX-III
jingzhaotoxin-XI 2575 κ-theraphotoxin-Cj1a, κ-TRTX-Cj1a, Jingzhaotoxin-11, JZTX-11, JZTX-XI
JMR-132 9114
JMV1116 670 JMV 1116, JMV-1116
JMV1431 656 JMV 1431, JMV-1431
JMV180 3888 Boc-Tyr(SO3H)Ahx-Gly-Trp-Ahx-Asp2phenylethyl ester, JMV 180, JMV-180
JMV2004 1568 JMV 2004, JMV-2004
JMV310 898 JMV 310, JMV-310
JMV431 1569 JMV 431, JMV-431
JMV449 1570 JMV 449, JMV-449
JMV457 1571 tert-butoxy-carbonyl-Arg-Arg-Pro-D-Tyr-Ile-Leu-OH, JMV 457
JMV458 1572 JMV 458, JMV-458
JMV594 624 [D-Phe6,Statine13]Bombesin(6-14), JMV 594
JMV641 3889 JMV 641, JMV-641
JPE1375 5763 JPE 1375
JV-1-10 1106 [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Arg9,Abu15,Nle27, D-Arg29]hGH-RH(1-29)NH2
JV-1-36 1107 [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Arg9,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2, JV 1-36
JV-1-37 1108
JV-1-38 1109 JV 1-38
JV-1-39 1110
JV-1-40 1111
JV-1-41 1112
JV-1-42 1113 JV 1-42
JV-1-43 1114
JV-1-62 1115
JV-1-63 1116 JV 1-63
 
K Back to top
K31440 3890 Ac-(D-Tyr11,His12,Nle17)sauvagine(11-40), K 31440, K-31440
K41498 3891 [D-Phe11,His12,Nle17]sauvagine(11-40), K 41498, K-41498
kaliotoxin 2546 BmKTX, KTX, potassium channel toxin α-KTx 3.6
kallidin  {Sp: Human} 650 [Lys]bradykinin, kallidin II, Lys-BK, Lysyl-bradykinin
kassinin 2088
KBP-066 10660 DACRA, KBP 066, KBP066
KBP-088 10683 DACRA, KBP 088, KBP088, KeyBiosciencePeptide 088
[125I]KC-Tyr Ligand is labelled Ligand is radioactive 832
KE 108 2013 KE-108, KE108
KH28 5306 KH 28, KH-28
kisspeptin-10  {Sp: Human} 1283 KP-10, KP10
kisspeptin-13  {Sp: Human} 1284 KP-13, KP13
kisspeptin-14  {Sp: Human} 1285 KP-14
kisspeptin-52  {Sp: Mouse} 3709 KP-52
kisspeptin-10  {Sp: Mouse, Rat} 3711 KP-10
kisspeptin-15 1286 KP-15
kisspeptin-28 1287 KP-28
kisspeptin-54  {Sp: Human} 1288 KP-54, KP54, metastin
kisspeptin-52  {Sp: Rat} 3710 KP-52
kisspeptin-9 1289 KP-9
[125I]kisspeptin-10 (human) Ligand is labelled Ligand is radioactive 1281 [125I]-KP10, [125I]KP-10
[125I]kisspeptin-13 (human) Ligand is labelled Ligand is radioactive 3792 [125I]-kisspeptin13, [125I]-KP13, [125I]KP13
[125I]kisspeptin-14 (human) Ligand is labelled Ligand is radioactive 4013 [125I]KP14
[125I]kisspeptin-54 (human) Ligand is labelled Ligand is radioactive 1282 [125I]KP-54, [125I]metastin
kremen 1  {Sp: Human} 3702 Dickkopf receptor, Kringle domain-containing transmembrane protein 1, Kringle-containing protein marking the eye and the nose
kremen 2  {Sp: Human} 3703 Dickkopf receptor 2, Kremen protein 2, Kringle domain-containing transmembrane protein 2, Kringle-containing protein marking the eye and the nose
α-KTx 13.2 2550 OsK2
γ-KTx1.7 7689 CeErg4, potassium channel toxin gamma-KTx 1.7
kurtoxin 2521 Ktx
 
L Back to top
L-156,602 577 L 156602, PD 124966
L-362,823 2072 L 362823, L-362823
L-362,855 2014 L 362855, L-362855
L-363,301 2047 L 363301, L 363568, MK 301, MSD-L 363301
L-363,377 2048 L 363377, L-363377
L-363,409 2049 L 363409, MK 363-409
L-365,209 2241 L 365209, L-365209
L-366,682 2243 cyclo(Pro-Trp-Ile-Pip-Pip-His), L 366682
L-366,875 2244 L 366875, L-366875
L-366,948 2245 L 366948, L-366948
labradimil 672 [Hyp3,Thi5,4-Me-Tyr8ψ(CH2-NH)Arg9]bradykinin, cereport, lobradimil, RMP-7
lactomedin 1 10228
lanreotide Approved drug 2031 BIM 23014, DC 13-116, lanreotide acetate, Somatuline®
larazotide 13724 AT-1001, AT-2347, AT1001, AT2347
large neuromedin N  {Sp: Human} 1576 large NN, NmN-125
large neuromedin N  {Sp: Mouse} 5303
large neuromedin N  {Sp: Rat} 5304 NmN-125
large neurotensin  {Sp: Human} 1577 large NT
Large proline-rich protein BAG6 Immunopharmacology Ligand 11143 BAG6
lariocidin 14119
lasso D  {Sp: Rat} 5899
lassomycin 14265
α-latrotoxin 5897 alpha-LTX, alpha-latrotoxin, alpha-latrotoxin-Lt1a, alpha-LTX-Lt1a
[L-Bpa5,Ile13]motilin (human) 1451
LCB1 11236
LCB3 11237
LDV-FITC Ligand is labelled 6759
Lei-Dab7 2315
leiurotoxin I 2316 Leiurotoxin-1 (LeTx1), potassium channel toxin α-KTx 5.1, scyllatoxin (ScyTx)
lepirudin Approved drug 6469 1-L-leucine-2-L-threonine-63-desulfohirudin, Refludan®
leptin  {Sp: Human} 5015
lerodalcibep Approved drug 14319 LIB-003, LIB003, sequence 3 [US10738102B2]
[Leu14]bombesin 11259
[Leu14, ψ 13-14)]bombesin 629
[Leu8,des-Arg9]bradykinin 641
[Leu9,des-Arg10]kallidin 642 [Lys,Leu8,des-Arg9]bradykinin, Lys-[Leu8][des-Arg9]BK, Lys-[Leu8][des-Arg9]bradykinin
[Leu]enkephalin  {Sp: Human, Mouse, Rat} 1613 [Leu]-enkephalin, leucine enkephalin
[Leu13]motilin (human) 1453
[3H]Leu-N/OFQ Ligand is labelled Ligand is radioactive 3824 [3H]-Leu-N/OFQ, [3H]-Leu-nociceptin.orphanin FQ
[Leu8]-phyllolitorin 6168
leuprolide Approved drug 1175 ABBOTT-43818, Camcevi®, Fensolvi® (leuprolide acetate injectable suspension), Lupron®, TAP-144
[Leu31,Pro34]NPY 1545 [Leu31,Pro34] neuropeptide Y, [Leu31,Pro34]-NPY
[125I][Leu31,Pro34]NPY Ligand is labelled Ligand is radioactive 3762 [125I]-[Leu31,Pro34]neuropeptide Y, [125I]-[Leu31,Pro34]NPY
[Leu31,Pro34]NPY (pig) 1524 porcine [Leu31,Pro24] neuropeptide Y, porcine [Leu31,Pro34] neuropeptide Y
[Leu31,Pro34]PYY (human) 1527 human [Leu31,Pro34] peptide tyrosine tyrosine, human [Leu31,Pro34] peptide YY
[Leu31,Pro34]PYY (pig) 1526 [Leu31,Pro34] peptide tyrosine tyrosine, [Leu31,Pro34] peptide YY
LFF571 14344 J3.333.591A, LFF 571, LFF-571
LGR7-truncate 3893
LH  {Sp: Human} Approved drug 1159 luteinising hormone, luteinizing hormone
LH  {Sp: Mouse} 4389 luteinising hormone, luteinizing hormone
LH  {Sp: Rat} 4391 luteinising hormone, luteinizing hormone
[125I]LH Ligand is labelled Ligand is radioactive 3793 [125I]-LH, [125I]-luteinising hormone, [125I]-luteinizing hormone
LH β subunit  {Sp: Human} 3732 LHβ, luteinising hormone subunit beta, luteinizing hormone subunit beta, lutropin subunit beta
LH β subunit  {Sp: Mouse} 4388 LHβ, luteinising hormone β subunit, lutropin β subunit
LH β subunit  {Sp: Rat} 4390 LH beta subunit, luteinising hormone subunit beta, luteinizing hormone subunit beta, lutropin subunit beta
LIF  {Sp: Human} Immunopharmacology Ligand 5016 cholinergic differentiation factor (CDF), differentiation-inducing factor (DIF), human interleukin in DA cells (HILDA)
LIGHT  {Sp: Human} Immunopharmacology Ligand 5070 Herpesvirus entry mediator-ligand, TR2
LIH383 11084
linaclotide Approved drug 5017 Constella®, Linzess®, MM-416775
liraglutide Approved drug 1133 NN-2211 , NN2211, NNC 90-1170, NNC-90-1170, Victoza®
litorin 617 litorine
LittleLEN  {Sp: Mouse} 14333 L-LEN, Little-LEN
liver enriched antimicrobial peptide 2  {Sp: Human} Immunopharmacology Ligand 9734 LEAP2
livoletide 10884 AZP-531, AZP531, Cyclo(des-acyl ghrelin(6-13)), Des-acyl ghrelin
lixisenatide Approved drug 7387 Adlyxin®, AVE-0010, Lyxumia®
[3H]-LKP Ligand is labelled Ligand is radioactive 11369
LL-37  {Sp: Human} Immunopharmacology Ligand 5527 antibacterial protein LL-37, cathelicidin LL 37 (human)
low-density lipoprotein receptor-related protein 4  {Sp: Human} 5320 LRP4, LRP-4, multiple epidermal growth factor-like domains 7
5-LOX activating protein  {Sp: Human} Immunopharmacology Ligand 5183 FLAP, 5-lipoxygenase-activating protein, arachidonate 5-lipoxygenase-activating protein
L-Phe-Phe-Phe 12435
Lqh Tx 15-1 14044
L-Trp-Trp-Trp 12424
[125I]LTT-SRIF-28 Ligand is labelled Ligand is radioactive 2023 3-[125I](Leu8, D-Trp22, Tyr25)somatostatin-28, 3-[125I]LTT-SRIF-28, [125I](Leu8, D-Trp22, Tyr25)-somatostatin-28
LTX(N4C) 5898 latrotoxin(N4C)
[L-Tyr8]CYN 154806 2029 cyanamid 154806
LUNA18 12931 compound 45 [PMID: 37463267]
luspatercept Approved drug 10538 ACE-536, ACE536, luspatercept-aamt, Reblozyl®
LV-2172 9442
LV-2186 10252 compound 5b
LV-2211 12420 [Tic22]26RFa(20-26), analog 28 [PMID: 34299587]
LVP  {Sp: Pig} 2172 [Lys8]-vasopressin, [Lys8]AVP, lysine vasopressin, syntopressin
LVV-hemorphin  {Sp: Human} 5353
LY3463251 12843
LY3540378 12502
lymphocyte antigen 86  {Sp: Human} Immunopharmacology Ligand 14568
lymphotoxin-α  {Sp: Human} Immunopharmacology Ligand 5064 TNFSF1, LTα, TNFβ
lymphotoxin-β  {Sp: Human} 5075 TNFSF3, LTβ
lymphotoxin β2α1 heterotrimer  {Sp: Human} 6142
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2 3842 [K15, Arg16, Leu27]VIP(1-7)/GRF(8-27)
Lys-CoA 7036 Ac-Lys(CoA)-NH2
[3H]Lys-[des-Arg9]BK Ligand is labelled Ligand is radioactive 3825 [3H]-Lys-[des-Arg9]-bradykinin, [3H]-Lys-[des-Arg9]BK
Lys-[Hyp3]-bradykinin  {Sp: Human} 3580 [Hyp3]-lysyl-bradykinin, Lys-[Hyp3]-BK
Lys-kallidin 637 [Lys,Lys]bradykinin
[3H]Lys-[Leu8][des-Arg9]BK Ligand is labelled Ligand is radioactive 3826 [3H]-Lys-[Leu8][des-Arg9]-bradykinin, [3H]-Lys-[Leu8][des-Arg9]BK
[19Lys,26Leu]-galparan 6097
[Lys5,Me-Leu9,Nle10]NKA-(4-10) 3843 [Lys5,Me-Leu9,Mle10]neurokinin A(4-10)
Lys[Z(NO2)]-Val 9486
 
M Back to top
M1145 6101
M1151 6102 GWTLNSAGYLLGPK(ε-NH-C(O)X)-amide
M1152 6103 WTLNSAGYLLGPK(ε-NH-C(O)X)-amide
M1153 6104 RGRGNWTLNSAGYLLGPK(ε-NH-C(O)X)-amide
M1160 6074
M15 3896 galanin(1-13)substance P(5-11)amide, galantide
M242 6099 M 242, M-242
M32 3897 galanin(1-13)neuropeptide Y-amide(25-36)amide
M35 3898 galanin(1-13)bradykinin(2-9)amide
M372049 5020 M 372049, M-372049
M40 3899 galanin(1-13)Pro-Pro-Ala-Leu-Ala-Leu-Ala-Leu-Ala-amide
M617 6100
M65 3305 des-(Gln25-Gln41)-maxadilan, maxadilan Δ25-41
M871 3900 galanin(2-13)Glu-His-(Pro)3(Ala-Leu)2Ala-amide
macrophage migration inhibitory factor  {Sp: Human} Immunopharmacology Ligand 9981 L-dopachrome isomerase, MMIF
macrophage stimulating protein 1  {Sp: Human} 5023 MST1, hepatocyte growth factor-like
maltotriose-[125I][Tyr3,Thr8]octreotide Ligand is labelled Ligand is radioactive 5631 [125I]-Mtr-TOCA, maltotriose-[125I]-Tyr3-octreotate
mambalgin-1 10308
mamba toxin CM-3 13153 Adrenergic toxin rho-elapitoxin-Dp1b, rho-EPTX-Dp1b
MANSC (415-431)  {Sp: Human} 10539
margatoxin 2547 MgTx, potassium channel toxin α-KTx 2.2
martentoxin 14032 MarTX
mast cell degranulating peptide 2548 MCD peptide, MCDP, Peptide 401
matrix metalloproteinase 1  {Sp: Human} 6655
matrix metalloproteinase 13  {Sp: Human} 6656
matrix metalloproteinase 2  {Sp: Human} 4470 72 kDa type IV collagenase, MMP-2
matrix metalloproteinase 2  {Sp: Mouse} 4471 72 kDa type IV collagenase, gelatinase A, MMP-2
matrix metalloproteinase 2  {Sp: Rat} 4472 72 kDa type IV collagenase, gelatinase A, MMP-2
maurotoxin 2332 MTX, potassium channel toxin α-KTx 6.2
maxadilan 2264
Max.d.4 2265 des-(Leu24-Leu42)-maxadilan, maxadilan Δ24-42
mazdutide Approved drug 13924 compound 1 [US9938335B2], IBI-362, IBI362, LY-3305677, LY3305677
MBP10 1339 MBP 10, MBP-10
MBP7 7038
MCH6-17 1293 melanin-concentrating hormone (6-17)
[125I]MCH (human, mouse, rat) Ligand is labelled Ligand is radioactive 1296 [125I]-melanin-concentrating hormone
[3H]MCH (human, mouse, rat) Ligand is labelled Ligand is radioactive 3827 [3H]-MCH, [3H]-melanin-concentraing hormone
MCH (salmon) 1301 salmon melanin-concentrating hormone
κM-conotoxin RIIIK 11476 κM-RIIIK, kappaM-RIIIK
MC148R 778 MC 148, MC 148 CC chemokine
M-CSF  {Sp: Human} Immunopharmacology Ligand 4905 CSF-1, lanimostim, macrophage-CSF
MD5 13458 compound B [PMID: 39028865]
melanin-concentrating hormone  {Sp: Human, Mouse, Rat} 1298
melittin 14002
MEN 10376 2116 [Tyr5,D-Trp6,8,9,Lys10]-alpha-NEUROKININ A, Fragment 4-10, MEN-10,376, MEN-10376, neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)-
MEN10627 3901 cyc(2β-5β)(Met-Asp-Trp-Phe-Dap-Leu), MEN-10627
[125I][MePhe7]NKB Ligand is labelled Ligand is radioactive 3763 [125I]-[MePhe7]neurokinin A, [125I]-[MePhe7]NKB
Met-Ckβ7 788 Ckβ7, Met-chemokine β 7
[Met5]dynorphin-(1-17) 1659
[Met]enkephalin  {Sp: Human, Mouse, Rat} Immunopharmacology Ligand 1614 1-5 Adrenorphin, [Met]-enkephalin, IRT-101, methionine enkephalin, np2 enkephalin, opioid growth factor (OGF)
Met-Lys-bradykinin 638 Met-kallidin
Met-Met-Trp-Leu-Leu 5836
metreleptin Approved drug 7333 Myalept®, r-metHuLeptin, R-methuleptin
MG-101 PDB Ligand 13381 MG101, N-acetyl-L-leucyl-L-leucyl-L-norleucinal
MG-115 11639 Cbz-Leu-Leu-norvalinal, N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-norvalinal, Z-LL-Nva-CHO
MG-132 PDB Ligand 8616 compound 5b [PMID: 16686537], MG132, N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal, Z-Leu-leu-leu-al, Z-LLL-CHO
mGIPAnt-1 11998
MHC binding peptide 6250
microcin J25 14257 Mcc25, MccJ25
microtubule associated protein tau  {Sp: Human} 9275
mideplanin 10830 CTA A1, MDL 62873, MDL-62873, MDL62873
minimised INSL5 analogue 7 8334
minimised INSL5 analogue 7 A chain 8335
minimised relaxin-3 analogue 2 8336
minimised relaxin-3 analogue 3 8326
minimised relaxin-3 analogue A chain 8327 minimised relaxin-3 analogue 2 A chain, minimised relaxin-3 analogue 3 A chain
minimised relaxin-3 analogue 3 B chain 8328
mini-TyrRS 823 NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase
[125I]mini-TyrRS Ligand is labelled Ligand is radioactive 818 125I-NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase
MIT1 1865 mamba intestinal toxin-1
mitochondrial peptde fMMYALF 14142
mitochondrial peptide fMFADRW 14144
MK-7110 Immunopharmacology Ligand 11395 CD24-Fc, CD24Fc
[125I]MK-678 Ligand is labelled Ligand is radioactive 2061
MLCK inhibitor peptide 18 9351 Myosin Light Chain Kinase Inhibitor Peptide 18
Müllerian inhibiting substance  {Sp: Human} 6686
MM07 8523 cyclo[1-6]CRPRLCHKGPMPF
MM54 6186 cyclo(1-6)CRPRLC-KH-cyclo(9-14)CRPRLC
mM1_034_F21W_Y27F 14546
MMK-1 Immunopharmacology Ligand 6240 MMK 1
motilin  {Sp: Dog} 1457
motilin  {Sp: Human, Pig} 1458
motilin  {Sp: Rabbit} 1459
motilin-associated peptide  {Sp: Human} 5376
motilin-(1-11) (human) 1460 motilin1-11 (human)
motilin-(1-12) (human) 1461 motilin1-12 (human)
motilin-(1-13) (human) 1462 motilin1-13 (human)
motilin-(1-19) (human) 1463 motilin1-19 (human)
motilin-(2-22) (human) 1464 motilin2-22 (human)
[125I]motilin (human) Ligand is labelled Ligand is radioactive 3794 [125I]-motilin
motixafortide Approved drug Immunopharmacology Ligand 10679 4F-Benzoyl-TN14003, Aphexda®, BKT140, BL-8040, TF14016
[Mpa1,D-Tyr(Et)2,D-Tic7,Aib9]OT 2255 [deamino β-mercaptopropionic acid,-D-Tyr2,D-Tic7,Aib9]OT, [Mpa1,O-ethyl-D-Tyr2,D-Tic7,Aib9]OT
[Mpa1,D-Tyr(Et)2,D-Tic7,D-Tic9]OT 2254 [deamino β-mercaptopropionic acid,D-Tyr(Et)2,D-Tic7,D-Tic9]OT, [Mpa1,O-ethyl-D-Tyr2,D-Tic7,D-Tic9]OT
[Mpa1,D-Tyr(Et)2,D-Tic7]OT 2256 [deamino β-mercaptopropionic acid-D-Tyr(Et)2,D-Tic7]OT
mPT1_084 14552
MS05 1322
β-MSH  {Sp: Human} 3606 β-melanocyte stimulating hormone
α-MSH  {Sp: Human, Mouse, Rat} 1320 α-melanocyte stimulating hormone
γ-MSH  {Sp: Human, Mouse, Rat} 1333 γ-melanocyte stimulating hormone, melanotropin gamma
β-MSH  {Sp: Mouse} 3607 β-melanocyte stimulating hormone
β-MSH  {Sp: Rat} 3608 β-melanocyte stimulating hormone
MSMB (91-114)  {Sp: Human} 10541
MT-II 1323 melanotan II, MTII
mucosal addressin cell adhesion molecule 1  {Sp: Human} Immunopharmacology Ligand 9339 MAdCAM-1, addressin, MAdCAM1
multi-Leu (ML)-peptide 8648 ML-peptide
murepavadin 10832 POL7080, RG-7929, RG7929, RO-7033877, RO7033877
muscarinic toxin 1 311 MT1, MTx1
muscarinic toxin 2 312 MT2, MTx2
muscarinic toxin 3 313 mamba toxin-3, MT3
muscarinic toxin 7 314 m1-toxin 1, MT7, recombinant mamba venom toxin, rMT7
muscarinic toxin β 13152 Adrenergic toxin rho-elapitoxin-Dp1a, MTβ, rho-EPTX-Dp1a
mutant ANP  {Sp: Human} 10211 mANP, mutant atrial natriuretic peptide
myostatin  {Sp: Human} 5025 GDF-8, GDF8, growth/differentiation factor 8
myr-PKI 10619 Protein kinase inhibitor-(14-22)-amide, myristoylated
MZ-4-169 1117 [Nac0,D-Arg2,Phe(4-Cl)6,Abu15,Nle27]hGHRH-(1-29) NH2
MZ-4-181 1118 [Nac0-His1,D-Arg2,Phe(4-Cl)6,Abu15,Nle27]-hGH RH-(1-29)NH2
MZ-4-243 1119 [Nac0,D-Arg2,Phe(4-CI)6,Abu15,Nle27]hGHRH-(1-28)Agm
MZ-4-71 1120 MZ 4-71
MZ-5-156 1121 MZ 5-156
MZ-5-192 1122
MZ-5-78 1123
MZ-6-55 1124 [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2, MZ 6-55
 
N Back to top
N-0385 11956 example 2 [WO2018112648A1], Ms-QFR-Kbt, N0385
N36 6246
NAB739 13588
N-Aβcore hexapeptide 13244 N-Aβ(10-15), N-Aβ10-15, N-Aβcore
N-α-Ac-PYY-(22-36) (rat) 1532 N-α-Ac-PYY22-36 (rat)
N-α-Ac-PYY-(25-36) (rat) 1533 N-α-Ac-PYY25-36 (rat)
nafarelin Approved drug 3902 Synarel®
nangibotide Immunopharmacology Ligand 14581 LR12
Nanoluciferase-labelled relaxin Ligand is labelled 11464
NanoLuc-INSL3 Ligand is labelled 11913
NanoLuc R3/I5 chimera Ligand is labelled 11465
Natural cytotoxicity triggering receptor 3 ligand 1  {Sp: Human} Immunopharmacology Ligand 11142 B7H6, B7-H6
navepegritide Approved drug 14293 TransCon CNP, Yuviwel®
[125I]N-biotin-[Ahx0, Bpa3]U-II (human) Ligand is labelled Ligand is radioactive 9440
NC 8-12 2052
NC 4-28B 2017
5nd 8723
[125I]NDP-MSH Ligand is labelled Ligand is radioactive 1326 [125I]-NDP-MSH, [125I][Nle4,dPhe7]α-MSH
α-neodynorphin  {Sp: Human} 3737 α-neo-dynorphin
α-neoendorphin  {Sp: Human, Mouse, Rat} 1600
β-neoendorphin  {Sp: Human, Mouse, Rat} 1644
nepadutant 2123 LS-55819, MEN 11420, MEN-11420, MEN11420
nerinetide 12332 NA-1, Tat-NR2B9c
netrin 1  {Sp: Human} 12847
netrin-G3 ligand  {Sp: Human} 6607 LRIG4
neuregulin-1  {Sp: Human} 5027 NRG-1, breast cancer cell differentiation factor p45, glial growth factor (GGF), heregulin, Neu differentiation factor (NDF)
neuregulin-2  {Sp: Human} 5029 NRG-2
neuregulin-3  {Sp: Human} 5030 NRG-3, neuregulin 3
neuregulin-4  {Sp: Human} 5031 NRG-4, neuregulin 4
neurokinin A  {Sp: Human, Mouse, Rat} 2089 NKA, substance K
neurokinin B  {Sp: Human, Mouse, Rat, Pig} 2090 neurokinin β, neuromedin K
neuroligin 1  {Sp: Human} 12818
neuromedin B  {Sp: Human, Mouse, Rat, Pig} 613 NMB
neuromedin B (1-30) (human) 6163 NMB30
neuromedin C  {Sp: Human} 6178 NMC
neuromedin N  {Sp: Human} 3625
neuromedin N  {Sp: Mouse, Rat} 1578 NN
neuromedin S-33  {Sp: Human} 1468 NmS-33, NMS, NMS-33
neuromedin S-36  {Sp: Mouse} 3614 NmS-36, NMS-36
neuromedin S-36  {Sp: Rat} 3615 NmS-36, NMS-36
neuromedin U-8  {Sp: Dog} 1472 NmU-8, canine neuromedin U-8
neuromedin U-25  {Sp: Human} 1470 NmU-25, human neuromedin U-25, NMU-25
neuromedin U-23  {Sp: Mouse} 3613 NmU-23, mouse neuromedin U, NMU-23
neuromedin U-25  {Sp: Pig} 1471 NmU-25, porcine neuromedin U-25
neuromedin U-8  {Sp: Pig} 1473 NmU-8, NMU-8, porcine neuromedin U-8
neuromedin U-23  {Sp: Rat} 1469 NmU-23, NMU-23
[125I]neuromedin U-25 (human) Ligand is labelled Ligand is radioactive 1474 [125I]NmU-25 (human), [125I]neuromedin U, [125I]NMU-25
[125I]neuromedin U-8 (pig) Ligand is labelled Ligand is radioactive 1476 [125I]NmU-8 (pig), porcine [125I]neuromedin U-8
[125I]neuromedin U-23 (rat) Ligand is labelled Ligand is radioactive 1475 [125I]NmU-23 (rat), rat [125I]neuromedin U-23
neuronostatin  {Sp: Human, Pig} 5654 neuronostatin-13
neuropeptide γ  {Sp: Human, Mouse, Rat} 3667
neuropeptide AF  {Sp: Human} 3735 NPAF
neuropeptide AF  {Sp: Mouse} 4443 NPAF
neuropeptide AF  {Sp: Rat} 4442 NPAF
neuropeptide B-23  {Sp: Human} 1501 NPB-23
neuropeptide B-29  {Sp: Human} 1502 NPB-29
neuropeptide B-23  {Sp: Mouse} 3628 NPB-23
neuropeptide B-29  {Sp: Mouse} 3630 NPB-29
neuropeptide B-23  {Sp: Rat} 3629 NPB-23
neuropeptide B-29  {Sp: Rat} 3631 NPB-29
neuropeptide EI  {Sp: Human} 5374 NEI, neuropeptide E-I, neuropeptide-glutamic acid-isoleucine
neuropeptide FF  {Sp: Human, Mouse, Rat} 1479 NPFF
neuropeptide GE  {Sp: Human} 5375 neuropeptide G-E, neuropeptide-glycine-glutamic acid, NGE
neuropeptide head activator 2496 HA
neuropeptide K  {Sp: Human, Rat} 2091 NP-K
neuropeptide S  {Sp: Human} 1490 NPS
neuropeptide S  {Sp: Mouse} 1491 NPS, mouse neuropeptide S
neuropeptide S  {Sp: Rat} 1492 NPS, rat neuropeptide S
neuropeptide SF  {Sp: Human} 3736 NPSF
neuropeptide SF  {Sp: Mouse} 4444 NPSF
neuropeptide SF  {Sp: Rat} 4445 NPSF
neuropeptide W-23  {Sp: Human} 1495 NPW-23
neuropeptide W-30  {Sp: Human} 1496 NPW-30
neuropeptide W-30  {Sp: Mouse} 3618 NPW-30
neuropeptide W-23  {Sp: Mouse, Rat} 3616 NPW-23
neuropeptide W-30  {Sp: Rat} 3620 NPW-30
neuropeptide Y  {Sp: Human, Mouse, Rat} 1504 NPY
neuropeptide Y-(3-36)  {Sp: Human, Mouse, Rat} 3627 NPY 3-36, NPY-(3-36)
neurotensin  {Sp: Human, Mouse, Rat, Bovine} 1579 NT
neurotensin-(8-13) 7363
[125I]neurotensin (human, mouse, rat) Ligand is labelled Ligand is radioactive 1574 [125I]NT
[3H]neurotensin (human, mouse, rat) Ligand is labelled Ligand is radioactive 3830 [3H]-neurotensin
neurotrophin-3  {Sp: Human} 5033 NT-3, HDNF, nerve growth factor 2, neurotrophic factor, NGF-2, NT3
neurotrophin-4  {Sp: Human} 5034 NT-4, neurotrophin-5, NT-5
neurturin  {Sp: Human} 5032 NRTN
NG29 10254 SarLys[DPhe8]desArg9-bradykinin
NG291 10255 [Hyp3,Thi5,NChg7,Thi8]-bradykinin
NGF  {Sp: Human} Approved drug 5026 beta-nerve growth factor, beta-NGF, Oxervate®, Sentinel®
[125I]NGF (human) Ligand is labelled Ligand is radioactive 4849 [125I]-nerve growth factor
[125I]NKA (human, mouse, rat) Ligand is labelled Ligand is radioactive 3795 [125I]-neurokinin A, [125I]-NKA
[125I][Nle75,Tyr77]apelin-36 (human) Ligand is labelled Ligand is radioactive 603
[Nle8,18,Tyr34]PTH-(1-34)-NH2 (bovine) 1805
[Nle8,18,Tyr34]PTH-(3-34)-NH2 (bovine) 1806
[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat) Ligand is labelled Ligand is radioactive 1791
[nLeu13,Glu14]motilin (human) 1455
NM4-C16 9009
[N-Me,des-Sar]Gal-B2 6109
N-methyl-Phe-Lys-Pro-D-Cha-Cha-D-Arg-CO2H 572
N-methyl-Phe-Lys-Pro-D-Cha-Trp-D-Arg-CO2H 576
NMU (104-114) 10569
NN1213 13441 NN-1213, peptide 21 [PMID: 38960379]
NNC1702 9760 des-His1-[Glu9, Lys24(4 X γGlu), Leu27]glucagon
NOC-ATE 2053
nociceptin/orphanin FQ  {Sp: Human, Mouse, Rat} 1681 N/OFQ
N-octanoyl-L-homoserine lactone PDB Ligand 12447 C8-HSL, Octanoyl-L-homoserine lactone
NODAGA-[Tyr3]-octreotide 5627 NODAGA-Tyr3-octreotide, NODAGATOC
[67Ga]NODAGA-[Tyr3]octreotide Ligand is labelled Ligand is radioactive 5628 [67Ga]-NODAGA-Tyr3-octreotide, Ga-NODAGATOC
[3H]N/OFQ Ligand is labelled Ligand is radioactive 1688 [3H]nociceptin, [3H]nociceptin/orphanin FQ, [3H]orphanin FQ
N/OFQ-(1-13)-NH2 1682 nociceptin(1-13)NH2, nociceptin/orphanin FQ(1-13)NH2, orphanin FQ(1-13)NH2
N/OFQ-NH2 1683 nociceptin-NH2, nociceptin/orphanin FQ--NH2, orphanin FQ-NH2
nogapendekin alfa Approved drug 11594 Anktiva®: nogapendekin alfa + inbakicept-pmln, IL15 D72
Noggin  {Sp: Human} 10975
norrin  {Sp: Human} 1063 Norrie disease protein, X-linked exudative vitreoretinopathy 2 protein
norrin  {Sp: Mouse} 2947
NOSO-502 13157
novokinin 6893
noxiustoxin 2552 NTx, potassium channel toxin α-KTx 2.1, Toxin II.11
NPC 17731 657 D-Arg[Hyp3,trans-4-propoxy-D-proline(transpropyl)7,Oic8]bradykinin, NPC-17731, NPC17731
NPC 18565 658 [D-Arg(Hyp3,D-Hyp7(transpropyl),Oic8)des-Arg9]bradykinin, des-Arg9 fragment of NPC 17731, NPC-18565, NPC18565
NPC-349 675 [D-Arg0,Hyp2,3,Thi5,8,D-Phe7]bradykinin, NPC 349
NPC-567 676 [D-Arg0,Hyp3,D-Phe7]bradykinin, BIM 31006, NPC 567
[3H]NPC17731 Ligand is labelled Ligand is radioactive 3831 [3H]-NPC17731
[125I]NPFF Ligand is labelled Ligand is radioactive 3797 [125I]-neuropeptide FF, [125I]-NPFF
[Nphe1]N/OFQ-(1-13)-NH2 1695 [Nphe1]nociceptin(1-13)NH2, [Nphe1]nociceptin/orphanin FQ(1-13)NH2, [Nphe1]orphanin FQ(1-13)NH2
3-N3-Phpa-LVA 2193
[125I]3-N3-Phpa-LVA Ligand is labelled Ligand is radioactive 2206
[3H]NPVF Ligand is labelled Ligand is radioactive 4019 [3H]-NPVF, [3H]neuropeptide VF
[125I]NPW-23 (human) Ligand is labelled Ligand is radioactive 1497 [125I]neuropeptide W, [125I]neuropeptide W-23, [125I]NPW
NPY  {Sp: Pig} 1505 porcine neuropeptide Y
NPY-(13-36) 3903 neuropeptide Y (13-36)
NPY-(2-36) 1549 neuropeptide Y (2-36)
NPY-(13-36) (human) 1535 human neuropeptide Y (13-36)
[125I]NPY (human, mouse, rat) Ligand is labelled Ligand is radioactive 1518 [125I]neuropeptide Y
[3H]NPY (human, mouse, rat) Ligand is labelled Ligand is radioactive 1521 [3H]neuropeptide Y
NPY-(18-36) (human, pig) 1557 human neuropeptide Y (18-36), porcine neuropeptide Y (18-36)
NPY-(13-36) (pig) 1507 porcine neuropeptide Y (13-36)
NPY-(16-36) (pig) 1536 porcine neuropeptide Y (16-36)
NPY-(20-36) (pig) 1538 porcine neuropeptide Y (20-36)
NPY-(22-36) (pig) 1539 porcine neuropeptide Y (22-36)
NPY-(2-36) (pig) 1508 porcine neuropeptide Y (2-36)
NPY-(26-36) (pig) 1540 porcine neuropeptide Y (26-36)
NPY-(3-36) (pig) 1510 porcine neuropeptide Y (3-36)
Nrf2 peptide [PMID: 23647822] 8772
N-stearyl-[Nle17] neurotensin-(6-11)/VIP-(7-28) 2266 (SN)VIPhybrid, N-stearyl-[Nle17] neurotensin(6-11)/VIP(7-28)
N-stearyl-[Nle17]VIP 2271 N-stearyl-[Nle17]vasoactive intestinal peptide
NX210 13257 NX-210, NX-210c, NX210c, SCO-spondin derived peptide NX210
 
O Back to top
obestatin  {Sp: Human} 5336
obestatin  {Sp: Mouse, Rat} 5337
obtustatin 6581
ocriplasmin Approved drug 7446 Jetrea®, microplasmin
Octpep-1 12265
octreotide Approved drug 2055 DRG-0115, Mycapssa®, Oczyesa®, Sandostatin®, SMS 201,995
OH-LVA 2195
[125I]OH-LVA Ligand is labelled Ligand is radioactive 2207
OHM-11526 1467 [Phe3,Leu13]motilin (porcine)
olamkicept Immunopharmacology Ligand 9729 FE 999301, FE-301, FE-999301, TJ301
olatorepatide 14425 HS-20094, HS20094
omiganan 14110 CLS001, MBI 226
OMN6 14120
oncostatin M  {Sp: Human} 5035 OSM
ontorpacept 12036 TTI-621, TTI621
OP-145 13987 P60.4Ac
opiorphin 11538 Gln-Arg-Phe-Ser-Arg, L-Glutaminyl-L-arginyl-L-phenylalanyl-L-seryl-L-arginine, QRFSR peptide
oprelvekin Approved drug Immunopharmacology Ligand 6971 Neumega®
orexin-A  {Sp: Human, Mouse, Rat} 1697 hypocretin-1
[125I]orexin A (human, mouse, rat) Ligand is labelled Ligand is radioactive 3798 [125I]-orexin A
orexin-B  {Sp: Human} 1699 hypocretin-2, orexin b
orexin-B  {Sp: Mouse, Rat} 3720 hypocretin-2
[Orn5]URP 9438
oryzatensin 10227
OSK1-K16-D20 2556 [K16,D20]-OSK1
osteocrin  {Sp: Human} 5036 musclin
osteopontin  {Sp: Human} 6753 bone sialoprotein 1, nephropontin, secreted phosphoprotein 1, SPP-1, urinary stone protein, uropontin
OSTN (115-133) 10570
OSTN (81-102) 10573
[3H]OT (human, mouse, rat) Ligand is labelled Ligand is radioactive 2176 [3H]oxytocin
OX-40 ligand  {Sp: Human} Immunopharmacology Ligand 5076 glycoprotein Gp34, TXGP-1
oxytocin  {Sp: Human, Mouse, Rat} Approved drug 2174 OT, Otx, Pitocin®, Syntocinon®
 
P Back to top
P05 2325 AmP05, leiurotoxin I-like toxin P05, Potassium channel toxin α-KTx 5.2
P11 6595
PACAP-38  {Sp: Human, Mouse, Rat} 2258 pituitary adenylate cyclase activating polypeptide-38
PACAP-27  {Sp: Human, Mouse, Rat, Sheep} 2257 pituitary adenylate cyclase activating polypeptide-27
PACAP-(6-38) 2267 pituitary adenylate cyclase activating polypeptide (6-38)
[125I]PACAP-27 Ligand is labelled Ligand is radioactive 2261 [125I]-PACAP-27, [125I]pituitary adenylate cyclase activating polypeptide-27
palifermin Approved drug 6954 Kepivance®, keratinocyte growth factor
palopegteriparatide Approved drug 13484 mPEG-PTH (1-34), TransCon PTH, Yorvipath®
Pam2CSK4 Immunopharmacology Ligand 8560
Pam3CSK4 Immunopharmacology Ligand 8558
[p-aminoPhe6]ang II 595 [p-aminoPhe6] angiotensin II
PAMP-20  {Sp: Human} 4057 Human PAMP(1-20), Proadrenomedullin N-terminal 20 peptide (human)
PAMP-12 (human) 4056 Human PAMP(9-20), proadrenomedullin N-terminal 20 Peptide (Human, 9-20)
pancreatic polypeptide  {Sp: Bovine} 1511 PP, bovine pancreatic polypeptide
pancreatic polypeptide  {Sp: European common frog} 1480 PP, frog pancreatic polypeptide
pancreatic polypeptide  {Sp: Human} 1512 PP
pancreatic polypeptide  {Sp: Mouse} 3626 PP
pancreatic polypeptide  {Sp: Rat} 1513 PP
pandinotoxin-K α 2553 potassium channel toxin α-KTx 7.1, potassium channel-blocking toxin 2, toxin PiTX-K-α
pasireotide Approved drug 2018 pasireotide diaspartate, Signifor®, SOM 230, SOM 320, SOM-230
PBC-264 3948 pBC 264, propionyl-BC264
[3H]PBC-264 Ligand is labelled Ligand is radioactive 899 [3H]-Propionyl-BC-264, [3H]-Propionyl-BC264, [3H]propionyl-BC-264
PBP10 1043 PBP 10
pCXCL8-1aa Immunopharmacology Ligand 9938
[125I]PD151242 Ligand is labelled Ligand is radioactive 1001 [125I](N-[{hexahydro-1-azepinyl}carbonyl])Leu(1-Me)-DTrp-DTyr, [125I]-PD151242
PDEF(98-114)H105A 13832
PDGFA  {Sp: Human} 5042 PDGF subunit A, PDGF-1, platelet-derived growth factor subunit A
PDGF AA  {Sp: Human} 5038 platelet-derived growth factor AA homodimer
PDGF AB  {Sp: Human} 5041 platelet-derived growth factor AB heterodimer
PDGFB  {Sp: Human} 5043 PDGF subunit B, PDGF-2, platelet-derived growth factor B chain, platelet-derived growth factor subunit B
PDGF BB  {Sp: Human} Approved drug 5039 Gemesis®, platelet-derived growth factor BB homodimer, Regranex®, RWJ-60235
PDGFD  {Sp: Human} 5323 Iris-expressed growth factor (IEGF), PDGF-D
peceleganan 13758 PL-5, V681
pegcetacoplan Approved drug Immunopharmacology Ligand 13826 APL-2, Empaveli®
pegdinetanib 10472 Angiocept®, BMS-844203, BMS844203, CT-322, CT322
pegfilgrastim Approved drug 6969 Neulasta®
peginesatide Approved drug 7447 AF37702, Hematide®, Omontys®
peginterferon alfa-2b Approved drug Immunopharmacology Ligand 7462 PegIntron®, Sylatron®
peginterferon beta-1a Approved drug Immunopharmacology Ligand 7637 interferon beta 1-alpha, PEG-INF-β-1a, Plegridy®
pegloticase Approved drug 7463 Krystexxa®, puricase
PEG40-NMU 7928
pegozafermin 14215
pegvisomant Approved drug 7485 B2036-PEG, Somavert®
PEN  {Sp: Mouse} 9139
PEN  {Sp: Rat} 9140
pentagastrin Approved drug 870 AY-6608, ICI-50123, Peptavlon®
[Pen5]U-(4-11) (human) 2160 human [Pen5]-urotensin (4-11)
pepcan-12 9188
peptide 234 4012
peptide 5A 10588
peptide Cp40 [PMID: 25982307] Immunopharmacology Ligand 9220 peptide 14
peptide III-BTD 1696
peptide KLK2b(c1) 8484
peptide ligand 2 [PMID: 19055415] 8849 (cdGTyr(3-NO2)GBNc, LXY3
peptide 14 [PMID: 36580549] 12333
peptide 30 [PMID: 27019010] Immunopharmacology Ligand 9253
Peptide 5 [PMID: 28562585] 9588
peptide P19 [PMID: 15652659] 9163 [Ser11](N-CNP,C-ANP)pBNP(2-25)
peptide YY  {Sp: Human} 1514 PYY, peptide tyrosine tyrosine
peptide YY  {Sp: Mouse, Rat, Pig} 1515 PYY, peptide tyrosine tyrosine
periostin  {Sp: Human} Immunopharmacology Ligand 14663
persephin  {Sp: Human} 5045 PSPN
petrelintide 13804 ZP-8396, ZP8396
pexiganan 14042 MSI-78
[(pF)Phe4]N/OFQ-(1-13)-NH2 1686 [(pF)Phe4]nociceptin(1-13)NH2, [(pF)Phe4]nociceptin/orphanin FQ(1-13)NH2, [(pF)Phe4]orphanin FQ(1-13)NH2, peptide 4a
PG-106 6546 PG 106, PG106
PG-901 1341 PG 901, PG901
PG 97-269 2268 [Acetyl-His1,D-Phe2,Lys15,Arg16,Leu17]VIP(3-7)/GRF(8-27)
PG 99-465 2272 Myr-His1[Lys12,Lys27,28,Gly29,30,Thr31]VIP, PG99-465
p-guanidinobenzoyl-MCH-(7-17) 1300
[Phaa1,D-Tyr(Et)2,Lys6,des-Gly9]AVP 2208
[Phaa1,D-Tyr(Et)2,Val4,Lys6,Tyr-NH28,des-Gly9]AVP 2209 TyrPhaa
[Phaa1,D-Tyr(Me)2,Arg6,Tyr-NH29]AVP 2210
[Phaa1,D-Tyr2,Val4,Arg6,Arg-NH29]AVP 2211
[Phe13]bombesin 615
[Phe8,ψ(CH2-NH)Arg9]BK 3846 [Phe8,ψ(CH2-NH)Arg9]bradykinin
[Phe3,Leu13]motilin (human) 1454
phelorphan 11655 deamino-norcysteinyl-L-phenylalanyl-L-phenylalanine
[Phe(Me)7]neurokinin B 2113 [MePhe7]NKB
[Phe3]OT 2178 [Phe3]oxytocin, oxypressin
[Phe23]PTH-(1-34) (human) 1807
[Phe13,Tyr19]MCH 1297 [Phe13,Tyr19]-melanin-concentrating hormone
[125I][Phe13,Tyr19]MCH Ligand is labelled Ligand is radioactive 3844 [Phe13,[125I]Tyr19]MCH, [Phe13,[125I]Tyr19]melanin-concentrating hormone
PHI  {Sp: Mouse, Rat} 4397 intestinal peptide PHI-27, peptide histidine isoleucine, PHI-27
PHI  {Sp: Pig} 2273 peptide histidine-isoleucine
PHM  {Sp: Human} 2274 peptide histidine-methionine
ω-phonetoxin-IIA 2540 ω-phonetoxin-2A, Neurotoxin Tx3-4, Omega-ctenitoxin-Pn3a, Phoneutriatoxin 3-4
[(3-Ph-Pr6), His7,D-Ala11,D-Pro13,ψ13-14),Phe14]bombesin-(6-14) 627
phrixotoxin 1 2582 PaTX 1
phrixotoxin 2 2583 κ-theraphotoxin-Ps1b, κ-TRTX-Ps1b, PaTX 2, PaTX2
PHV  {Sp: Human} 3706 intestinal peptide PHV-42, peptide histidine valine
PHV  {Sp: Rat} 2275 intestinal peptide PHV-42, peptide histidine-valine
phyllolitorin 6166 [Phe8]-phyllolitorin
phyllomedusin 2093
physalaemin 2094
pigment epithelium-derived factor  {Sp: Human} 13831
Pi-hexatoxin-Hi1a 10306 π-Hi1a, π-HXTXHi1a, pi-Hi1a
Pi-theraphotoxin-Hm3a 10305 π-TRTX-Hm3a
PL017 1671 3-N-Me-Phe-morphiceptin, PL 017, PL-017
PL-3994 9067
[3H]PL017 Ligand is labelled Ligand is radioactive 3832 [3H]-PL017
placental growth factor  {Sp: Human} 5314 PIGF
platypus venom heptapeptide 1 13200
plecanatide Approved drug 9069 [3-glutamic acid(D>E)]human uroguanylin, SP-304, Trulance®
pleiotrophin  {Sp: Human} 6618 HBNF, heparin binding growth factor 8 (HBGF-8), neurite growth-promoting factor 1 (NEGF-1)
PLG0206 13313 WLBU2
PMX205 Immunopharmacology Ligand 5762 ALS-205, PMX 205, PMX-205
PMX53 579 Ac-(cyclo-2,6)-F-[OPdChaWR], PMX 53, PMX-53
ω-PnTx3-3 2541 ω-CNTX-Pn2a, ω-ctenitoxin-Pn2a, Neurotoxin Tx3-3, PnTx3-3
PnTx-3-6 2542 ω-CNTX-Pn4a, ω-ctenitoxin-Pn4a, Neurotoxin Tx3-6, PhAlpha-1-beta, PhAlpha-1-beta toxin
polybia-MP1 8861 MP1, MP-1
polymyxin B Approved drug 10338 Aerosporin®
Pomc (141-162) 10572
povetacicept Immunopharmacology Ligand 14426 ALPN-303, TACI vTD-Fc
P4pal-10 10270 P4pal10
[PP1-17,Ala31,Aib32]NPY (human) 1561
[125I][PP1-17,Ala31,Aib32]NPY (human) Ligand is labelled Ligand is radioactive 1559
P2pal18S 6659 P2pal-18S
PP-(13-36) (human) 1550 human pancreatic polypeptide (13-36)
PP-(20-36) (human) 1552 human pancreatic polypeptide (20-36)
PP-(2-36) (human) 1551 human pancreatic polypeptide (2-36)
[125I]PP (human) Ligand is labelled Ligand is radioactive 3800 [125I]-pancreatic polypeptide, [125I]-PP
P32 [PMID: 27108698] 9384
P4 [PMID: 25923432] 8344
P59 [PMID: 27108698] 9385
P8 [PMID: 25923432] 8345
pralmorelin Approved drug 1092 GHRP-2, growth hormone-releasing peptide-2, KP 102
pramlintide Approved drug 7482 AC0137, Symlin®
p122-RhoGAP  {Sp: Rat} 5237
PRL-2915 2066 PRL 2915
PRL-2970 2067 PRL 2970
pr1 nanopeptide 8263
[Pro3]GIP 3847 [Pro3]gastric inhibitory polypeptide
programmed cell death 1 ligand 1  {Sp: Human} Immunopharmacology Ligand 9606 PD-L1, B7 homolog 1, B7-H1, PDL1, programmed death ligand 1
proinsulin C-peptide  {Sp: Human} 6145
prokineticin-1  {Sp: Human} 1866 EG-VEGF, endocrine gland-derived vascular endothelial growth factor
prokineticin-2  {Sp: Human} 1867
prokineticin-2β  {Sp: Human} 1868 PK2β
prokineticin-1  {Sp: Mouse} 3715 endocrine gland vascular endothelial growth factor, prokineticin 1
prokineticin-2  {Sp: Mouse, Rat} 3717 prokineticin 2
prokineticin-1  {Sp: Rat} 3716 endocrine gland vascular endothelial growth factor
prolactin  {Sp: Human} 5049
[Pro7]neurokinin B 2126
[Pro34]NPY 3848
[Pro34]PYY (human) 1546 human [Pro34] peptide tyrosine tyrosine, human [Pro34] peptide YY
prosaptide  {Sp: Human} 6067
[Pro9]SP 3849 [Pro9]substance P
protein C  {Sp: Human} 4473 activated protein C, anticoagulant protein C, autoprothrombin IIA, vitamin K-dependent protein C
protein C  {Sp: Mouse} 4476
protein C  {Sp: Rat} 4479
protein C heavy chain  {Sp: Human} 4475
protein C heavy chain  {Sp: Mouse} 4478
protein C heavy chain  {Sp: Rat} 4481
protein C light chain  {Sp: Human} 4474
protein C light chain  {Sp: Mouse} 4477
protein C light chain  {Sp: Rat} 4480
protein S  {Sp: Human} 5050 protein Sα, vitamin K-dependent protein S
protoxin II 7571 β/ω-theraphotoxin-Tp2a, β/ω-TRTX-Tp2a, protoxin-2, ProTx-2, ProTx-II, ProTx2, PT-II
PrP106-126  {Sp: Human} 6244
PrRP-20  {Sp: Human} 1871 human prolactin-releasing peptide-20, PrRP20
PrRP-31  {Sp: Human} 1873 human prolactin-releasing peptide-31, PrP31, PrRP31
PrRP-20  {Sp: Rat} 1872 rat prolactin-releasing peptide-20
PrRP-31  {Sp: Rat} 1874 rat prolactin-releasing peptide-31
[125I]PrRP31 Ligand is labelled Ligand is radioactive 4022 [125I]-PrRP31
PrRP-(24-31) (human) 1870 human prolactin-releasing peptide-24-31
[125I]PrRP-20 (human) Ligand is labelled Ligand is radioactive 1875 [125I]prolactin-releasing peptide-20
psalmotoxin 1 4292 PcTx1
[125I]psalmotoxin 1 Ligand is labelled Ligand is radioactive 4073 [125I]-PcTx1
pseudechetoxin 2354
PSMα3 6267
PTH  {Sp: Human} Approved drug 1785 Natpar®, Natpara®, rhPTH[1-84]
PTH  {Sp: Mouse} 3632 mouse parathyroid hormone
PTH  {Sp: Rat} 1786
PTH-(1-34) (rat) 4449
PTHrP  {Sp: Human} 3738 parathyroid hormone-like hormone, parathyroid hormone-related peptide
PTHrP-(107-139)  {Sp: Human} 3670 osteostatin, parathyroid hormone-related peptide 107-139
PTHrP-(1-36)  {Sp: Human} 1790 human parathyroid hormone related peptide, PTHrP (1-36), PTHrP-1-36
PTHrP-(38-94)  {Sp: Human} 3671 parathyroid hormone-related peptide 38-94, PTHrP (38-94)
PTHrP-(107-139)  {Sp: Mouse} 3718 osteostatin (mouse), parathyroid hormone-related peptide 107-139, PTHrP (107-139)
PTHrP-(107-139)  {Sp: Rat} 3719 osteostatin (rat), parathyroid hormone-related peptide 107-139, PTHrP (107-139)
PTHrP-(1-34) (human)  {Sp: Human} 1822 parathyroid hormone-related peptide
PTHrP-(7-34) (human, rat, mouse) 1814 parathyroid hormone related peptide 7-34
PTHrP-(1-21)/PTH-(22-34) (human) 1788 hybrid of human PTHrP and human PTH
PTHrP-(1-20)/TIP-(23-39) (human) 1787
PWT2-N/OFQ 8865
PWT1-NPS 9167
[Pyr1]apelin-13  {Sp: Human, Mouse, Rat} 599 Glu1-apelin-13
[125I](Pyr1)apelin-13 Ligand is labelled Ligand is radioactive 601
[3H](Pyr1)[Met(0)11]-apelin-13 Ligand is labelled Ligand is radioactive 604
PYY-(3-36)  {Sp: Human} 1517 human peptide tyrosine tyrosine (3-36), human peptide YY (3-36), PYY (3-36), PYY3-36
PYY-(3-36)  {Sp: Mouse, Rat} 1554 peptide tyrosine tyrosine (3-36), peptide YY (3-36), PYY (3-36), PYY3-36
[125I]PYY Ligand is labelled Ligand is radioactive 1519 [125I]peptide tyrosine tyrosine, [125I]peptide YY
[125I]PYY-(3-36) (human) Ligand is labelled Ligand is radioactive 3802 [125I]-peptide YY(3-36), [125I]-PYY(3-36)
PYY-(13-36) (mouse, rat, pig) 1516 porcine peptide tyrosine tyrosine (13-36), porcine peptide YY (13-36), rat peptide tyrosine tyrosine (13-36), rat peptide YY (13-36)
PYY-(3-36) (pig) 1543 porcine peptide tyrosine tyrosine (3-36), porcine peptide YY (3-36)
[125I]PYY (pig) Ligand is labelled Ligand is radioactive 1520 [125I]pPYY
 
Q Back to top
QM107 13527
QRFP26  {Sp: Mouse} 5896 mouse homologue of P518, P550
QRFP43  {Sp: Mouse} 3712 pyroglutamylated arginine-phenylalanine-amide peptide, QRFP-43
QRFP26  {Sp: Rat} 10251 26RFa
QRFP43  {Sp: Rat} 3713 pyroglutamylated arginine-phenylalanine-amide peptide, QRFP-43
[125I]QRFP43 (human) Ligand is labelled Ligand is radioactive 3803 [125I-Tyr-32]-QRFP, [125I]-pyro-glutamylated arginine-amide peptide, [125I]-QRFP
QRFP26 (26RFa)  {Sp: Human} 5895 26RFa, P518
QRFP43 (43RFa)  {Sp: Human} 3665 43RFa, pyroglutamylated arginine-phenylalanine-amide peptide, QRFP, QRFP-43
Qu-SPX 11419
QWF Immunopharmacology Ligand 9568 Boc-Gln-D-Trp(CH0)-Phe-OBzl, Nα-[Nα-[Nα-(tert-butyloxycabonyl)-L-glutaminyl]-N1-formyl-D-tryptophyl-L-phenylalanine benzyl ester
 
R Back to top
R396 2118 R 396, R-396
R-486 2105 [Trp7,β-Ala8]neurokinin A(4-10), MEN 10295, R 486, R486
R-715 661 [Ac-Lys-[d-βNal7,Ile8]des-Arg9]bradykinin, R 715, R715
R-954 3906 AcOrn[Oic(2),(αMe)Phe(5),dβNal(7),Ile(8)]desArg(9)-bradykinin, R954
Rac1  {Sp: Human} 5250 cell migration-inducing gene 5 protein, ras-like protein TC25
Rac2  {Sp: Human} 5251 p21-Rac2
Rac3  {Sp: Human} 5252 p21-Rac3, ras-related C3 botulinum toxin substrate 3
RAG8 10271
ramoplanin A2 14348 A-16686A2, MDL 62,198
ranatensin 618
RANK ligand  {Sp: Human} Immunopharmacology Ligand 5066 receptor activator of nuclear factor κB ligand, osteoclast differentiation factor (ODF), osteoprotegerin ligand, TNFSF11
rasburicase Approved drug 7467 Elitek®, Fasturtec®, SR-29142
RB-400 900 RB 400, RB400
R3 B1-22R 11461
R3(BΔ23-27)R/I5 chimeric peptide 3907
R3(BΔ23-27)R/I5 chimeric peptide (B chain) 3909
relaxin  {Sp: Human} 1989 H2 relaxin
relaxin-1  {Sp: Human} 1988 H1 relaxin
relaxin-3  {Sp: Human} 1990 H3 relaxin
relaxin  {Sp: Pig} 1992
relaxin  {Sp: Rat} 1993
relaxin-3  {Sp: Rat} 11923
relaxin  {Sp: Rhesus macaque} 1994
relaxin-1 (A chain)  {Sp: Human} 3744 H1 relaxin (A chain)
relaxin-3 (A chain)  {Sp: Human} 3748 H3 relaxin (A chain)
relaxin (A chain)  {Sp: Human} 3746 H2 relaxin (A chain)
relaxin A chain  {Sp: Pig} 4438
relaxin A chain  {Sp: Rat} 4436
relaxin A chain  {Sp: Rhesus macaque} 4440
relaxin-1 (B chain)  {Sp: Human} 3743 H1 relaxin (B chain)
relaxin-3 (B chain)  {Sp: Human} 1997 H3 relaxin (B chain), insulin-like peptide INSL7
relaxin (B chain)  {Sp: Human} 3745 H2 relaxin (B chain)
relaxin B chain  {Sp: Pig} 4439
relaxin B chain  {Sp: Rat} 4437
relaxin B chain  {Sp: Rhesus macaque} 4441
relaxin-3 B chain dimer 8337
[125I]relaxin-3-B/INSL5 A chimera Ligand is labelled Ligand is radioactive 3789 [125I]H3-B/INSL5 A chimera
[125I]relaxin-3 (human) Ligand is labelled Ligand is radioactive 1999 [125I]H3-relaxin (human)
[125I]relaxin (human) Ligand is labelled Ligand is radioactive 5398 [125I]H2 relaxin
[33P]relaxin (human) Ligand is labelled Ligand is radioactive 1991 [33P]H2 relaxin (human), [33P]Human gene 2 relaxin
reltecimod 13721 AB 103, AB103, p2TA
RES7011 3911 RES 701-1, RES-701-1
resokine 8736 aTyr 1920, HisRSN4, HRS(1-60)
retatrutide 13769 LY-3437943, LY3437943, Triple G
retinoblastoma-associated protein  {Sp: Human} 5253 Rb, pRb, retinoblastoma cell cycle regulation protein
RF9 1486 1-Adamantanecarbonyl-RF-NH2
[125I]26RFa (human) Ligand is labelled Ligand is radioactive 10253
RFRP-1  {Sp: Human} 5340 neuropeptide RFRP-1
RFRP-2  {Sp: Human} 5373 neuropeptide RFRP-2
RFRP-3  {Sp: Human} 4016 neuropeptide RFRP-3, NPVF
RgIA4 9472
R5-HIV-1 gp120 3910
Rhodei-litorin 6165 rohdeilitorin
Rho GDP dissociation inhibitor beta  {Sp: Human} 5174 D4-GDI, Rho GDP-dissociation inhibitor 2, Rho-GDI 2, Rho-GDI beta
rho-TIA 507 ρ-TIA, ρ-TIA conotoxin, 19-amino acid conopeptide, rho-conotoxin TIA
RhTx 12544 Tau-scoloptoxin04-Sm1a
ΔR3/I5 11916
R3/I5 1998 H3 relaxin B-chain/INSL5 A-chain chimera, H3 relaxin/INSL5 chimera, H3-B/INSL5 A chimera
ribaxamase 14218 P3A, SYN-004
ribosomal protein S19  {Sp: Human} 3728 RP-S19, RPS19, S19 ribosomal protein
ribosomal protein S6  {Sp: Human} 5256 40S ribosomal protein S6, phosphoprotein NP33, rpS6
rilonacept Approved drug Immunopharmacology Ligand 6790 Arcalyst®, IL-1 Trap, interleukin-1 Trap
R3/I5- SmBiT Ligand is labelled 11911
risuteganib 14194 ALG-1001, ALG1001, Luminate®
RLF-(A11-B10)-isopeptide amideA26 (xA11-B10) 11922
Ro 25-1392 2276 Ac-His1[Glu8,OCH3-Tyr10,Lys12,Nle17,Ala19,Asp25,Leu26,Lys27,28]VIP, Ro 251392, Ro251392
Ro 25-1553 2259 Ac-His1[Glu8,Lys12,Nle17,Ala19,Asp25,Leu26,Lys27,28,Gly29,30,Thr31]VIP-NH2(cyclo 21-25), Ro 251553, Ro-251553
romiplostim Approved drug Immunopharmacology Ligand 6974 MG531, Nplate®
rotigaptide 9214 Dipeptide 9f [PMID 19175320], GAP-486, ZP-123
R2R01 14150
RSLV-132 Immunopharmacology Ligand 10412 RSLV132
R-spondin-1  {Sp: Human} 3697 hRspo1, roof plate-specific spondin-1
R-spondin-2  {Sp: Human} 3698 hRspo2, Roof plate-specific spondin-2
R-spondin-3  {Sp: Human} 3699 hPWTSR, hRspo3, Roof plate-specific spondin-3
R-spondin-4  {Sp: Human} 3700 hRspo4, roof plate-specific spondin-4
R-spondin-1  {Sp: Mouse} 5539 cristin-3, cysteine-rich and single thrombospondin domain-containing protein 3, mCristin-3, roof plate-specific spondin-1
R-spondin-2  {Sp: Mouse} 5540 cristin-2, cysteine-rich and single thrombospondin domain-containing protein 2, mCristin-2, roof plate-specific spondin-2
R-spondin-3  {Sp: Mouse} 5541 cristin-1, nucleopondin, roof plate-specific spondin-3
R-spondin-4  {Sp: Mouse} 4383 cristin-4, cysteine-rich and single thrombospondin domain-containing protein 4, mCristin-4, roof plate-specific spondin-4
 
S Back to top
S36057 1294 S 36057, S-36057
S36077 1295 S 36077, S-36077
S36539 1308 S 36539, S-36539
S36540 1309 S 36540, S-36540
S36541 1310 S 36541, S-36541
S38151 1311 p-guanidinobenzoyl-[Des-Gly10]-MCH(7-17), S 38151, S-38151
[125I]S36057 Ligand is labelled Ligand is radioactive 1317
SAAP-148 13873 P148
sANP 5053 natriuretic peptide receptor/guanylyl cyclase A-selective agonist type A naturetic peptide (G9T, R11S, G16R)
sarafotoxin S6b 995
[125I]sarafotoxin S6b Ligand is labelled Ligand is radioactive 993
sarafotoxin S6c 1008 S6C, Sarafotoxin-C, SRTX-C
[Sar1,Ala8]Ang-II 6915
saralasin 598 P-113
[125I][Sar1]Ang-II Ligand is labelled Ligand is radioactive 6897
[Sar1,Cha4]Ang-II 6903
[Sar1,Cha8]Ang-II 6904
[125I][Sar1, D-Ala8]Ang II Ligand is labelled Ligand is radioactive 12299 125I-Sarcosine1, D-Alanine8-Angiotensin II
[Sar1, D-Ala12]galanin(1-16) 6082 [Sar1, D-Ala12]Gal(1-16), AR-M961
[Sar,D-Phe8,des-Arg9]bradykinin 643 [N-methylglycine,D-Phe8,des-Arg9]bradykinin, [sarcosine,D-Phe8,des-Arg9]bradykinin, Sar[DPhe8][des-Arg9]BK
[Sar1,Gly4,Gly8]Ang-II 6916
sargramostim Approved drug 7905 Leukine®
[Sar1,Ile8]Ang-II 6905
[125I][Sar1,Ile8]Ang-II Ligand is labelled Ligand is radioactive 6906
[Sar1,Ile4,Ile8]Ang-II 6914
[Sar9,Met(O2)11]SP 3850 [Sar9,Met(O2)11]substance P, [Sar9]substance P sulfone
SA10SC-RLX 12501
sauvagine 918
[125I]sauvagine (frog) Ligand is labelled Ligand is radioactive 916
sBmTX 3 2584 sBmTX3-delYP
SC-67655 Immunopharmacology Ligand 8889
(R)-SCH-23390 14202 (R)-SCH23390
sCKβ8-1 6251 CKβ8-1 (46-137)
sclerostin  {Sp: Human} 3704 SOST
α-scorpion toxin 2 2618 α-mammal toxin Lqh2, Lqh II, LqhII, LqTx-2
β-scorpion toxin Cn2 2632 β-mammal toxin Cn2, Toxin 2, Toxin II.9.2.2
β-scorpion toxin Css IV 2620 β-mammal toxin Css4, Css IV
β-scorpion toxin TiTXγ 2627 β-mammal/insect toxin Ts7, Tityustoxin VII, TsTX-VII
ScTx1 2576 κ-theraphotoxin-Sc1a, κ-TRTX-Sc1a, stromatoxin-1
SDF1 P2G 8536
SDF-1, 1-9[P2G] dimer 851 stromal cell-derived factor-1, N-terminal fragment analogue dimer
SE301 14149 SE-301
sea anemone toxin BDS-I 2578 antihypertensive protein BDS-1, blood depressing substance 1 (BDS-1)
secretin  {Sp: Human} Approved drug 3643 ChiRhoStim®, secretin synthetic human
secretin  {Sp: Mouse} 3644
secretin  {Sp: Pig} 1155
secretin  {Sp: Rat} 2943
secretin-(5-27) (pig) 1156 secretin5-27 (porcine)
[125I]secretin (pig) Ligand is labelled Ligand is radioactive 1153
seglitide 2051 MK 678, MK-678, MK678
selectin P ligand  {Sp: Human} Immunopharmacology Ligand 10014
selepressin 11454 FE202158
semaglutide Approved drug 9724 Kayshild®, NN-9535, NN9535, NNC0480 0389, Ozempic® (injectable semaglutide), Rybelsus® (oral semaglutide), Wegovy®
semaphorin 3A  {Sp: Human} Immunopharmacology Ligand 9902
senktide 2127 suc[Asp6,MePhe3]SP(6-11), suc[Asp6,MePhe3]SP(6-11))
[3H]senktide Ligand is labelled Ligand is radioactive 3834 [3H]-senktide
septide 2095 [pGlu6,Pro9]substance P
seractide acetate Approved drug 6966
[Ser8]GnRH 1171 seabream GnRH
sermorelin Approved drug 6998 Geref®, sermorelin acetate
[Ser11](N-CNP,C-ANP)pBNP2-15 4853 P18
serum amyloid A  {Sp: Human} 6242 SAA
setmelanotide Approved drug 9272 BIM-22493, Imcivree®, IRC-022493, RM-493
SFKN-NH2 11226 NPS(1-4)NH2, peptide 3 [PMID: 28267583], PEPTIDE1{S.F.R.N.[am]}$$$$
SFKN-NH2 13997
SFLLRN-NH2 5361
sFRP-1  {Sp: Human} 3691 SARP-2, secreted apoptosis-related protein 2
sFRP-2  {Sp: Human} 3692 SARP-1, secreted apoptosis-related protein 1
sFRP-3  {Sp: Human} 3693 Frezzled, Frizzled-related protein 1, secreted Frizzled-related protein 3
sFRP-4  {Sp: Human} 3694 frizzled protein, human endometrium (FrpHE)
sFRP-5  {Sp: Human} 3695 Frizzled-related protein 1b (FRP-1b), secreted apoptosis-related protein 3 (SARP-3)
SGTx1 7761 κ-theraphotoxin-Scg1a, κ-TRTX-Scg1a, toxin SGTx1
SHAAGtide 6275
ShK(L5) 2557 ShK-170
ShK Toxin 2549 potassium channel toxin ShK, Stichodactyla helianthus toxin
SHU9119 1325 (Ac-cyclo-[Nle4Asp5,D-Nal(2)7,Lys10]α-MSH-(4-10)-NH2), SHU 9119, SHU-9119
[125I]SHU9119 Ligand is labelled Ligand is radioactive 3804 [125I]-SHU9119
siamycin I 14232 Siamycin-I
SI5α-b 11604
SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate 5634
SiFA-Asn(AcNH-β-Glc)-Tyr3-octreotate 5633
SKF-105494 2229 SK&F-105494, SKF 105494
SLIGKV-NH2 3740
SLIGRL-NH2 3741
slotoxin 2310 Potassium channel toxin α-KTx 1.11, SloTx
SNG001 Immunopharmacology Ligand 11129
SNX482 4315 SNX-482, toxin SNX-482
somatrogon Approved drug 12013 hGH-CTP, MOD-4023, MOD4023, Ngenla®, somatrogon-ghla
sonefpeglutide 14554
soralimixin 14372 BRII-693, F365, QPX9003
SOR-C13 12562
sovateltide Approved drug 3886 IRL 1620, IRL-1620, IRL2620, PMZ-1620, SPI-1620, Suc[Glu9,Ala11,15]ET-110-21, Tycamzzi®
SPAG11B (61-103)  {Sp: Human} 10542
spantide I 2096 [Arg1,Trp7,9,Leu11]substance P, [D-Arg1,D-Trp7,9,Leu11]-Substance P
spantide II 2097
spexin-1  {Sp: Human} 11417
[125I]spexin-1 Ligand is labelled Ligand is radioactive 11418
[125I]SP (human, mouse, rat) Ligand is labelled Ligand is radioactive 3805 [125I]-SP, [125I]-substance P
[3H]SP (human, mouse, rat) Ligand is labelled Ligand is radioactive 3835 [3H]-SP, [3H]-substance P
spinorphin  {Sp: Human} 1026 LVVYPWT
SPR741 13250 NAB741
SQ007-5 8379
s-RhTx 12546
SRIF-14  {Sp: Human, Mouse, Rat} 2019 somatostatin-14, SS14, SST-14
SRIF-28  {Sp: Human, Mouse, Rat} 2020 somatostatin 1-28, SST-28
SsmTx-1 7764
sst3-ODN-8 2077 carbamoyl-des-AA1,2,4,5,12,13[d-Cys3,Tyr7,d-Agl8(Me,2-naphthoyl)]-somatostatin-14
[125I]Sta Ligand is labelled Ligand is radioactive 4850 [125I]-Sta
stem cell factor  {Sp: Human} Immunopharmacology Ligand 5055 SCF, c-Kit ligand
STM 434 8991
substance P  {Sp: Human, Mouse, Rat} 2098 SP
substance P-(4-11) 2099 substance P(4-11)
substance P-(6-11) 2100 substance P(6-11)
substance P-OMe 2101 SPME, SPOMe, substance P methylester
surotomycin 14281 CB-183,315, MK-4261
survodutide 13383 BI 456906, BI456906
SVEP1  {Sp: Human} 12044 polydom
sviceucin 14264 SSV-2083
 
T Back to top
T134 852
T140 853 [L-3-(2-naphthyl)-alanine3]-T134
T22 854 [Tyr5,12,Lys7]-polyphemusin II
tadekinig alfa Immunopharmacology Ligand 10077
TAK 044 3913 TAK-044, TAK044
TAK-448 10222 analogue 24 [PMID: 27589480], RVT-602, TAK448
taliglucerase alfa Approved drug 7444 Elelyso®, PRGCD
tamapin 2319 potassium channel toxin α-KTx 5.4
TamRLX Ligand is labelled 11462
taspoglutide 13315 BIM51077, ITM077, R1583
tatM2NX 11080 tat-M2NX
[tBaa1,D-Tyr(Et)2,Val4,Lys6,Arg-NH28,des-Gly9]AVP 2212
t-Boc-FLFLF 1030
t-Boc-Met-Leu-Phe 1029 tert-butoxycarbonyl (t-Boc) Met-Leu-Phe peptide
[tBu-D-Gly5]NPS 5812
[tBu-D-Gly5]NPS 12489
TC14012 Immunopharmacology Ligand 2902 TC 14012, TC-14012
T20(DP178) 5838 T20(DP178) [HIV-1 gp41 derived peptide]
T21/DP107 6245
teduglutide Approved drug Immunopharmacology Ligand 7049 ALX-0600, Gattex®, GLP2-2G, Revestive®
telitacicept Approved drug Immunopharmacology Ligand 11827 RC-18, RC18, Tai'ai®
teriparatide Approved drug 4448 Forsteo®, Forteo®, PTH-(1-34) (human)
terlipressin Approved drug 11241 glycyl-glycyl-glycyl-L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide (4->9)-disulfide, Glypressin®, N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin, Terlivaz®, Variquel®
tertiapin-Q 2383 TPN(Q)
[125I]tertiapin Y1/K12/Q13 Ligand is labelled Ligand is radioactive 2382
tesamorelin Approved drug 6959 (3E)-hex-3-enoylsomatoliberin, Egrifta®, TH9507
tethered chemerin 9 Immunopharmacology Ligand 9784
β3-tetrapeptide 2078
TFLLR-NH2 3742 PEPTIDE1{T.F.L.L.R.[am]}$$$$, Thr-Phe-Leu-Leu-Arg-amide
TFRGAP-NH2 5360
TG-0205221 PDB Ligand 11176 Cbz-Thr(tBu)-Cha-Ala(((S)-2-oxopyrrolidin-3-yl))-ol, N-benzyloxycarbonyl-O3-tert-butyl-L-threonyl-3-cyclohexyl-L-alanyl-3-((S)-2-oxopyrrolidin-3-yl)-L-alaninol, TG0205221
TGFα  {Sp: Human} 5059 EGF-like TGF, ETGF, TGF type 1, transforming growth factor-α
TGFβ1  {Sp: Human} Immunopharmacology Ligand 5060 TGF-beta-1, transforming growth factor beta-1
TGFβ2  {Sp: Human} 5061 cetermin, glioblastoma-derived T-cell suppressor factor (G-TSF), polyergin, TGF-beta-2, transforming growth factor beta-2
TGFβ3  {Sp: Human} 5062 TGF-beta-3, transforming growth factor beta-3
THG213.29 5860
[Thi5,8,D-Phe7]bradykinin 678
Thr10contulakin-G 1573
[Thr4,Gly7]OT 2179 [Thr4,Gly7]oxytocin
thrombin  {Sp: Human} 4453
thrombin  {Sp: Mouse} 4456
thrombin  {Sp: Rat} 4459
thrombin heavy chain  {Sp: Human} 4452 thrombin B chain
thrombin heavy chain  {Sp: Mouse} 4455 thrombin B chain (mouse)
thrombin heavy chain  {Sp: Rat} 4458 thrombin B chain (rat)
thrombin light chain  {Sp: Human} 4451 thrombin A chain
thrombin light chain  {Sp: Mouse} 4454 thrombin A chain (mouse)
thrombin light chain  {Sp: Rat} 4457 thrombin A chain (rat)
thrombopoietin  {Sp: Human} 5063
thrombospondin 1  {Sp: Human} Immunopharmacology Ligand 13047 THBS-1, TSP-1, TSP1
thymic stromal lymphopoietin  {Sp: Human} Immunopharmacology Ligand 5083 TSLP
TIMP1  {Sp: Human} 5309 fibroblast collagenase inhibitor, metalloproteinase inhibitor 1
TIMP2  {Sp: Human} 5310 CSC-21K, TIMP-2
TIMP3  {Sp: Human} 5311 MIG-5
TIMP4  {Sp: Human} 5312 TIMP-4
timtraxanib 11673 AVI-3207, AVI3207, N2-acetyl-L-arginyl-L-leucyl-L-tyrosyl-L-glutamic acid
TIP39  {Sp: Human, Bovine} 1815 human/bovine tuberoinfundibular peptide
TIP39  {Sp: Mouse, Rat} 3624 tuberoinfundibular peptide
TIP39-(3-39) (human/bovine) 1816 human/bovine tuberoinfundibular peptide 3-39
TIP39-(7-39) (human/bovine) 1827 human/bovine tuberoinfundibular peptide 7-39
TIP39-(9-39) (human/bovine) 1818 human/bovine tuberoinfundibular peptide 9-39
TIP39-(7-39) (mouse) 1828 mouse tuberoinfundibular peptide 7-39
tirzepatide Approved drug 11429 LY-3298176, LY3298176, Mounjaro®, Zepbound®
tissue factor pathway inhibitor  {Sp: Human} 11181
T20K 13239
TK-HR peptide 13042 tachykinin-HR
T-kinin  {Sp: Human, Rat} 639 [Ile,Ser]bradykinin, Ile-Ser-BK
TL6  {Sp: Human} Immunopharmacology Ligand 5072 activation-inducible TNF-related ligand, glucocorticoid- induced TNF-related ligand
TL1A  {Sp: Human} Immunopharmacology Ligand 5071 Tumor necrosis factor ligand superfamily member 15, membrane form
TLQP-21  {Sp: Human} 12220 TLQP21, TLQPPASSRRRHFHHALPPAR, VGF-derived peptide TLQP-21
tolyacetyl-c[DCys-Apa-DTrp-Orn-Val-Cys]-His-amide 2166
toxin BmP09 2306 B. martensi Karsch toxin, beta-toxin BmKAs1, BmK activator of skeletal-muscle ryanodine receptor
TP0556351 12057 compound 9 [PMID: 35687819], TP-0556351
TP508 9284 Chrysalin
TRAIL  {Sp: Human} 5065 Apo-2 ligand (Apo-2L)
trans-cinnamoyl-LIGRLO [N-[3H]propionyl]-NH2 Ligand is labelled Ligand is radioactive 3914
trebananib 8414 2xCon4[C], AMG-386, TN8-Con4
TRH  {Sp: Human, Mouse, Rat} Approved drug 2139 thyroliberin
[3H]TRH (human, mouse, rat) Ligand is labelled Ligand is radioactive 3836 [3H]-thyrotropin-releasing hormone, [3H]-TRH
Tri-DAP 9507 L-Ala-γ-D-Glu-mDAP
[125I]triptorelin Ligand is labelled Ligand is radioactive 1168 [125I][D-Trp6]GnRH
triptorelin Approved drug 1177 CL 118532, CL-118532, Decapeptyl®, Pamorelin®, Trelstar®, Triptodur®
trofinetide Approved drug 12482 ACP-2566, analogue 4 [PMID: 15837309], Daybue®, glycyl-alpha-methyl-L-prolyl-L-glutamic acid, NNZ-2566, NNZ2566
[Trp7, β-Ala8] neurokinin A-(4-10) 5782
[Trp8]GnRH 1172 frog GnRH
Trp11-neurotensin 1585
[Trp23]PTHrP-(1-36) (human) 1809
trptorelix-1 3916 Trp-1
[Trp23,Tyr36]PTHrP-(1-36)-NH2 (human) 1808
TRV023 11943 TRV 023, TRV-023
TRV026 11944 TRV 026, TRV-026
TRV027 6902 TRV 120027, TRV-027, TRV-120027, TRV120027
TSH  {Sp: Human} Approved drug 3920 Thyrogen®, thyroid-stimulating hormone, thyrotropin
TSH  {Sp: Mouse} 4393 thyroid-stimulating hormone, thyrotropin
TSH  {Sp: Rat} 4395 thyroid-stimulating hormone, thyrotropin
[125I]TSH (human) Ligand is labelled Ligand is radioactive 3806 [125I]-thyroid-stimulating hormone, [125I]-thyrotropin, [125I]-TSH
TSH β subunit  {Sp: Human} 3734 thyroid stimulating hormone beta, thyroid-stimulating hormone subunit beta, thyrotropin beta chain, thyrotropin subunit beta, TSH beta subunit, TSH-B, TSH-beta, TSHB
TSH β subunit  {Sp: Mouse} 4392 thyrotropin subunit beta, TSH beta subunit, TSHβ, TSH-B
TSH β subunit  {Sp: Rat} 4394 TSH beta subunit, TSHβ, TSHB
tumour necrosis factor membrane form  {Sp: Human} Immunopharmacology Ligand 5073 TNF membrane form, cachectin, necrosin, TNFα
tumour necrosis factor shed form  {Sp: Human} Immunopharmacology Ligand 5074 TNF shed form, cachectin, necrosin, TNF alpha soluble form, tumor necrosis factor soluble form
TWEAK  {Sp: Human} 5067 Apo-3 ligand (Apo3L), CD255, TNF-related weak inducer of apoptosis, Tumor necrosis factor ligand superfamily member 12, membrane form
[125I]Tyr-Ala-hexarelin Ligand is labelled Ligand is radioactive 1095
[125I][Tyr4]bombesin Ligand is labelled Ligand is radioactive 623 [125I-Tyr4]BN
[125I][Tyr8]bradykinin Ligand is labelled Ligand is radioactive 3765 [125I]-[Tyr8]-bradykinin, [125I]-[Tyr8]BK, [125I][Tyr8]BK
[Tyr8]bradykinin 671 [Tyr8]BK
Tyr0α-CGRP (human) 692 Tyr0α-calcitonin gene-related peptide (human)
[125I]Tyr0-CRF (human, rat, mouse) Ligand is labelled Ligand is radioactive 914 [125I]-Tyr0-corticotropin
[125I]Tyr10-CST14 Ligand is labelled Ligand is radioactive 2024 [125I]-[Tyr10]CST-14, [125I]Tyr10-cortistatin14
[125I][Tyr5,DAla6,NMeLeu7,Pro9-NEt]GnRH Ligand is labelled Ligand is radioactive 1165
[125I][Tyr11]des-Br-NPB-23 Ligand is labelled Ligand is radioactive 1498 [125I][Tyr11]des-Br-neuropeptide B-23
[125I]Tyr4-des-octanoyl-ghrelin Ligand is labelled Ligand is radioactive 3810 [125I]-Tyr4-des-octanoyl-ghrelin
[125I][Tyr26]galanin (human) Ligand is labelled Ligand is radioactive 5391 [125I]-[Tyr26]galanin
[125I][Tyr26]galanin (pig) Ligand is labelled Ligand is radioactive 6117
[125I][Tyr26]galanin (rat/mouse) Ligand is labelled Ligand is radioactive 5390 [125I]-[Tyr26]galanin
[125I][Tyr4]ghrelin (human) Ligand is labelled Ligand is radioactive 1096 [125I-Tyr4]-ghrelin, [125I-Tyr4]ghrelin
[Tyr34]GLP-2 (human) 1145 human [Tyr34] glucagon-like peptide 2
[Tyr8]GnRH 1173
[125I]Tyr45-kisspeptin-15 Ligand is labelled Ligand is radioactive 1280 [125I-Tyr45]-KP15, [125I-Tyr45]kisspeptin-15, [125I-Tyr45]KP-15
[3H]Tyr14-N/OFQ Ligand is labelled Ligand is radioactive 1687 [3H]14-Tyr-N/OFQ, [3H]14-Tyr-nociceptin, [3H]14-Tyr-nociceptin/orphanin FQ, [3H]14-Tyr-orphanin FQ
[125I]Tyr10NPS (human) Ligand is labelled Ligand is radioactive 1493 human [125I]Tyr10-neuropeptide S
Tyr3-octreotide 5649 SMS 204,090, TOC, Tyr3-SMS 201,995
[Tyr34]PTH-(1-34) (human) 1810
[Tyr34]PTH-(1-34)-NH2 (human) 1811
[Tyr34]PTH-(3-34)-NH2 (human) 1812 [Tyr34]-PTH 3-34-NH2
[Tyr36]-PTHrP-(1-36) amide (human) 1813 [Tyr36]-PTHrP 1-36 amide
[125I]Tyr0-sauvagine Ligand is labelled Ligand is radioactive 5389 [125I]-Tyr0-sauvagine
[125I](Tyr10)secretin-27 (rat) Ligand is labelled Ligand is radioactive 3759 [125I]-(Tyr10)secretin
[125I]Tyr3 SMS 201-995 Ligand is labelled Ligand is radioactive 2062 [125I][Tyr3]octreotide
[125I]Tyr11-SRIF-14 Ligand is labelled Ligand is radioactive 2060 [125I]Tyr11-SS-14
[125I]Tyr7-Sst3-ODN-8 Ligand is labelled Ligand is radioactive 2075
[125I][Tyr3,Thr8]octreotide Ligand is labelled Ligand is radioactive 5630 [125I]-TOCA, [125I]-Tyr3-octreotate
 
U Back to top
ubonodin 14235
UFP-101 1694 [Nphe1,Arg14,Lys15]N/OFQ-NH2, [Nphe1,Arg14,Lys15]nociceptin-NH2, UFP 101, UFP101
UFP-102 1685 [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2, UFP 102, UFP102
UFP-112 3917 [(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2, UFP 112, UFP112
Ugr 9-1 11475 π-AnmTX Ugr 9a-1
[125I]U-II (human) Ligand is labelled Ligand is radioactive 2158 human [125I-Tyr9] urotensin-II, human [125I] urotensin-II
U-II-(4-11) (human) 2152 human urotensin-II (4-11)
ularitide 8446 ESP-305
ulinastatin  {Sp: Human} Approved drug Immunopharmacology Ligand 10359 Miraclid®, Ulinase®, Urinastatin®
uPar fragment 6249 D2D388-274, uPAR(88-274)
urantide 2167 [Pen5,DTrp7,Orn8]U-II (4-11) (human)
urocortin 1  {Sp: Human} 919 UCN
urocortin 2  {Sp: Human} 921 urocortin II
urocortin 3  {Sp: Human} 928 JNJ-39588146, JNJ-9588146, RT-400, stresscopin
urocortin 2  {Sp: Mouse} 927
urocortin 1  {Sp: Mouse, Rat} 920
urocortin 3  {Sp: Mouse, Rat} 929
urocortin 2  {Sp: Rat} 3545
[125I]urocortin 1 (mouse, rat) Ligand is labelled Ligand is radioactive 917
uroguanylin  {Sp: Human} 5084
Urolinin 9441
urotensin 1 (fish) 922
urotensin-II  {Sp: Human} 2153 U-II
urotensin-II  {Sp: Mouse} 2154 U-II
urotensin-II  {Sp: Rat} 2155 U-II
urotensin II-related peptide  {Sp: Human, Mouse, Rat} 2156 URP, urotensin-related peptide
 
V Back to top
[Val4]AVP 2180 VDAVP, 4-Val-argipressin
valspodar 11745 3'-keto-Bmt(1)-Val(2)-cyclosporin A, Amdray®, PSC-833, PSC833, SDZ PSC 833, SDZ PSC833, SDZ-PSC-833
vanillotoxin-1 5542 tau/kappa-theraphotoxin-Pc1a, tau/kappa-TRTX-Pc1a, VaTx1
vanillotoxin-2 5543 tau-theraphotoxin-Pc1b, tau-TRTX-Pc2a, VaTx2
vanillotoxin-3 5544 tau-theraphotoxin-Pc1c, tau-TRTX-Pc1c, VaTx3
vapreotide Approved drug 2054 BMY 41606, CCRIS 6495, RC 160, RC-160, Sanvar®, vapreotide acetate
variant MCH 1302 variant melanin-concentraing hormone
vascular cell adhesion protein 1  {Sp: Human} 6758 VCAM-1, CD_antigen=CD106, INCAM-100, V-CAM 1
vasopressin  {Sp: Human, Mouse, Rat} Approved drug 2168 AVP, ADH, antidiuretic hormone, arginine vasopressin, argipressin
vCCL4 774 viral CCL4
vCXCL1 8496
VEGFA  {Sp: Human} 5085 vascular endothelial growth factor A, vascular permeability factor (VPF), VEGF-A
VEGFB  {Sp: Human} 5086 VEGF-B, VEGF-related factor
VEGFC  {Sp: Human} 5087 Flt4 ligand (Flt4-L), vascular endothelial growth factor-related protein, VEGF-C
VEGFD  {Sp: Human} 5088 c-fos induced growth factor, FIGF
VEGFE  {Sp: Human} 5089 fallotein, PDGF-C, PDGFC, spinal cord-derived growth factor, VEGF-E
velaglucerase alfa Approved drug 7464 EC 3.2.1.45, VPRIV®
veldoreotide 8487 COR-005, DG3173, PTR-3173, somatoprim
VIP  {Sp: Human, Mouse, Rat} Immunopharmacology Ligand 1152
[125I]VIP (human, mouse, rat) Ligand is labelled Ligand is radioactive 2277 [125I]-VIP, [125I]vasoactive intestinal peptide
vitronectin  {Sp: Human} 6746 VN, S-protein, serum-spreading factor, V75
vitronectin V10 subunit  {Sp: Human} 6748
vitronectin V65 subunit  {Sp: Human} 6747
Vm24 Immunopharmacology Ligand 10050 α-KTx 23.1
vMCC-I 816 MCV MC148R
vMIP-I 815 HHV8 vMIP-I, viral macrophage inflammatory protein
vMIP-II 768 vMIP-II, viral macrophage inflammatory protein-II
vMIP-III 4359 HHV8 vMIP-III, KSHV vMIP-III
voclosporin Approved drug Immunopharmacology Ligand 11388 1,11-anhydro[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl- N-methyl-L-valyl-[(2S,3R,4R,6E)-3-hydroxy-4-methyl- 2-(methylamino)nona-6,8-dienoyl][(2S)-2-aminobutanoyl]- N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine], E-ISA247, ISA(TX)247, ISA-247, ISA247, ISATX247, Lupkynis®, R 1524, R-1524, R1524
von Willebrand factor  {Sp: Human} Approved drug 6755 Vonvendi®, vWF
vosoritide Approved drug 9068 BMN 111, BMN-111, Voxzogo®
V3 peptide 6248
 
W Back to top
waglerin-1 3984
wFw-Isn-NH2 5869
WKYMVm Immunopharmacology Ligand 1048 Trp-Lys-Tyr-Met-Val-[D]Met, WKYMVM
Wnt-1  {Sp: Human} 3672
Wnt-11  {Sp: Human} 3689 protein Wnt-11
Wnt-16  {Sp: Human} 3690 protein Wnt-16
Wnt-2  {Sp: Human} 3673 Int-1-like protein 1, Int-1-related protein
Wnt-3  {Sp: Human} 3675
Wnt-4  {Sp: Human} 3547 protein Wnt-4
Wnt-6  {Sp: Human} 3678 protein Wnt-6, WNT6
Wnt-10a  {Sp: Human} 3687 protein Wnt-10a
Wnt-3a  {Sp: Human} 3549 protein Wnt-3a
Wnt-5a  {Sp: Human} 3548 protein Wnt-5a
Wnt-7a  {Sp: Human} 3679 protein Wnt-7a
Wnt-8a  {Sp: Human} 3682 protein Wnt-8d
Wnt-9a  {Sp: Human} 3684 WNT-14
Wnt-10b  {Sp: Human} 3688 WNT-12, WNT10B
Wnt-2b  {Sp: Human} 3674 protein Wnt-13, protein Wnt-2b, WNT-13
Wnt-5b  {Sp: Human} 3676
Wnt-7b  {Sp: Human} 3681 protein Wnt-7b
Wnt-8b  {Sp: Human} 3683
Wnt-9b  {Sp: Human} 3686 WNT-14b, WNT-15
Wnt-inhibitory factor  {Sp: Human} 5372 WIF-1, wnt inhibitory factor 1
WRWWWW Immunopharmacology Ligand 1040 WRW4
WWGKKYRASKLGLAR 5760
 
X Back to top
XCL1  {Sp: Human} Immunopharmacology Ligand 3647 c motif cytokine 1, cytokine SCM-1α, lymphotactin α
XCL2  {Sp: Human} Immunopharmacology Ligand 4370 C motif cytokine 2, lymphotactin β
XCL1  {Sp: Mouse} Immunopharmacology Ligand 4447 lymphotactin-α
XCL1  {Sp: Rat} Immunopharmacology Ligand 4446 lymphotactin-α
[125I]XCL1 (human) Ligand is labelled Ligand is radioactive 857 [125I]ATAC, [125I]lymphotactin, [125I]SCM-1α
xenin  {Sp: Human, Mouse, Rat} 1587 xenin-25
X4-HIV-1 gp120 3919 X4 human immunodeficiency virus type 1 gp120
XMP-629 14069 XOMA-629
 
Y Back to top
YH35324 Immunopharmacology Ligand 13448 IgETRAP, YH-35324
YJ34 8722
Y-KE88 5641
[125I]Y-RFRP-3 Ligand is labelled Ligand is radioactive 1484 [125I]YVP
Y-RFRP-3 1482 YVP
YSFKPMPLaR 5776 C5a65-74Y65,F67,P69,P71,D-Ala73
 
Z Back to top
Z-Arg-Leu-Val-Agly-Ile-Val-OMe 6534
Z-AVLD-FMK 11712
Z-DEVD-FMK 5294 benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone
Z-DQMD-FMK 5295 benzyloxycarbonyl-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone
Z-FA-FMK Immunopharmacology Ligand 11257 MDL 201053, MDL-201053, MDL201053, Z-Phe-DL-Ala-fluoromethylketone, ZFA-fmk
ziconotide Approved drug 2536 ω-conotoxin MVIIA, Prialt®, SNX-111
Z-IETD-FMK 5296
zilucoplan Approved drug Immunopharmacology Ligand 10404 RA-101495, RA101495, Zilbrysq®
Z-LEHD-FMK 5298 benzyloxycarbonyl-Leu-Glu(OMe)-His-Asp(OMe)-fluoromethylketone
zolucatetide 14191
Z-VDVAD-FMK 5299 benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethylketone
Z-VEID-FMK 5300 benzyloxycarbonyl-Val-Glu(OMe)-Ile-Asp(OMe)-fluoromethylketone
Z-WEHD-FMK 5301 benzyloxycarbonyl-Trp-Glu(OMe)-His-Asp(OMe)-fluoromethylketone
zyklophin 9193
Z-YVAD-FMK 5302 benzyloxycarbonyl-Tyr-Val-Ala-Asp(OMe)-fluoromethylketone, caspase-1 Inhibitor VI
ZZL-7 12316 Ac-Ala-Val-Ome